<!DOCTYPE html>
<html>
<head>

      <meta http-equiv="Content-Type" content="text/html; charset=utf-8">

        <script> var url = encodeURIComponent('https://www.mdpi.com/journal/biomedicines');</script>

        <script> var body_html = '<body> <div > <div > <div > <a > <h2>25th Anniversary</h2> </a> <a > <h2>Journals</h2> </a> <div > <div > <h2>Information</h2> </div> <div > <div > <div > <a >For Authors</a> <a >For Reviewers</a> <a >For Editors</a> <a >For Librarians</a> <a >For Publishers</a> <a >For Societies</a> </div> <div > <a >Article Processing Charges</a> <a >Open Access Policy</a> <a >Institutional Open Access Program</a> <a >Editorial Process</a> <a >Awards</a> <a >Research and Publication Ethics</a> </div> </div> </div> </div> <a > <h2>Author Services</h2> </a> <div > <div > <h2>Initiatives</h2> </div> <div > <div > <div > <a >Sciforum</a> <a >MDPI Books</a> <a >Preprints</a> <a >Scilit</a> <a >SciProfiles</a> <a >Encyclopedia</a> <a >JAMS</a> <a >Proceedings Series</a> </div> </div> </div> </div> <a > <h2>About</h2> </a> </div> <div > <a >Sign In / Sign Up</a> </div> </div> </div> <div > <h2 >Notice</h2> <a > <i >clear</i> </a> </div> <div > <div > <div > <h2 >Notice</h2> <p> You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader. </p> </div> </div> <div > <div > <a >Continue</a> <a >Cancel</a> </div> </div> <a > <i >clear</i> </a> </div> <div > <p> All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. </p> </div> <div > <p> Feature Papers represent the most advanced research with significant potential for high impact in the field. Feature Papers are submitted upon individual invitation or recommendation by the scientific editors and undergo peer review prior to publication. </p> <p> The Feature Paper can be either an original research article, a substantial novel research study that often involves several techniques or approaches, or a comprehensive review paper with concise and precise updates on the latest progress in the field that systematically reviews the most exciting advances in scientific literature. This type of paper provides an outlook on future directions of research or possible applications. </p> </div> <div > <p> Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to authors, or important in this field. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal. </p> </div> <div > <div >  </div> <section > <header> <div > <div > <div > <ul> <li > <a >25th Anniversary</a> </li> <li > <a >Journals</a> </li> <li > <a >Information</a> <ul > <li> <div > <div > <ul> <li> <a >For Authors</a> </li> <li> <a >For Reviewers</a> </li> <li> <a >For Editors</a> </li> <li> <a >For Librarians</a> </li> <li> <a >For Publishers</a> </li> <li> <a >For Societies</a> </li> </ul> </div> <div > <ul> <li> <a >Article Processing Charges</a> </li> <li> <a >Open Access Policy</a> </li> <li> <a >Institutional Open Access Program</a> </li> <li> <a >Editorial Process</a> </li> <li> <a >Awards</a> </li> <li> <a >Research and Publication Ethics</a> </li> </ul> </div> </div> </li> </ul> </li> <li > <a >Author Services</a> </li> <li > <a >Initiatives</a> <ul > <li> <div > <div > <ul> <li> <a > Sciforum </a> </li> <li> <a > MDPI Books </a> </li> <li> <a > Preprints </a> </li> <li> <a > Scilit </a> </li> <li> <a > SciProfiles </a> </li> <li> <a > Encyclopedia </a> </li> <li> <a > JAMS </a> </li> <li> <a > Proceedings Series </a> </li> </ul> </div> </div> </li> </ul> </li> <li > <a >About</a> </li> </ul> </div> <div > <div> <a >Sign In / Sign Up</a> <a >Submit</a> </div> </div> </div> </div> <div > <div > <div > <div > <a > Covered in: PubMed </a> </div></div> <div > <div > <a > IMPACTFACTOR 6.081 </a> </div> </div> </div> <div > Journals </div> <div > Biomedicines </div> </div> </header> <div > <div > <div > <div > <div > <ul > <li> <a > <div > Translational Insights and New Therapeutic Perspectives in Head and Neck Tumors </div> </a> </li> <li > <a > <div > Extracellular Vesicles in Innate Immune Cell Programming </div> </a> </li> <li > <a > <div > The Fight against COVID-19 on the Multi-Protease Front and Surroundings </div> </a> </li> <li > <a > <div > Near-Infrared-Triggered Upconverting Nanoparticles for Biomedicine Applications </div> </a> </li> <li > <a > <div > Zinc Signaling in the Mammary Gland: For Better and for Worse </div> </a> </li> </ul> </div> </div> <div > <div > <h2 >Journal Description</h2> </div> <div > <div > <h1> Biomedicines </h1> <div > Biomedicines is an international, scientific, <a >peer-reviewed</a>, open access journal on biomedicines published monthly online by MDPI. <a >The Society for Regenerative Medicine (Russian Federation) (RPO)</a> is affiliated with Biomedicines and its members receive discounts on the article processing charges. <ul> <li>Open Access— free for readers,with <a >article processing charges (APC)</a> paid by authors or their institutions.</li> <li>High Visibility: indexed within <a >Scopus</a>, <a >SCIE (Web of Science)</a>, <a >PubMed</a>, <a >PMC</a>, <a >CAPlus / SciFinder</a>, and many <a >other databases</a>.</li> <li>Journal Rank: JCR - Q1 (Biochemistry Molecular Biology) / CiteScore - Q2 (General Biochemistry, Genetics and Molecular Biology)</li> <li>Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 16.3 days after submission; acceptance to publication is undertaken in 3.5 days (median values for papers published in this journal in the first half of 2021).</li> <li>Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.</li> <li>Companion journals for Biomedicines include: IJTM and <a >BioMed</a>.</li> </ul> </div> <div > Impact Factor: 6.081 (2020) ; 5-Year Impact Factor: 5.718 (2020) </div> <div> <a > <i >subject</i> Imprint Information </a> <a > <i >get_app</i> Journal Flyer </a> <a > Open Access </a> ISSN: 2227-9059 </div> </div> </div> </div> <div > <div > <h2 >Latest Articles</h2> </div> <div > <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: <a > Supplementary File 1 (ZIP, 6450 KiB) </a> </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: <a >Abstract Page</a> <a >Full-Text HTML</a> </div> </div> <div >Open AccessArticle</div> <a >Regulation of Oncogenic Targets by Tumor-Suppressive <i>miR-150-3p</i> in Lung Squamous Cell Carcinoma</a> <div > by <span ><div >Keiko Mizuno</div>, </span><span ><div >Kengo Tanigawa</div>, </span><span ><div >Shunsuke Misono</div>, </span><span ><div >Takayuki Suetsugu</div>, </span><span ><div >Hiroki Sanada</div>, </span><span ><div >Akifumi Uchida</div>, </span><span ><div >Minami Kawano</div>, </span><span ><div >Kentaro Machida</div>, </span><span ><div >Shunichi Asai</div>, </span><span ><div >Shogo Moriya</div>, </span><span ><div >Hiromasa Inoue</div> and </span><span ><div >Naohiko Seki</div></span> </div> <div > Biomedicines <b>2021</b>, 9(12), 1883; https://doi.org/10.3390/biomedicines9121883 (registering DOI) - 11 Dec 2021 </div> <div > Abstract <div > Several recent studies have shown that both strands of certain miRNAs derived from miRNA duplexes are involved in cancer pathogenesis. Our own recent studies revealed that both strands of the <i>miR-150</i> duplex act as tumor-suppressive miRNAs in lung adenocarcinoma (LUAD) through the targeting [...] Read more. </div> <div > Several recent studies have shown that both strands of certain miRNAs derived from miRNA duplexes are involved in cancer pathogenesis. Our own recent studies revealed that both strands of the <i>miR-150</i> duplex act as tumor-suppressive miRNAs in lung adenocarcinoma (LUAD) through the targeting of several oncogenes. The aim of the study here was to further investigate the tumor-suppressive roles of <i>miR-150-3p</i> (the passenger strand) in lung squamous cell carcinoma (LUSQ) and its control of cancer-promoting genes in LUSQ cells. The downregulation of <i>miR-150-3p</i> in LUSQ tissues was confirmed by data in The Cancer Genome Atlas (TCGA). The ectopic expression of <i>miR-150-3p</i> attenuated cancer cell aggressive features, e.g., cell cycle arrest, migration and invasive abilities. Our target search strategy successfully identified a total of 49 putative targets that were listed as subjects of <i>miR-150-3p</i> regulation in LUSQ cells. Interestingly, among these targets, 17 genes were categorized as related to the “cell cycle” based on Gene Ontology (GO) classification, namely <i>CENPA</i>, <i>CIT</i>, <i>CCNE1</i>, <i>CCNE2</i>, <i>TIMELESS</i>, <i>BUB1</i>, <i>MCM4</i>, <i>HELLS</i>, <i>SKA3</i>, <i>CDCA2</i>, <i>FANCD2</i>, <i>NUF2</i>, <i>E2F2</i>, <i>SUV39H2</i>, <i>CASC5</i>, <i>ZWILCH</i> and <i>CKAP2</i>). Moreover, we show that the expression of <i>HELLS</i> (helicase, lymphoid specific) is directly controlled by <i>miR-150-3p</i>, and its expression promotes the malignant phenotype of LUSQ cells. Full article </div> </div> <div > (This article belongs to the Special Issue MicroRNA in Solid Tumor and Hematological Diseases 2.0) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 178 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Functional Characterization of Spinocerebellar Ataxia Associated Dynorphin A Mutant Peptides <div > by <span ><div >Andreas Lieb</div>, </span><span ><div >Germana Thaler</div>, </span><span ><div >Barbara Fogli</div>, </span><span ><div >Olga Trovato</div>, </span><span ><div >Mitja Amon Posch</div>, </span><span ><div >Teresa Kaserer</div> and </span><span ><div >Luca Zangrandi</div></span> </div> <div > Biomedicines <b>2021</b>, 9(12), 1882; https://doi.org/10.3390/biomedicines9121882 (registering DOI) - 11 Dec 2021 </div> <div > Abstract <div > Mutations in the prodynorphin gene (<i>PDYN</i>) are associated with the development of spinocerebellar ataxia type 23 (SCA23). Pathogenic missense mutations are localized predominantly in the <i>PDYN</i> region coding for the dynorphin A (DynA) neuropeptide and lead to persistently elevated mutant peptide [...] Read more. </div> <div > Mutations in the prodynorphin gene (<i>PDYN</i>) are associated with the development of spinocerebellar ataxia type 23 (SCA23). Pathogenic missense mutations are localized predominantly in the <i>PDYN</i> region coding for the dynorphin A (DynA) neuropeptide and lead to persistently elevated mutant peptide levels with neurotoxic properties. The main DynA target in the central nervous system is the kappa opioid receptor (KOR), a member of the G-protein coupled receptor family, which can elicit signaling cascades mediated by G-protein dissociation as well as β-arrestin recruitment. To date, a thorough analysis of the functional profile for the pathogenic SCA23 DynA mutants at KOR is still missing. To elucidate the role of DynA mutants, we used a combination of assays to investigate the differential activation of G-protein subunits and β-arrestin. In addition, we applied molecular modelling techniques to provide a rationale for the underlying mechanism. Our results demonstrate that DynA mutations, associated with a severe ataxic phenotype, decrease potency of KOR activation, both for G-protein dissociation as well as β-arrestin recruitment. Molecular modelling suggests that this loss of function is due to disruption of critical interactions between DynA and the receptor. In conclusion, this study advances our understanding of KOR signal transduction upon DynA wild type or mutant peptide binding. Full article </div> </div> <div > (This article belongs to the Special Issue Neuropeptides in Biomedicines) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page </div> </div> <div >Open AccessArticle</div> Low-Dose Niacin Supplementation Improves Motor Function in US Veterans with Parkinson’s Disease: A Single-Center, Randomized, Placebo-Controlled Trial <div > by <span ><div >Chandramohan Wakade</div>, </span><span ><div >Raymond Chong</div>, </span><span ><div >Marissa Seamon</div>, </span><span ><div >Sharad Purohit</div>, </span><span ><div >Banabihari Giri</div> and </span><span ><div >John C. Morgan</div></span> </div> <div > Biomedicines <b>2021</b>, 9(12), 1881; https://doi.org/10.3390/biomedicines9121881 (registering DOI) - 10 Dec 2021 </div> <div > Abstract <div > A six-month double-blind, placebo-controlled randomized study was conducted to ascertain whether low-dose daily niacin supplementation would improve motor symptoms in Parkinson’s disease (PD) patients. A total of 47 PD patients were assigned to receive low-dose niacin or a placebo. At the end of [...] Read more. </div> <div > A six-month double-blind, placebo-controlled randomized study was conducted to ascertain whether low-dose daily niacin supplementation would improve motor symptoms in Parkinson’s disease (PD) patients. A total of 47 PD patients were assigned to receive low-dose niacin or a placebo. At the end of the double-blind phase, all participants received open-label niacin for the next six months. All patients were evaluated at baseline, after six months, and after one year of treatment. The primary outcome measure was the Unified Parkinson’s Disease Rating Scale III (UPDRS III) scores. Secondary outcome measures were depression, sleep quality, mental flexibility and cognition, and physical fatigue. Niacin treatment was well-tolerated by forty-five subjects. The mean [95% CI] change in UPDRS III scores at six months of placebo was −0.05 [95% CI, −2.4 to 2.32], and niacin was −1.06 [95% CI, −3.68 to 1.57]. From six to twelve months when both groups received open-label niacin supplementation, the average UPDRS III scores significantly decreased for the placebo group by 4.58 [95% CI, −0.85 to 8.30] and the niacin group by 4.63 [95% CI, 1.42 to 7.83] points. Low-dose niacin supplementation is a well-tolerated adjunct therapy and may improve motor function in PD when taken over a longer period. Full article </div> </div> <div > (This article belongs to the Special Issue Biomarkers in Neurodegenerative Diseases 2.0) </div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page </div> </div> <div >Open AccessArticle</div> The Neuropeptide VIP Limits Human Osteoclastogenesis:Clinical Associations with Bone Metabolism Markers in Patients with Early Arthritis <div > by <span ><div >David Castro-Vazquez</div>, </span><span ><div >Amalia Lamana</div>, </span><span ><div >Paula Arribas-Castaño</div>, </span><span ><div >Irene Gutiérrez-Cañas</div>, </span><span ><div >Raúl Villanueva-Romero</div>, </span><span ><div >Selene Pérez-García</div>, </span><span ><div >Carmen Martínez</div>, </span><span ><div >Yasmina Juarranz</div>, </span><span ><div >Sara Fernández de Córdoba</div>, </span><span ><div >Isidoro González-Álvaro</div>, </span><span ><div >Rosa P. Gomariz</div> and </span><span ><div >Mar Carrión</div></span> </div> <div > Biomedicines <b>2021</b>, 9(12), 1880; https://doi.org/10.3390/biomedicines9121880 (registering DOI) - 10 Dec 2021 </div> <div > Abstract <div > We aimed to evaluate the direct action of VIP on crucial molecules involved in human osteoclast differentiation and function. We also investigated the relationship between VIP serum levels and bone remodeling mediators in early arthritis patients. The expression of VIP receptors and osteoclast [...] Read more. </div> <div > We aimed to evaluate the direct action of VIP on crucial molecules involved in human osteoclast differentiation and function. We also investigated the relationship between VIP serum levels and bone remodeling mediators in early arthritis patients. The expression of VIP receptors and osteoclast gene markers in monocytes and in vitro differentiated osteoclasts was studied by real-time PCR. NFATc1 activity was measured using a TransAM<sup>®</sup> kit. Osteoclastogenesis was confirmed by quantification of tartrate-resistant acid phosphatase positive multinucleated cells. OsteoAssay<sup>®</sup> Surface Multiple Well Plate was used to evaluate bone-resorbing activity. The ring-shaped actin cytoskeleton and the VPAC1 and VPAC2 expression were analyzed by immunofluorescence. We described the presence of VIP receptors in monocytes and mature osteoclasts. Osteoclasts that formed in the presence of VIP showed a decreased expression of osteoclast differentiation gene markers and proteolytic enzymes involved in bone resorption. VIP reduced the resorption activity and decreased both β3 integrin expression and actin ring formation. Elevated serum VIP levels in early arthritis patients were associated with lower BMD loss and higher serum OPG concentration. These results demonstrate that VIP exerts an anti-osteoclastogenic action impairing both differentiation and resorption activity mainly through the negative regulation of NFATc1, evidencing its bone-protective effects in humans. Full article </div> </div> <div > (This article belongs to the Special Issue Neuropeptides in Biomedicines) </div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 104 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> <a ><i>ACTB</i> Mutations Analysis and Genotype–Phenotype Correlation in Becker’s Nevus</a> <div > by <span ><div >Shangzhi Dai</div>, </span><span ><div >Huijun Wang</div> and </span><span ><div >Zhimiao Lin</div></span> </div> <div > Biomedicines <b>2021</b>, 9(12), 1879; https://doi.org/10.3390/biomedicines9121879 (registering DOI) - 10 Dec 2021 </div> <div > Abstract <div > Becker’s nevus (BN) is a cutaneous hamartoma which is characterized by circumscribed hyperpigmentation with hypertrichosis. Recent studies have revealed that BN patients harbored postzygotic <i>ACTB</i> mutations, which were restricted to arrector pili muscle lineage. We screened for <i>ACTB</i> mutations in 20 Chinese patients [...] Read more. </div> <div > Becker’s nevus (BN) is a cutaneous hamartoma which is characterized by circumscribed hyperpigmentation with hypertrichosis. Recent studies have revealed that BN patients harbored postzygotic <i>ACTB</i> mutations, which were restricted to arrector pili muscle lineage. We screened for <i>ACTB</i> mutations in 20 Chinese patients with BN and found that recurrent mutations (c.C439A or c.C439T) in <i>ACTB</i> were detected in the majority of BN patients. However, more than 20% of the patients were negative for <i>ACTB</i> mutations, suggesting a possible genetic heterogeneity in Becker’s nevus. Interestingly, these mutations were also detected in dermal tissues outside the arrector pili muscle. We further performed genotype–phenotype correlation analysis, which revealed that lesions above the waistline, including the trunk above the anterior superior spine level, upper limbs and face, or covering more than 1% BSA were more likely to be positive for <i>ACTB</i> mutations. Altogether, our results provide further evidence of postzygotic <i>ACTB</i> mutations in BN patients and suggest a possible genotype–phenotype correlation of BN. Full article </div> </div> <div > (This article belongs to the Special Issue Somatic Mosaicism in Skin Disorders) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> BET Proteins Regulate Expression of Osr1 in Early Kidney Development <div > by <span ><div >Janina Schreiber</div>, </span><span ><div >Nastassia Liaukouskaya</div>, </span><span ><div >Lars Fuhrmann</div>, </span><span ><div >Alexander-Thomas Hauser</div>, </span><span ><div >Manfred Jung</div>, </span><span ><div >Tobias B. Huber</div> and </span><span ><div >Nicola Wanner</div></span> </div> <div > Biomedicines <b>2021</b>, 9(12), 1878; https://doi.org/10.3390/biomedicines9121878 (registering DOI) - 10 Dec 2021 </div> <div > Abstract <div > In utero renal development is subject to maternal metabolic and environmental influences affecting long-term renal function and the risk of developing chronic kidney failure and cardiovascular disease. Epigenetic processes have been implicated in the orchestration of renal development and prenatal programming of nephron [...] Read more. </div> <div > In utero renal development is subject to maternal metabolic and environmental influences affecting long-term renal function and the risk of developing chronic kidney failure and cardiovascular disease. Epigenetic processes have been implicated in the orchestration of renal development and prenatal programming of nephron number. However, the role of many epigenetic modifiers for kidney development is still unclear. Bromodomain and extra-terminal domain (BET) proteins act as histone acetylation reader molecules and promote gene transcription. BET family members Brd2, Brd3 and Brd4 are expressed in the nephrogenic zone during kidney development. Here, the effect of the BET inhibitor JQ1 on renal development is evaluated. Inhibition of BET proteins via JQ1 leads to reduced growth of metanephric kidney cultures, loss of the nephron progenitor cell population, and premature and disturbed nephron differentiation. Gene expression of key nephron progenitor transcription factor Osr1 is downregulated after 24 h BET inhibition, while Lhx1 and Pax8 expression is increased. Mining of BRD4 ChIP-seq and gene expression data identify Osr1 as a key factor regulated by BRD4-controlled gene activation. Inhibition of BRD4 by BET inhibitor JQ1 leads to downregulation of Osr1, thereby causing a disturbance in the balance of nephron progenitor cell self-renewal and premature differentiation of the nephron, which ultimately leads to kidney hypoplasia and disturbed nephron development. This raises questions about the potential teratogenic effects of BET inhibitors for embryonic development. In summary, our work highlights the role of BET proteins for prenatal programming of nephrogenesis and identifies Osr1 as a potential target of BET proteins. Full article </div> </div> <div > (This article belongs to the Special Issue Glomerular Microenvironment: Cellular Stress in Chronic Kidney Disease) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 5893 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page </div> </div> <div >Open AccessArticle</div> Rapid Androgen-Responsive Proteome Is Involved in Prostate Cancer Progression <div > by <span ><div >Jong-Kwang Kim</div>, </span><span ><div >Jaehun Jung</div>, </span><span ><div >Dong-Hoon Shin</div>, </span><span ><div >Hye-Jin You</div>, </span><span ><div >Seho Cha</div>, </span><span ><div >Bo-Seul Song</div>, </span><span ><div >Jae-Young Joung</div>, </span><span ><div >Weon-Seo Park</div>, </span><span ><div >Kwang-Pyo Kim</div> and </span><span ><div >Jae-Kyung Myung</div></span> </div> <div > Biomedicines <b>2021</b>, 9(12), 1877; https://doi.org/10.3390/biomedicines9121877 - 10 Dec 2021 </div> <div > Abstract <div > Androgen exerts its functions by binding with an androgen receptor (AR). It can activate many signaling pathways that are important to the progression of castration-resistant prostate cancer (CRPC). Here, we characterized the rapid proteomic changes seen at 5, 15, 30, and 60 min [...] Read more. </div> <div > Androgen exerts its functions by binding with an androgen receptor (AR). It can activate many signaling pathways that are important to the progression of castration-resistant prostate cancer (CRPC). Here, we characterized the rapid proteomic changes seen at 5, 15, 30, and 60 min after the androgen treatment of VCaP cells via the tandem mass tag (TMT) labeling strategy. A total of 5529 proteins were successfully identified and quantified. Dynamic time profiling of protein expression patterns allowed us to identify five protein clusters involved in various stages of androgen-initiated signal transmission and processing. More details of protein functions and localization patterns, and our elucidation of an AR-interacting protein network, were obtained. Finally, we validated the expression level of AR-regulated proteins known to be significantly regulated in CRPC patients using the mouse xenograft model and patient samples. Our work offers a systematic analysis of the rapid proteomic changes induced by androgen and provides a global view of the molecular mechanisms underlying CRPC progression. Full article </div> </div> <div > (This article belongs to the Special Issue Novel Strategy for Treating Castration-Resistant Prostate Cancer) </div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 216 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page </div> </div> <div >Open AccessArticle</div> α-Synuclein Overexpression Increases Dopamine D2/3 Receptor Binding and Immune Activation in a Model of Early Parkinson’s Disease <div > by <span ><div >Kathrine Stokholm</div>, </span><span ><div >Majken Borup Thomsen</div>, </span><span ><div >Jenny-Ann Phan</div>, </span><span ><div >Line K. Møller</div>, </span><span ><div >Cecilie Bay-Richter</div>, </span><span ><div >Søren H. Christiansen</div>, </span><span ><div >David P. D. Woldbye</div>, </span><span ><div >Marina Romero-Ramos</div> and </span><span ><div >Anne M. Landau</div></span> </div> <div > Biomedicines <b>2021</b>, 9(12), 1876; https://doi.org/10.3390/biomedicines9121876 - 10 Dec 2021 </div> <div > Abstract <div > Progressive degeneration of dopaminergic neurons, immune activation, and α-synuclein pathology characterize Parkinson’s disease (PD). We previously reported that unilateral intranigral injection of recombinant adeno-associated viral (rAAV) vectors encoding wild-type human α-synuclein produced a rat model of early PD with dopamine terminal dysfunction. Here [...] Read more. </div> <div > Progressive degeneration of dopaminergic neurons, immune activation, and α-synuclein pathology characterize Parkinson’s disease (PD). We previously reported that unilateral intranigral injection of recombinant adeno-associated viral (rAAV) vectors encoding wild-type human α-synuclein produced a rat model of early PD with dopamine terminal dysfunction. Here we tested the hypothesis that decreases in dopamine result in increased postsynaptic dopamine D2/D3 receptor expression, neuroinflammation, and reduced synaptic vesicle glycoprotein 2A (SV2A) density. Rats were injected with rAAV encoding α-synuclein or green fluorescent protein and subjected to non-pharmacological motor tests, before euthanization at 12 weeks post-injection. We performed: 1) in situ hybridization of nigral tyrosine hydroxylase mRNA, 2) HPLC of striatal dopamine content, and 3) autoradiography with [<sup>3</sup>H]raclopride, [<sup>3</sup>H]DTBZ, [<sup>3</sup>H]GBR12935, [<sup>3</sup>H]PK11195, and [<sup>3</sup>H]UCB-J to measure binding at D2/3 receptors, vesicular monoamine transporter 2, dopamine transporters, mitochondrial translocator protein, and SV2A, respectively. rAAV-α-synuclein induced motor asymmetry and reduced tyrosine hydroxylase mRNA and dopamine content in ipsilateral brain regions. This was paralleled by elevated ipsilateral postsynaptic dopamine D2/3 receptor expression and immune activation, with no changes to synaptic SV2A density. In conclusion, α-synuclein overexpression results in dopaminergic degeneration that induced compensatory increases in D2/3 binding and immune activation, recapitulating many of the pathological characteristics of PD. Full article </div> </div> <div > (This article belongs to the Special Issue Animal Models of Parkinson's Disease) </div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 7125 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> A Novel Peptide-MHC Targeted Chimeric Antigen Receptor T Cell Forms a T Cell-like Immune Synapse <div > by <span ><div >Stacie Shiqi Wang</div>, </span><span ><div >Kylie Luong</div>, </span><span ><div >Fiona Margaret Gracey</div>, </span><span ><div >Shareen Jabar</div>, </span><span ><div >Brad McColl</div>, </span><span ><div >Ryan Stanley Cross</div> and </span><span ><div >Misty Rayna Jenkins</div></span> </div> <div > Biomedicines <b>2021</b>, 9(12), 1875; https://doi.org/10.3390/biomedicines9121875 (registering DOI) - 10 Dec 2021 </div> <div > Abstract <div > Chimeric Antigen Receptor (CAR) T cell therapy is a promising form of adoptive cell therapy that re-engineers patient-derived T cells to express a hybrid receptor specific to a tumour-specific antigen of choice. Many well-characterised tumour antigens are intracellular and therefore not accessible to [...] Read more. </div> <div > Chimeric Antigen Receptor (CAR) T cell therapy is a promising form of adoptive cell therapy that re-engineers patient-derived T cells to express a hybrid receptor specific to a tumour-specific antigen of choice. Many well-characterised tumour antigens are intracellular and therefore not accessible to antibodies at the cell surface. Therefore, the ability to target peptide-MHC tumour targets with antibodies is key for wider applicability of CAR T cell therapy in cancer. One way to evaluate the effectiveness and efficiency of ligating tumour target cells is studying the immune synapse. Here we generated a second-generation CAR to targeting the HLA-A*02:01 restricted H3.3K27M epitope, identified as a possible therapeutic target in ~75% of diffuse midline gliomas, used as a model antigen to study the immune synapse. The pMHCI-specific CAR demonstrated specificity, potent activation, cytokine secretion and cytotoxic function. Furthermore, we characterised killing kinetics using live cell imaging as well as CAR synapse confocal imaging. Here we provide evidence of robust CAR targeting of a model peptide-MHC antigen and that, in contrast to protein-specific CARs, these CARs form a TCR-like immune synapse which facilitates TCR-like killing kinetics. Full article </div> </div> <div > (This article belongs to the Special Issue Novel Small-Molecule and Immune-Modulating Agents for Cancer Therapy) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Vitamin D Prevents High Glucose-Induced Lipid Droplets Accumulation in Cultured Endothelial Cells: The Role of Thioredoxin Interacting Protein <div > by <span ><div >Roberta Scrimieri</div>, </span><span ><div >Alessandra Cazzaniga</div>, </span><span ><div >Sara Castiglioni</div> and </span><span ><div >Jeanette A. M. Maier</div></span> </div> <div > Biomedicines <b>2021</b>, 9(12), 1874; https://doi.org/10.3390/biomedicines9121874 - 10 Dec 2021 </div> <div > Abstract <div > Vitamin D (VitD) exerts protective effects on the endothelium, which is fundamental for vascular integrity, partly by inhibiting free radical formation. We found that VitD prevents high glucose-induced Thioredoxin Interacting Protein (TXNIP) upregulation. Increased amounts of TXNIP are responsible for the accumulation of [...] Read more. </div> <div > Vitamin D (VitD) exerts protective effects on the endothelium, which is fundamental for vascular integrity, partly by inhibiting free radical formation. We found that VitD prevents high glucose-induced Thioredoxin Interacting Protein (TXNIP) upregulation. Increased amounts of TXNIP are responsible for the accumulation of reactive oxygen species and, as a consequence, of lipid droplets. This is associated with increased amounts of triglycerides as the result of increased lipogenesis and reduced fatty acid oxidation. Remarkably, VitD rebalances the redox equilibrium, restores normal lipid content, and prevents the accumulation of lipid droplets. Our results highlight TXNIP as one of the targets of VitD in high glucose-cultured endothelial cells and shed some light on the protective effect of VitD on the endothelium. Full article </div> </div> <div > (This article belongs to the Special Issue Vitamin D in Health and Disease) </div> ►▼ Show Figures <div ><div ><div ><p>Graphical abstract</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 815 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> An Orthotopic Model of Uveal Melanoma in Zebrafish Embryo: A Novel Platform for Drug Evaluation <div > by <span ><div >Chiara Tobia</div>, </span><span ><div >Daniela Coltrini</div>, </span><span ><div >Roberto Ronca</div>, </span><span ><div >Alessandra Loda</div>, </span><span ><div >Jessica Guerra</div>, </span><span ><div >Elisa Scalvini</div>, </span><span ><div >Francesco Semeraro</div> and </span><span ><div >Sara Rezzola</div></span> </div> <div > Biomedicines <b>2021</b>, 9(12), 1873; https://doi.org/10.3390/biomedicines9121873 - 10 Dec 2021 </div> <div > Abstract <div > Uveal melanoma is a highly metastatic tumor, representing the most common primary intraocular malignancy in adults. Tumor cell xenografts in zebrafish embryos may provide the opportunity to study in vivo different aspects of the neoplastic disease and its response to therapy. Here, we [...] Read more. </div> <div > Uveal melanoma is a highly metastatic tumor, representing the most common primary intraocular malignancy in adults. Tumor cell xenografts in zebrafish embryos may provide the opportunity to study in vivo different aspects of the neoplastic disease and its response to therapy. Here, we established an orthotopic model of uveal melanoma in zebrafish by injecting highly metastatic murine B16-BL6 and B16-LS9 melanoma cells, human A375M melanoma cells, and human 92.1 uveal melanoma cells into the eye of zebrafish embryos in the proximity of the developing choroidal vasculature. Immunohistochemical and immunofluorescence analyses showed that melanoma cells proliferate during the first four days after injection and move towards the eye surface. Moreover, bioluminescence analysis of luciferase-expressing human 92.1 uveal melanoma cells allowed the quantitative assessment of the antitumor activity exerted by the canonical chemotherapeutic drugs paclitaxel, panobinostat, and everolimus after their injection into the grafted eye. Altogether, our data demonstrate that the zebrafish embryo eye is a permissive environment for the growth of invasive cutaneous and uveal melanoma cells. In addition, we have established a new luciferase-based in vivo orthotopic model that allows the quantification of human uveal melanoma cells engrafted in the zebrafish embryo eye, and which may represent a suitable tool for the screening of novel drug candidates for uveal melanoma therapy. Full article </div> </div> <div > (This article belongs to the Special Issue Zebrafish Models for Development and Disease 3.0) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 13497 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Displacement of Gray Matter and Incidence of Seizures in Patients with Cerebral Cavernous Malformations <div > by <span ><div >Chi-Jen Chou</div>, </span><span ><div >Cheng-Chia Lee</div>, </span><span ><div >Ching-Jen Chen</div>, </span><span ><div >Huai-Che Yang</div> and </span><span ><div >Syu-Jyun Peng</div></span> </div> <div > Biomedicines <b>2021</b>, 9(12), 1872; https://doi.org/10.3390/biomedicines9121872 - 10 Dec 2021 </div> <div > Abstract <div > Seizures are the most common presentation in patients with cerebral cavernous malformations (CCMs). Based on the hypothesis that the volume or proportion of gray matter (GM) displaced by CCMs is associated with the risk of seizure, we developed an algorithm by which to [...] Read more. </div> <div > Seizures are the most common presentation in patients with cerebral cavernous malformations (CCMs). Based on the hypothesis that the volume or proportion of gray matter (GM) displaced by CCMs is associated with the risk of seizure, we developed an algorithm by which to quantify the volume and proportion of displaced GM and the risk of seizure. Image analysis was conducted on 111 patients with solitary CCMs (divided into seizure and nonseizure groups) from our gamma knife radiosurgery (GKRS) database from February 2005 and March 2020. The CCM algorithm proved effective in quantifying the GM and CCM using T1WI MRI images. In the seizure group, 11 of the 12 patients exhibited seizures at the initial presentation, and all CCMs in the seizure group were supratentorial. The location of the limbic lobe within the CCM was significantly associated with the risk of seizure (OR = 19.6, <i>p</i> = 0.02). The risk of seizure increased when the proportion of GM displaced by the CCM exceeded 31%. It was also strongly correlated with the volume of displaced GM. The volume and proportion of displaced GM were both positively correlated with the risk of seizure presentation/development and thus could be used to guide seizure prophylaxis in CCM patients. Full article </div> </div> <div > (This article belongs to the Special Issue Artificial Intelligence in Biological and Biomedical Imaging) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessReview</div> The Role of Oxidative Stress and Therapeutic Potential of Antioxidants in Graves’ Ophthalmopathy <div > by <span ><div >Tzu-Yu Hou</div>, </span><span ><div >Shi-Bei Wu</div>, </span><span ><div >Hui-Chuan Kau</div> and </span><span ><div >Chieh-Chih Tsai</div></span> </div> <div > Biomedicines <b>2021</b>, 9(12), 1871; https://doi.org/10.3390/biomedicines9121871 - 10 Dec 2021 </div> <div > Abstract <div > Graves’ ophthalmopathy (GO) is the most common extrathyroidal manifestation of Graves’ disease. It is characterized initially by an inflammatory process, followed by tissue remodeling and fibrosis, leading to proptosis, exposure keratopathy, ocular motility limitation, and compressive optic neuropathy. The pathogenic mechanism is complex [...] Read more. </div> <div > Graves’ ophthalmopathy (GO) is the most common extrathyroidal manifestation of Graves’ disease. It is characterized initially by an inflammatory process, followed by tissue remodeling and fibrosis, leading to proptosis, exposure keratopathy, ocular motility limitation, and compressive optic neuropathy. The pathogenic mechanism is complex and multifactorial. Accumulating evidence suggests the involvement of oxidative stress in the pathogenesis of GO. Cigarette smoking, a major risk factor for GO, has been shown to induce reactive oxygen species (ROS) generation and oxidative damage in GO orbital fibroblasts. In addition, an elevation in ROS and antioxidant enzymes is observed in tears, blood, and urine, as well as orbital fibroadipose tissues and fibroblasts from GO patients. In vitro and in vivo studies have examined the efficacy of various antioxidant supplements for GO. These findings suggest a therapeutic role of antioxidants in GO patients. This review summarizes the current understanding of oxidative stress in the pathogenesis and potential antioxidants for the treatment of GO. Full article </div> </div> <div > (This article belongs to the Special Issue Oxidative Stress and Inflammation: From Mechanisms to Therapeutic Approaches 3.0) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessReview</div> Validity of Anti-PSMA ScFvD2B as a Theranostic Tool: A Narrative-Focused Review <div > by <span ><div >Barbara Frigerio</div>, </span><span ><div >Elena Luison</div>, </span><span ><div >Alessandro Desideri</div>, </span><span ><div >Federico Iacovelli</div>, </span><span ><div >Chiara Camisaschi</div>, </span><span ><div >Ettore C. Seregni</div>, </span><span ><div >Silvana Canevari</div> and </span><span ><div >Mariangela Figini</div></span> </div> <div > Biomedicines <b>2021</b>, 9(12), 1870; https://doi.org/10.3390/biomedicines9121870 - 10 Dec 2021 </div> <div > Abstract <div > Prostate cancer (PCa) is the second leading cause of cancer among men, and its diagnosis and adequate staging are fundamental. Among the biomarkers identified in recent years for PCa management, prostate-specific-membrane-antigen (PSMA), physiologically expressed at a low level on healthy prostate and in [...] Read more. </div> <div > Prostate cancer (PCa) is the second leading cause of cancer among men, and its diagnosis and adequate staging are fundamental. Among the biomarkers identified in recent years for PCa management, prostate-specific-membrane-antigen (PSMA), physiologically expressed at a low level on healthy prostate and in other normal tissues and highly overexpressed in PCa, represents a reliable marker ideal for imaging and therapy. The development of anti-PSMA antibodies, such as D2B, demonstrated slow clearance of intact antibodies compared with fragments resulting in low tumor-to-blood ratios; however, the modular structural and functional nature of antibodies allowed the generation of smaller fragments, such as scFvs. In this review of the anti-PSMA antibody fragment scFvD2B, we combined further characterization of its biomolecular and tissue cross-reactivity characteristics with a comprehensive summary of what has already been performed in preclinical models to evaluate imaging and therapeutic activities. A molecular dynamics study was performed, and ScFvD2B occupied a limited conformational space, characterized by low-energy conformational basins, confirming the high stability of the protein structure. In the cross-reactivity study, the weak/absent immunoreactivity in non-tumor tissues was comparable to the PSMA expression reported in the literature. Biodistribution studies and therapeutic treatments were conducted in different animal models obtained by subcutaneous or locoregional injection of PSMA-positive-versus-negative xenografts. The maximum tumor uptake was observed for <sup>123</sup>I(SPECT), <sup>124</sup>I(PET), and optical imaging, which avoids kidney accumulation (compared with radiometals) and leads to an optimal tumor-to-kidney and tumor-to-background ratios. Regarding its possible use in therapy, experimental data suggested a strong and specific antitumor activity, in vitro and in vivo, obtained using CAR-T or NK-92/CAR cells expressing scFvD2B. Based on presented/reviewed data, we consider that scFvD2B, due to its versatility and robustness, seems to: (i) overcome some problems observed in other studied scFvs, very often relatively unstable and prone to form aggregates; (ii) have sufficient tumor-to-background ratios for targeting and imaging PSMA-expressing cancer; (iii) significantly redirect immune killing cells to PSMA-positive tumors when inserted in second-generation CAR-T or NK-92/CAR cells. These data suggest that our product can be considered the right reagent to fill the gap that still exists in PCa diagnosis and treatment. Full article </div> </div> <div > (This article belongs to the Special Issue Antibody Based Delivery of Toxins and Other Active Molecules for Cancer Therapy) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 425 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Deciphering the Role of Pyrvinium Pamoate in the Generation of Integrated Stress Response and Modulation of Mitochondrial Function in Myeloid Leukemia Cells through Transcriptome Analysis <div > by <span ><div >Yu-Hsuan Fu</div>, </span><span ><div >Chi-Yang Tseng</div>, </span><span ><div >Jeng-Wei Lu</div>, </span><span ><div >Wen-Hui Lu</div>, </span><span ><div >Pei-Qi Lan</div>, </span><span ><div >Chien-Yuan Chen</div>, </span><span ><div >Da-Liang Ou</div> and </span><span ><div >Liang-In Lin</div></span> </div> <div > Biomedicines <b>2021</b>, 9(12), 1869; https://doi.org/10.3390/biomedicines9121869 (registering DOI) - 09 Dec 2021 </div> <div > Abstract <div > Pyrvinium pamoate, a widely-used anthelmintic agent, reportedly exhibits significant anti-tumor effects in several cancers. However, the efficacy and mechanisms of pyrvinium against myeloid leukemia remain unclear. The growth inhibitory effects of pyrvinium were tested in human AML cell lines. Transcriptome analysis of Molm13 [...] Read more. </div> <div > Pyrvinium pamoate, a widely-used anthelmintic agent, reportedly exhibits significant anti-tumor effects in several cancers. However, the efficacy and mechanisms of pyrvinium against myeloid leukemia remain unclear. The growth inhibitory effects of pyrvinium were tested in human AML cell lines. Transcriptome analysis of Molm13 myeloid leukemia cells suggested that pyrvinium pamoate could trigger an unfolded protein response (UPR)-like pathway, including responses to extracellular stimulus [<i>p</i>-value = 2.78 × 10<sup>−6</sup>] and to endoplasmic reticulum stress [<i>p</i>-value = 8.67 × 10<sup>−7</sup>], as well as elicit metabolic reprogramming, including sulfur compound catabolic processes [<i>p</i>-value = 2.58 × 10<sup>−8</sup>], and responses to a redox state [<i>p</i>-value = 5.80 × 10<sup>−5</sup>]; on the other hand, it could elicit a pyrvinium blunted protein folding function, including protein folding [<i>p</i>-value = 2.10 × 10<sup>−8</sup>] and an ATP metabolic process [<i>p</i>-value = 3.95 × 10<sup>−4</sup>]. Subsequently, pyrvinium was verified to induce an integrated stress response (ISR), demonstrated by activation of the eIF2α-ATF4 pathway and inhibition of mTORC1 signaling, in a dose- and time-dependent manner. Additionally, pyrvinium could co-localize with mitochondria and then decrease the mitochondrial basal oxidative consumption rate, ultimately dysregulating the mitochondrial function. Similar effects were observed in cabozantinib-resistant Molm13-XR cell lines. Furthermore, pyrvinium treatment retarded Molm13 and Molm13-XR xenograft tumor growth. Thus, we concluded that pyrvinium exerts anti-tumor activity, at least, via the modulation of the mitochondrial function and by triggering ISR. Full article </div> </div> <div > (This article belongs to the Special Issue Acute Myeloid Leukemia: From Pathophysiology to Novel Therapeutic Approaches) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page </div> </div> <div >Open AccessArticle</div> Catalase Activity in Keratinocytes, Stratum Corneum, and Defatted Algae Biomass as a Potential Skin Care Ingredient <div > by <span ><div >Michal Szczepanczyk</div>, </span><span ><div >Tautgirdas Ruzgas</div>, </span><span ><div >Fredrika Gullfot</div>, </span><span ><div >Anna Gustafsson</div> and </span><span ><div >Sebastian Björklund</div></span> </div> <div > Biomedicines <b>2021</b>, 9(12), 1868; https://doi.org/10.3390/biomedicines9121868 - 09 Dec 2021 </div> <div > Abstract <div > The generation of reactive oxygen species presents a destructive challenge for the skin organ and there is a clear need to advance skin care formulations aiming at alleviating oxidative stress. The aim of this work was to characterize the activity of the antioxidative [...] Read more. </div> <div > The generation of reactive oxygen species presents a destructive challenge for the skin organ and there is a clear need to advance skin care formulations aiming at alleviating oxidative stress. The aim of this work was to characterize the activity of the antioxidative enzyme catalase in keratinocytes and in the skin barrier (i.e., the stratum corneum). Further, the goal was to compare the activity levels with the corresponding catalase activity found in defatted algae biomass, which may serve as a source of antioxidative enzymes, as well as other beneficial algae-derived molecules, to be employed in skin care products. For this, an oxygen electrode-based method was employed to determine the catalase activity and the apparent kinetic parameters for purified catalase, as well as catalase naturally present in HaCaT keratinocytes, excised stratum corneum samples collected from pig ears with various amounts of melanin, and defatted algae biomass from the diatom <i>Phaeodactylum tricornutum</i>. Taken together, this work illustrates the versatility of the oxygen electrode-based method for characterizing catalase function in samples with a high degree of complexity and enables the assessment of sample treatment protocols and comparisons between different biological systems related to the skin organ or algae-derived materials as a potential source of skin care ingredients for combating oxidative stress. Full article </div> </div> <div > (This article belongs to the Section Molecular and Translational Medicine) </div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessReview</div> PAD Inhibitors as a Potential Treatment for SARS-CoV-2 Immunothrombosis <div > by <span ><div >Willie Elliott, Jr.</div>, </span><span ><div >Maheedhara R. Guda</div>, </span><span ><div >Swapna Asuthkar</div>, </span><span ><div >Narasaraju Teluguakula</div>, </span><span ><div >Durbaka V. R. Prasad</div>, </span><span ><div >Andrew J. Tsung</div> and </span><span ><div >Kiran K. Velpula</div></span> </div> <div > Biomedicines <b>2021</b>, 9(12), 1867; https://doi.org/10.3390/biomedicines9121867 - 09 Dec 2021 </div> <div > Abstract <div > Since the discovery of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019, the virus’s dynamicity has resulted in the evolution of various variants, including the delta variant and the more novel mu variant. With a multitude of mutant strains posing as [...] Read more. </div> <div > Since the discovery of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019, the virus’s dynamicity has resulted in the evolution of various variants, including the delta variant and the more novel mu variant. With a multitude of mutant strains posing as challenges to vaccine efficacy, it is critical that researchers embrace the development of pharmacotherapeutics specific to SARS-CoV-2 pathophysiology. Neutrophil extracellular traps and their constituents, including citrullinated histones, display a linear connection with thrombotic manifestations in COVID-19 patients. Peptidylarginine deiminases (PADs) are a group of enzymes involved in the modification of histone arginine residues by citrullination, allowing for the formation of NETs. PAD inhibitors, specifically PAD-4 inhibitors, offer extensive pharmacotherapeutic potential across a broad range of inflammatory diseases such as COVID-19, through mediating NETs formation. Although numerous PAD-4 inhibitors exist, current literature has not explored the depth of utilizing these inhibitors clinically to treat thrombotic complications in COVID-19 patients. This review article offers the clinical significance of PAD-4 inhibitors in reducing thrombotic complications across various inflammatory disorders like COVID-19 and suggests that these inhibitors may be valuable in treating the origin of SARS-CoV-2 immunothrombosis. Full article </div> </div> <div > (This article belongs to the Section Microbiology in Human Health and Disease) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessReview</div> Metabolic Associated Fatty Liver Disease in Children—From Atomistic to Holistic <div > by <span ><div >Cristina Oana Mărginean</div>, </span><span ><div >Lorena Elena Meliț</div> and </span><span ><div >Maria Oana Săsăran</div></span> </div> <div > Biomedicines <b>2021</b>, 9(12), 1866; https://doi.org/10.3390/biomedicines9121866 - 09 Dec 2021 </div> <div > Abstract <div > Non-alcoholic fatty liver disease has become the most common chronic liver disease in children due to the alarmingly increasing incidence of pediatric obesity. It is well-documented that MAFLD prevalence is directly related to an incremental increase in BMI. The multiple hits theory was [...] Read more. </div> <div > Non-alcoholic fatty liver disease has become the most common chronic liver disease in children due to the alarmingly increasing incidence of pediatric obesity. It is well-documented that MAFLD prevalence is directly related to an incremental increase in BMI. The multiple hits theory was designed for providing insights regarding the pathogenesis of steatohepatitis and fibrosis in MAFLD. Recent evidence suggested that the microbiome is a crucial contributor in the pathogenesis of MAFLD. Aside from obesity, the most common risk factors for pediatric MAFLD include male gender, low-birth weight, family history of obesity, MAFLD, insulin resistance, type 2 diabetes mellitus, obstructive sleep apnea, and polycystic ovarium syndrome. Usually, pediatric patients with MAFLD have nonspecific symptoms consisting of fatigue, malaise, or diffuse abdominal pain. A wide spectrum of biomarkers was proposed for the diagnosis of MAFLD and NASH, as well as for quantifying the degree of fibrosis, but liver biopsy remains the key diagnostic and staging tool. Nevertheless, elastography-based methods present promising results in this age group as potential non-invasive replacers for liver biopsy. Despite the lack of current guidelines regarding MAFLD treatment in children, lifestyle intervention was proven to be crucial in the management of these patients. Full article </div> </div> <div > (This article belongs to the Special Issue NAFLD: From Mechanisms to Therapeutic Approaches) </div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 262 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Pharmacological Inhibition of NOX4 Improves Mitochondrial Function and Survival in Human Beta-Cells <div > by <span ><div >Andris Elksnis</div>, </span><span ><div >Jing Cen</div>, </span><span ><div >Per Wikström</div>, </span><span ><div >Per-Ola Carlsson</div> and </span><span ><div >Nils Welsh</div></span> </div> <div > Biomedicines <b>2021</b>, 9(12), 1865; https://doi.org/10.3390/biomedicines9121865 - 08 Dec 2021 </div> <div > Abstract <div > Previous studies have reported beneficial effects of NADPH oxidase 4 (NOX4) inhibition on beta-cell survival in vitro and in vivo. The mechanisms by which NOX4 inhibition protects insulin producing cells are, however, not known. The aim of the present study was to investigate [...] Read more. </div> <div > Previous studies have reported beneficial effects of NADPH oxidase 4 (NOX4) inhibition on beta-cell survival in vitro and in vivo. The mechanisms by which NOX4 inhibition protects insulin producing cells are, however, not known. The aim of the present study was to investigate the effects of a pharmacological NOX4 inhibitor (GLX7013114) on human islet and EndoC-βH1 cell mitochondrial function, and to correlate such effects with survival in islets of different size, activity, and glucose-stimulated insulin release responsiveness. We found that maximal oxygen consumption rates, but not the rates of acidification and proton leak, were increased in islets after acute NOX4 inhibition. In EndoC-βH1 cells, NOX4 inhibition increased the mitochondrial membrane potential, as estimated by JC-1 fluorescence; mitochondrial reactive oxygen species (ROS) production, as estimated by MitoSOX fluorescence; and the ATP/ADP ratio, as assessed by a bioluminescent assay. Moreover, the insulin release from EndoC-βH1 cells at a high glucose concentration increased with NOX4 inhibition. These findings were paralleled by NOX4 inhibition-induced protection against human islet cell death when challenged with high glucose and sodium palmitate. The NOX4 inhibitor protected equally well islets of different size, activity, and glucose responsiveness. We conclude that pharmacological alleviation of NOX4-induced inhibition of beta-cell mitochondria leads to increased, and not decreased, mitochondrial ROS, and this was associated with protection against cell death occurring in different types of heterogeneous islets. Thus, NOX4 inhibition or modulation may be a therapeutic strategy in type 2 diabetes that targets all types of islets. Full article </div> </div> <div > (This article belongs to the Special Issue Targeting Pancreatic Islets from a Therapeutic Perspective) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 631 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Anti-Inflammatory Mesenchymal Stromal Cell-Derived Extracellular Vesicles Improve Pathology in Niemann–Pick Type C Disease <div > by <span ><div >Lien Van Hoecke</div>, </span><span ><div >Caroline Van Cauwenberghe</div>, </span><span ><div >Verena Börger</div>, </span><span ><div >Arnout Bruggeman</div>, </span><span ><div >Jonas Castelein</div>, </span><span ><div >Griet Van Imschoot</div>, </span><span ><div >Elien Van Wonterghem</div>, </span><span ><div >Robin Dittrich</div>, </span><span ><div >Wouter Claeys</div>, </span><span ><div >Junhua Xie</div>, </span><span ><div >Bernd Giebel</div> and </span><span ><div >Roosmarijn E. Vandenbroucke</div></span> </div> <div > Biomedicines <b>2021</b>, 9(12), 1864; https://doi.org/10.3390/biomedicines9121864 - 08 Dec 2021 </div> <div > Abstract <div > Niemann–Pick type C (NPC) disease is a rare neurovisceral lipid storage disease with progressive neurodegeneration, leading to premature death. The disease is caused by loss-of-function mutations either in the <i>NPC1</i> or <i>NPC2</i> gene which results in lipid accumulation in the late endosomes and [...] Read more. </div> <div > Niemann–Pick type C (NPC) disease is a rare neurovisceral lipid storage disease with progressive neurodegeneration, leading to premature death. The disease is caused by loss-of-function mutations either in the <i>NPC1</i> or <i>NPC2</i> gene which results in lipid accumulation in the late endosomes and lysosomes. The involved disease mechanisms are still incompletely understood, making the design of a rational treatment very difficult. Since the disease is characterized by peripheral inflammation and neuroinflammation and it is shown that extracellular vesicles (EVs) obtained from mesenchymal stromal cells (MSCs) provide immunomodulatory capacities, we tested the potential of MSC-EV preparations to alter NPC1 disease pathology. Here, we show that the administration of an MSC-EV preparation with in vitro and in vivo confirmed immune modulatory capabilities is able to reduce the inflammatory state of peripheral organs and different brain regions of NPC1-diseased mice almost to normal levels. Moreover, a reduction of foamy cells in different peripheral organs was observed upon MSC-EV treatment of NPC1<sup>−/−</sup> mice. Lastly, the treatment was able to decrease microgliosis and astrogliosis, typical features of NPC1 patients that lead to neurodegeneration. Altogether, our results reveal the therapeutic potential of MSC-EVs as treatment for the genetic neurovisceral lipid storage disease NPC, thereby counteracting both central and peripheral features. Full article </div> </div> <div > (This article belongs to the Special Issue Extracellular Vesicles in Neurological Disorders: Translational Research) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> </div> <div > More Articles... </div> </div> </div> </div> <div > <div > <div > <div > <a > Submit to <i>Biomedicines</i> </a> Review for Biomedicines <div > Share </div> </div> <div > <h2 >Journal Menu</h2> ► ▼ Journal Menu <ul > <li > <ul> <li > Biomedicines Home </li> <li > Aims Scope </li> <li > Editorial Board </li> <li > Reviewer Board </li> <li > Topical Advisory Panel </li> <li > Instructions for Authors </li> <li > Special Issues </li> <li > Sections Collections </li> <li > Article Processing Charge </li> <li > Indexing Archiving </li> <li > Most Cited Viewed </li> <li > Journal Statistics </li> <li > Journal History </li> <li > Journal Awards </li> <li > Society Collaborations </li> <li > Conferences </li> <li > Editorial Office </li> </ul> </li> </ul> </div> <h2 >Journal Browser</h2> ► ▼ Journal Browser <div > <div > <ul > <li > <a > <i > arrow_forward_ios </i> Forthcoming issue </a> <a > <i > arrow_forward_ios </i> Current issue </a> </li> <div > <div > <div > <li > Vol. 9 (2021) </li> <li > Vol. 8 (2020) </li> <li > Vol. 7 (2019) </li> <li > Vol. 6 (2018) </li> <li > Vol. 5 (2017) </li> <li > Vol. 4 (2016) </li> <li > Vol. 3 (2015) </li> <li > Vol. 2 (2014) </li> <li > Vol. 1 (2013) </li> </div> </div> </div> </ul> </div> </div> </div> </div> <div > <div > <h2>Highly Accessed Articles</h2> </div> <div > <div > View More... </div> </div> </div> <div > <div > <h2>Latest Books</h2> </div> <div > <div > More Open Access Books... </div> </div> </div> </div> <div > <div > <div > <h2>E-Mail Alert</h2> </div> </div> <div > <div > <h2>News</h2> </div> <div > <div > 9 December 2021 Biomedicines | 10th Anniversary </div> <div > 22 November 2021 720 MDPI Editorial Board Members Receiving "2021 Highly Cited Researchers" Distinction </div> <div > 16 November 2021 Topical Advisory Panel Established to Support Editorial Board </div> <div > More News Announcements... </div> </div> </div> <div > <div > <h2>Topics</h2> </div> <div > <div ><div> Topic in Life, Biomedicines</div> Microangiopathy in Rheumatic Diseases Editor-in-Chief: Sevdalina LambovaDeadline: 15 December 2021</div> <div ><div> Topic in Biomedicines, BioMed, Reports</div> Photodynamic Therapy Editor-in-Chief: Stefano BacciDeadline: 31 December 2021</div> <div ><div> Topic in IJMS, Biomedicines, Antioxidants, CIMB, JCM</div> Sterile Inflammation in Solid Organ Transplantation Editors-in-Chief: Jerzy W. Kupiec-Weglinski, Joan Roselló-Catafau, René Adam, Teresa Carbonell Camós, Arnau Panisello-RosellóDeadline: 10 February 2022</div> <div ><div> Topic in IJMS, Biomedicines, Life, BioMed, Reprod. Med.</div> Pathogenesis of Pregnancy-Related Complications Editors-in-Chief: Ilona Hromadnikova, Katerina KotlabovaDeadline: 28 February 2022</div> <div > More Topics </div> </div> </div> <div > <div > <h2>Conferences</h2> </div> <div > <div > Announce Your Conference </div> <div > 5–8 April 2022 Viruses 2022 - At the Leading Edge of Virology Research</div> <div > More Conferences... </div> </div> </div> <div > <div > <h2>Special Issues</h2> </div> <div > <div > Edit a Special Issue </div> <div ><div> Special Issue in Biomedicines</div> Hydrogels for Biomedical Application Guest Editors: Elvira De Giglio, Maria A. BonifacioDeadline: 15 December 2021</div> <div ><div> Special Issue in Biomedicines</div> Peptide-Based Drug Development Guest Editors: William Lubell, Jackie Wilce, Johan RosengrenDeadline: 31 December 2021</div> <div ><div> Special Issue in Biomedicines</div> Endothelial Dysfunction: From a Pathophysiological Mechanism to a Potential Therapeutic Target Guest Editor: Pasquale AmbrosinoDeadline: 15 January 2022</div> <div ><div> Special Issue in Biomedicines</div> New Insights in Radiotherapy Guest Editor: Carlos Martinez-CampaDeadline: 25 January 2022</div> <div > More Special Issues </div> </div> </div> <div > <div > <h2>Topical Collections</h2> </div> <div > <div ><div> Topical Collection in Biomedicines</div> Stem Cells and Cancer Therapeutics Collection Editors: Lluis Espinosa, Teresa Lobo-Jarne</div> <div ><div> Topical Collection in Biomedicines</div> Targeting Cell Metabolism as Cancer Therapy Collection Editor: Veronique Baud</div> <div ><div> Topical Collection in Biomedicines</div> Neurotoxicity: Mechanisms and Potential Therapeutic Strategies Collection Editor: David R. Wallace</div> </div> </div> <div > <div > <h2>Jobs in Research</h2> </div> <div > <div > Post New Job Opening </div> </div> </div> </div> </div> </div> </section> <div > <div > Biomedicines, EISSN 2227-9059, Published by MDPI <span> Disclaimer <div > The statements, opinions and data contained in the journal Biomedicines are solely those of the individual authors and contributors and not of the publisher and the editor(s). MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. </div> </span> <div > RSS Content Alert </div> </div> <div > <div > <h3> Further Information </h3> Article Processing Charges Pay an Invoice <a > Open Access Policy </a> <a > Contact MDPI </a> <a > Jobs at MDPI </a> </div> <div > <h3> Guidelines </h3> <a > For Authors </a> <a > For Reviewers </a> <a > For Editors </a> <a > For Librarians </a> <a > For Publishers </a> <a > For Societies </a> </div> <div > <h3> MDPI Initiatives </h3> <a > Sciforum </a> <a > MDPI Books </a> <a > Preprints </a> <a > Scilit </a> <a > SciProfiles </a> <a > Encyclopedia </a> <a > JAMS </a> <a > Proceedings Series </a> </div> <div > <h3> Follow MDPI </h3> <a > LinkedIn </a> <a > Facebook </a> <a > Twitter </a> </div> </div> <div > <div > <div > © 1996-2021 MDPI (Basel, Switzerland) unless otherwise stated </div> <div > <a > Disclaimer </a> <div > The statements, opinions and data contained in the journals are solely those of the individual authors and contributors and not of the publisher and the editor(s). MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. </div> <a > Terms and Conditions </a> <a > Privacy Policy </a> </div> </div> </div> </div> <div > <div > We use cookies on our website to ensure you get the best experience. Read more about our cookies <a >here</a>. </div> <div > <a >Accept</a> </div> </div> <div > <div > We have just recently launched a new version of our website. Help us to further improve by taking part in this short 5 minute survey here. here. </div> <div > <a >Never show this again</a> </div> </div> </div> <div > <div > <div > <h2 >Share Link</h2> </div> <div > <a >Copy</a> </div> </div> <a > <i >clear</i> </a> </div> <div > <div > <div > <h2 >Share</h2> </div> </div> <a > <i >clear</i> </a> </div> <a >Back to TopTop</a> </body>'</script>

      </head>
        <body class="valid" valid="valid" title="valid: True, node: 1, tag: body, level: 1" node_number="1"> <div class="valid" valid="valid" title="valid: True, node: 2, tag: div, level: 2" node_number="2"> <div class="valid" valid="valid" title="valid: True, node: 3, tag: div, level: 3" node_number="3"> <div class="valid" valid="valid" title="valid: True, node: 4, tag: div, level: 4" node_number="4"> <a class="valid" valid="valid" title="valid: True, node: 5, tag: a, level: 5" node_number="5"> <h2 class="valid" valid="valid" title="valid: True, node: 6, tag: h2, level: 6" node_number="6">25th Anniversary</h2> </a> <a class="valid" valid="valid" title="valid: True, node: 7, tag: a, level: 5" node_number="7"> <h2 class="valid" valid="valid" title="valid: True, node: 8, tag: h2, level: 6" node_number="8">Journals</h2> </a> <div class="valid" valid="valid" title="valid: True, node: 9, tag: div, level: 5" node_number="9"> <div class="valid" valid="valid" title="valid: True, node: 10, tag: div, level: 6" node_number="10"> <h2 class="valid" valid="valid" title="valid: True, node: 11, tag: h2, level: 7" node_number="11">Information</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 12, tag: div, level: 6" node_number="12"> <div class="valid" valid="valid" title="valid: True, node: 13, tag: div, level: 7" node_number="13"> <div class="valid" valid="valid" title="valid: True, node: 14, tag: div, level: 8" node_number="14"> <a class="valid" valid="valid" title="valid: True, node: 15, tag: a, level: 9" node_number="15">For Authors</a> <a class="valid" valid="valid" title="valid: True, node: 16, tag: a, level: 9" node_number="16">For Reviewers</a> <a class="valid" valid="valid" title="valid: True, node: 17, tag: a, level: 9" node_number="17">For Editors</a> <a class="valid" valid="valid" title="valid: True, node: 18, tag: a, level: 9" node_number="18">For Librarians</a> <a class="valid" valid="valid" title="valid: True, node: 19, tag: a, level: 9" node_number="19">For Publishers</a> <a class="valid" valid="valid" title="valid: True, node: 20, tag: a, level: 9" node_number="20">For Societies</a> </div> <div class="valid" valid="valid" title="valid: True, node: 21, tag: div, level: 8" node_number="21"> <a class="valid" valid="valid" title="valid: True, node: 22, tag: a, level: 9" node_number="22">Article Processing Charges</a> <a class="valid" valid="valid" title="valid: True, node: 23, tag: a, level: 9" node_number="23">Open Access Policy</a> <a class="valid" valid="valid" title="valid: True, node: 24, tag: a, level: 9" node_number="24">Institutional Open Access Program</a> <a class="valid" valid="valid" title="valid: True, node: 25, tag: a, level: 9" node_number="25">Editorial Process</a> <a class="valid" valid="valid" title="valid: True, node: 26, tag: a, level: 9" node_number="26">Awards</a> <a class="valid" valid="valid" title="valid: True, node: 27, tag: a, level: 9" node_number="27">Research and Publication Ethics</a> </div> </div> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 28, tag: a, level: 5" node_number="28"> <h2 class="valid" valid="valid" title="valid: True, node: 29, tag: h2, level: 6" node_number="29">Author Services</h2> </a> <div class="valid" valid="valid" title="valid: True, node: 30, tag: div, level: 5" node_number="30"> <div class="valid" valid="valid" title="valid: True, node: 31, tag: div, level: 6" node_number="31"> <h2 class="valid" valid="valid" title="valid: True, node: 32, tag: h2, level: 7" node_number="32">Initiatives</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 33, tag: div, level: 6" node_number="33"> <div class="valid" valid="valid" title="valid: True, node: 34, tag: div, level: 7" node_number="34"> <div class="valid" valid="valid" title="valid: True, node: 35, tag: div, level: 8" node_number="35"> <a class="valid" valid="valid" title="valid: True, node: 36, tag: a, level: 9" node_number="36">Sciforum</a> <a class="valid" valid="valid" title="valid: True, node: 37, tag: a, level: 9" node_number="37">MDPI Books</a> <a class="valid" valid="valid" title="valid: True, node: 38, tag: a, level: 9" node_number="38">Preprints</a> <a class="valid" valid="valid" title="valid: True, node: 39, tag: a, level: 9" node_number="39">Scilit</a> <a class="valid" valid="valid" title="valid: True, node: 40, tag: a, level: 9" node_number="40">SciProfiles</a> <a class="valid" valid="valid" title="valid: True, node: 41, tag: a, level: 9" node_number="41">Encyclopedia</a> <a class="valid" valid="valid" title="valid: True, node: 42, tag: a, level: 9" node_number="42">JAMS</a> <a class="valid" valid="valid" title="valid: True, node: 43, tag: a, level: 9" node_number="43">Proceedings Series</a> </div> </div> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 44, tag: a, level: 5" node_number="44"> <h2 class="valid" valid="valid" title="valid: True, node: 45, tag: h2, level: 6" node_number="45">About</h2> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 46, tag: div, level: 4" node_number="46"> <a class="valid" valid="valid" title="valid: True, node: 47, tag: a, level: 5" node_number="47">Sign In / Sign Up</a> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 48, tag: div, level: 2" node_number="48"> <h2 class="valid" valid="valid" title="valid: True, node: 49, tag: h2, level: 3" node_number="49">Notice</h2> <a class="valid" valid="valid" title="valid: True, node: 50, tag: a, level: 3" node_number="50"> <i class="valid" valid="valid" title="valid: True, node: 51, tag: i, level: 4" node_number="51">clear</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 52, tag: div, level: 2" node_number="52"> <div class="valid" valid="valid" title="valid: True, node: 53, tag: div, level: 3" node_number="53"> <div class="valid" valid="valid" title="valid: True, node: 54, tag: div, level: 4" node_number="54"> <h2 class="valid" valid="valid" title="valid: True, node: 55, tag: h2, level: 5" node_number="55">Notice</h2> <p class="valid" valid="valid" title="valid: True, node: 56, tag: p, level: 5" node_number="56"> You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader. </p> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 57, tag: div, level: 3" node_number="57"> <div class="valid" valid="valid" title="valid: True, node: 58, tag: div, level: 4" node_number="58"> <a class="valid" valid="valid" title="valid: True, node: 59, tag: a, level: 5" node_number="59">Continue</a> <a class="valid" valid="valid" title="valid: True, node: 60, tag: a, level: 5" node_number="60">Cancel</a> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 61, tag: a, level: 3" node_number="61"> <i class="valid" valid="valid" title="valid: True, node: 62, tag: i, level: 4" node_number="62">clear</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 63, tag: div, level: 2" node_number="63"> <p class="valid" valid="valid" title="valid: True, node: 64, tag: p, level: 3" node_number="64"> All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. </p> </div> <div class="valid" valid="valid" title="valid: True, node: 65, tag: div, level: 2" node_number="65"> <p class="valid" valid="valid" title="valid: True, node: 66, tag: p, level: 3" node_number="66"> Feature Papers represent the most advanced research with significant potential for high impact in the field. Feature Papers are submitted upon individual invitation or recommendation by the scientific editors and undergo peer review prior to publication. </p> <p class="valid" valid="valid" title="valid: True, node: 67, tag: p, level: 3" node_number="67"> The Feature Paper can be either an original research article, a substantial novel research study that often involves several techniques or approaches, or a comprehensive review paper with concise and precise updates on the latest progress in the field that systematically reviews the most exciting advances in scientific literature. This type of paper provides an outlook on future directions of research or possible applications. </p> </div> <div class="valid" valid="valid" title="valid: True, node: 68, tag: div, level: 2" node_number="68"> <p class="valid" valid="valid" title="valid: True, node: 69, tag: p, level: 3" node_number="69"> Editor&#8217;s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to authors, or important in this field. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal. </p> </div> <div class="valid" valid="valid" title="valid: True, node: 70, tag: div, level: 2" node_number="70"> <div class="valid" valid="valid" title="valid: True, node: 71, tag: div, level: 3" node_number="71">  </div> <section class="valid" valid="valid" title="valid: True, node: 72, tag: section, level: 3" node_number="72"> <header class="valid" valid="valid" title="valid: True, node: 73, tag: header, level: 4" node_number="73"> <div class="valid" valid="valid" title="valid: True, node: 74, tag: div, level: 5" node_number="74"> <div class="valid" valid="valid" title="valid: True, node: 75, tag: div, level: 6" node_number="75"> <div class="valid" valid="valid" title="valid: True, node: 76, tag: div, level: 7" node_number="76"> <ul class="valid" valid="valid" title="valid: True, node: 77, tag: ul, level: 8" node_number="77"> <li class="valid" valid="valid" title="valid: True, node: 78, tag: li, level: 9" node_number="78"> <a class="valid" valid="valid" title="valid: True, node: 79, tag: a, level: 10" node_number="79">25th Anniversary</a> </li> <li class="valid" valid="valid" title="valid: True, node: 80, tag: li, level: 9" node_number="80"> <a class="valid" valid="valid" title="valid: True, node: 81, tag: a, level: 10" node_number="81">Journals</a> </li> <li class="valid" valid="valid" title="valid: True, node: 82, tag: li, level: 9" node_number="82"> <a class="valid" valid="valid" title="valid: True, node: 83, tag: a, level: 10" node_number="83">Information</a> <ul class="valid" valid="valid" title="valid: True, node: 84, tag: ul, level: 10" node_number="84"> <li class="valid" valid="valid" title="valid: True, node: 85, tag: li, level: 11" node_number="85"> <div class="valid" valid="valid" title="valid: True, node: 86, tag: div, level: 12" node_number="86"> <div class="valid" valid="valid" title="valid: True, node: 87, tag: div, level: 13" node_number="87"> <ul class="valid" valid="valid" title="valid: True, node: 88, tag: ul, level: 14" node_number="88"> <li title="valid: False, node: 89, tag: li, level: 15" node_number="89"> <a title="valid: False, node: 90, tag: a, level: 16" node_number="90">For Authors</a> </li> <li title="valid: False, node: 91, tag: li, level: 15" node_number="91"> <a title="valid: False, node: 92, tag: a, level: 16" node_number="92">For Reviewers</a> </li> <li title="valid: False, node: 93, tag: li, level: 15" node_number="93"> <a title="valid: False, node: 94, tag: a, level: 16" node_number="94">For Editors</a> </li> <li title="valid: False, node: 95, tag: li, level: 15" node_number="95"> <a title="valid: False, node: 96, tag: a, level: 16" node_number="96">For Librarians</a> </li> <li title="valid: False, node: 97, tag: li, level: 15" node_number="97"> <a title="valid: False, node: 98, tag: a, level: 16" node_number="98">For Publishers</a> </li> <li title="valid: False, node: 99, tag: li, level: 15" node_number="99"> <a title="valid: False, node: 100, tag: a, level: 16" node_number="100">For Societies</a> </li> </ul> </div> <div class="valid" valid="valid" title="valid: True, node: 101, tag: div, level: 13" node_number="101"> <ul class="valid" valid="valid" title="valid: True, node: 102, tag: ul, level: 14" node_number="102"> <li title="valid: False, node: 103, tag: li, level: 15" node_number="103"> <a title="valid: False, node: 104, tag: a, level: 16" node_number="104">Article Processing Charges</a> </li> <li title="valid: False, node: 105, tag: li, level: 15" node_number="105"> <a title="valid: False, node: 106, tag: a, level: 16" node_number="106">Open Access Policy</a> </li> <li title="valid: False, node: 107, tag: li, level: 15" node_number="107"> <a title="valid: False, node: 108, tag: a, level: 16" node_number="108">Institutional Open Access Program</a> </li> <li title="valid: False, node: 109, tag: li, level: 15" node_number="109"> <a title="valid: False, node: 110, tag: a, level: 16" node_number="110">Editorial Process</a> </li> <li title="valid: False, node: 111, tag: li, level: 15" node_number="111"> <a title="valid: False, node: 112, tag: a, level: 16" node_number="112">Awards</a> </li> <li title="valid: False, node: 113, tag: li, level: 15" node_number="113"> <a title="valid: False, node: 114, tag: a, level: 16" node_number="114">Research and Publication Ethics</a> </li> </ul> </div> </div> </li> </ul> </li> <li class="valid" valid="valid" title="valid: True, node: 115, tag: li, level: 9" node_number="115"> <a class="valid" valid="valid" title="valid: True, node: 116, tag: a, level: 10" node_number="116">Author Services</a> </li> <li class="valid" valid="valid" title="valid: True, node: 117, tag: li, level: 9" node_number="117"> <a class="valid" valid="valid" title="valid: True, node: 118, tag: a, level: 10" node_number="118">Initiatives</a> <ul class="valid" valid="valid" title="valid: True, node: 119, tag: ul, level: 10" node_number="119"> <li class="valid" valid="valid" title="valid: True, node: 120, tag: li, level: 11" node_number="120"> <div class="valid" valid="valid" title="valid: True, node: 121, tag: div, level: 12" node_number="121"> <div class="valid" valid="valid" title="valid: True, node: 122, tag: div, level: 13" node_number="122"> <ul class="valid" valid="valid" title="valid: True, node: 123, tag: ul, level: 14" node_number="123"> <li title="valid: False, node: 124, tag: li, level: 15" node_number="124"> <a title="valid: False, node: 125, tag: a, level: 16" node_number="125"> Sciforum </a> </li> <li title="valid: False, node: 126, tag: li, level: 15" node_number="126"> <a title="valid: False, node: 127, tag: a, level: 16" node_number="127"> MDPI Books </a> </li> <li title="valid: False, node: 128, tag: li, level: 15" node_number="128"> <a title="valid: False, node: 129, tag: a, level: 16" node_number="129"> Preprints </a> </li> <li title="valid: False, node: 130, tag: li, level: 15" node_number="130"> <a title="valid: False, node: 131, tag: a, level: 16" node_number="131"> Scilit </a> </li> <li title="valid: False, node: 132, tag: li, level: 15" node_number="132"> <a title="valid: False, node: 133, tag: a, level: 16" node_number="133"> SciProfiles </a> </li> <li title="valid: False, node: 134, tag: li, level: 15" node_number="134"> <a title="valid: False, node: 135, tag: a, level: 16" node_number="135"> Encyclopedia </a> </li> <li title="valid: False, node: 136, tag: li, level: 15" node_number="136"> <a title="valid: False, node: 137, tag: a, level: 16" node_number="137"> JAMS </a> </li> <li title="valid: False, node: 138, tag: li, level: 15" node_number="138"> <a title="valid: False, node: 139, tag: a, level: 16" node_number="139"> Proceedings Series </a> </li> </ul> </div> </div> </li> </ul> </li> <li class="valid" valid="valid" title="valid: True, node: 140, tag: li, level: 9" node_number="140"> <a class="valid" valid="valid" title="valid: True, node: 141, tag: a, level: 10" node_number="141">About</a> </li> </ul> </div> <div class="valid" valid="valid" title="valid: True, node: 142, tag: div, level: 7" node_number="142"> <div class="valid" valid="valid" title="valid: True, node: 143, tag: div, level: 8" node_number="143"> <a class="valid" valid="valid" title="valid: True, node: 144, tag: a, level: 9" node_number="144">Sign In / Sign Up</a> <a class="valid" valid="valid" title="valid: True, node: 145, tag: a, level: 9" node_number="145">Submit</a> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 146, tag: div, level: 5" node_number="146"> <div class="valid" valid="valid" title="valid: True, node: 147, tag: div, level: 6" node_number="147"> <div class="valid" valid="valid" title="valid: True, node: 148, tag: div, level: 7" node_number="148"> <div class="valid" valid="valid" title="valid: True, node: 149, tag: div, level: 8" node_number="149"> <a class="valid" valid="valid" title="valid: True, node: 150, tag: a, level: 9" node_number="150"> Covered in: PubMed </a> </div></div> <div class="valid" valid="valid" title="valid: True, node: 151, tag: div, level: 7" node_number="151"> <div class="valid" valid="valid" title="valid: True, node: 152, tag: div, level: 8" node_number="152"> <a class="valid" valid="valid" title="valid: True, node: 153, tag: a, level: 9" node_number="153"> IMPACTFACTOR 6.081 </a> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 154, tag: div, level: 6" node_number="154"> Journals </div> <div class="valid" valid="valid" title="valid: True, node: 155, tag: div, level: 6" node_number="155"> Biomedicines </div> </div> </header> <div class="valid" valid="valid" title="valid: True, node: 156, tag: div, level: 4" node_number="156"> <div class="valid" valid="valid" title="valid: True, node: 157, tag: div, level: 5" node_number="157"> <div class="valid" valid="valid" title="valid: True, node: 158, tag: div, level: 6" node_number="158"> <div class="valid" valid="valid" title="valid: True, node: 159, tag: div, level: 7" node_number="159"> <div class="valid" valid="valid" title="valid: True, node: 160, tag: div, level: 8" node_number="160"> <ul class="valid" valid="valid" title="valid: True, node: 161, tag: ul, level: 9" node_number="161"> <li class="valid" valid="valid" title="valid: True, node: 162, tag: li, level: 10" node_number="162"> <a class="valid" valid="valid" title="valid: True, node: 163, tag: a, level: 11" node_number="163"> <div class="valid" valid="valid" title="valid: True, node: 164, tag: div, level: 12" node_number="164"> Translational Insights and New Therapeutic Perspectives in Head and Neck Tumors </div> </a> </li> <li class="valid" valid="valid" title="valid: True, node: 165, tag: li, level: 10" node_number="165"> <a class="valid" valid="valid" title="valid: True, node: 166, tag: a, level: 11" node_number="166"> <div class="valid" valid="valid" title="valid: True, node: 167, tag: div, level: 12" node_number="167"> Extracellular Vesicles in Innate Immune Cell Programming </div> </a> </li> <li class="valid" valid="valid" title="valid: True, node: 168, tag: li, level: 10" node_number="168"> <a class="valid" valid="valid" title="valid: True, node: 169, tag: a, level: 11" node_number="169"> <div class="valid" valid="valid" title="valid: True, node: 170, tag: div, level: 12" node_number="170"> The Fight against COVID-19 on the Multi-Protease Front and Surroundings </div> </a> </li> <li class="valid" valid="valid" title="valid: True, node: 171, tag: li, level: 10" node_number="171"> <a class="valid" valid="valid" title="valid: True, node: 172, tag: a, level: 11" node_number="172"> <div class="valid" valid="valid" title="valid: True, node: 173, tag: div, level: 12" node_number="173"> Near-Infrared-Triggered Upconverting Nanoparticles for Biomedicine Applications </div> </a> </li> <li class="valid" valid="valid" title="valid: True, node: 174, tag: li, level: 10" node_number="174"> <a class="valid" valid="valid" title="valid: True, node: 175, tag: a, level: 11" node_number="175"> <div class="valid" valid="valid" title="valid: True, node: 176, tag: div, level: 12" node_number="176"> Zinc Signaling in the Mammary Gland: For Better and for Worse </div> </a> </li> </ul> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 177, tag: div, level: 7" node_number="177"> <div class="valid" valid="valid" title="valid: True, node: 178, tag: div, level: 8" node_number="178"> <h2 class="valid" valid="valid" title="valid: True, node: 179, tag: h2, level: 9" node_number="179">Journal Description</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 180, tag: div, level: 8" node_number="180"> <div class="valid" valid="valid" title="valid: True, node: 181, tag: div, level: 9" node_number="181"> <h1 class="valid" valid="valid" title="valid: True, node: 182, tag: h1, level: 10" node_number="182"> Biomedicines </h1> <div class="valid" valid="valid" title="valid: True, node: 183, tag: div, level: 10" node_number="183"> Biomedicines is an international, scientific, <a class="valid" valid="valid" title="valid: True, node: 184, tag: a, level: 11" node_number="184">peer-reviewed</a>, open access journal on biomedicines published monthly online by MDPI.&#160;<a class="valid" valid="valid" title="valid: True, node: 185, tag: a, level: 11" node_number="185">The Society for Regenerative Medicine (Russian Federation) (RPO)</a> is affiliated with Biomedicines and&#160;its members receive discounts on the article processing charges. <ul class="valid" valid="valid" title="valid: True, node: 186, tag: ul, level: 11" node_number="186"> <li class="valid" valid="valid" title="valid: True, node: 187, tag: li, level: 12" node_number="187">Open Access&#8212; free for readers,with <a class="valid" valid="valid" title="valid: True, node: 188, tag: a, level: 13" node_number="188">article processing charges (APC)</a> paid by authors or their institutions.</li> <li class="valid" valid="valid" title="valid: True, node: 189, tag: li, level: 12" node_number="189">High Visibility:&#160;indexed within <a class="valid" valid="valid" title="valid: True, node: 190, tag: a, level: 13" node_number="190">Scopus</a>, <a class="valid" valid="valid" title="valid: True, node: 191, tag: a, level: 13" node_number="191">SCIE (Web of Science)</a>, <a class="valid" valid="valid" title="valid: True, node: 192, tag: a, level: 13" node_number="192">PubMed</a>, <a class="valid" valid="valid" title="valid: True, node: 193, tag: a, level: 13" node_number="193">PMC</a>, <a class="valid" valid="valid" title="valid: True, node: 194, tag: a, level: 13" node_number="194">CAPlus / SciFinder</a>, and many <a class="valid" valid="valid" title="valid: True, node: 195, tag: a, level: 13" node_number="195">other databases</a>.</li> <li class="valid" valid="valid" title="valid: True, node: 196, tag: li, level: 12" node_number="196">Journal Rank:&#160;JCR&#160;- Q1 (Biochemistry Molecular Biology) /&#160;CiteScore&#160;- Q2 (General Biochemistry, Genetics and Molecular Biology)</li> <li class="valid" valid="valid" title="valid: True, node: 197, tag: li, level: 12" node_number="197">Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 16.3 days after submission; acceptance to publication is undertaken in 3.5 days (median values for papers published in this journal in the first half of 2021).</li> <li class="valid" valid="valid" title="valid: True, node: 198, tag: li, level: 12" node_number="198">Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.</li> <li class="valid" valid="valid" title="valid: True, node: 199, tag: li, level: 12" node_number="199">Companion journals for&#160;Biomedicines include:&#160;IJTM and <a class="valid" valid="valid" title="valid: True, node: 200, tag: a, level: 13" node_number="200">BioMed</a>.</li> </ul> </div> <div class="valid" valid="valid" title="valid: True, node: 201, tag: div, level: 10" node_number="201"> Impact Factor: 6.081 (2020) ; 5-Year Impact Factor: 5.718 (2020) </div> <div class="valid" valid="valid" title="valid: True, node: 202, tag: div, level: 10" node_number="202"> <a class="valid" valid="valid" title="valid: True, node: 203, tag: a, level: 11" node_number="203"> <i class="valid" valid="valid" title="valid: True, node: 204, tag: i, level: 12" node_number="204">subject</i> Imprint Information </a> <a class="valid" valid="valid" title="valid: True, node: 205, tag: a, level: 11" node_number="205"> <i class="valid" valid="valid" title="valid: True, node: 206, tag: i, level: 12" node_number="206">get_app</i> Journal Flyer </a> <a class="valid" valid="valid" title="valid: True, node: 207, tag: a, level: 11" node_number="207"> Open Access </a> ISSN: 2227-9059 </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 208, tag: div, level: 7" node_number="208"> <div class="valid" valid="valid" title="valid: True, node: 209, tag: div, level: 8" node_number="209"> <h2 class="valid" valid="valid" title="valid: True, node: 210, tag: h2, level: 9" node_number="210">Latest Articles</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 211, tag: div, level: 8" node_number="211"> <div class="valid" valid="valid" title="valid: True, node: 212, tag: div, level: 9" node_number="212"> <div class="valid" valid="valid" title="valid: True, node: 213, tag: div, level: 10" node_number="213"> <div class="valid" valid="valid" title="valid: True, node: 214, tag: div, level: 11" node_number="214"> <div class="valid" valid="valid" title="valid: True, node: 215, tag: div, level: 12" node_number="215"> <a class="valid" valid="valid" title="valid: True, node: 216, tag: a, level: 13" node_number="216"> <i class="valid" valid="valid" title="valid: True, node: 217, tag: i, level: 14" node_number="217">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 218, tag: div, level: 13" node_number="218"> Supplementary material: <a class="valid" valid="valid" title="valid: True, node: 219, tag: a, level: 14" node_number="219"> Supplementary File 1 (ZIP, 6450 KiB) </a> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 220, tag: div, level: 12" node_number="220"> <a class="valid" valid="valid" title="valid: True, node: 221, tag: a, level: 13" node_number="221"> <i class="valid" valid="valid" title="valid: True, node: 222, tag: i, level: 14" node_number="222">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 223, tag: div, level: 12" node_number="223"> <a class="valid" valid="valid" title="valid: True, node: 224, tag: a, level: 13" node_number="224"> <i class="valid" valid="valid" title="valid: True, node: 225, tag: i, level: 14" node_number="225">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 226, tag: div, level: 13" node_number="226"> View online as: <a class="valid" valid="valid" title="valid: True, node: 227, tag: a, level: 14" node_number="227">Abstract Page</a> <a class="valid" valid="valid" title="valid: True, node: 228, tag: a, level: 14" node_number="228">Full-Text HTML</a> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 229, tag: div, level: 12" node_number="229">Open AccessArticle</div> <a class="valid" valid="valid" title="valid: True, node: 230, tag: a, level: 12" node_number="230">Regulation of Oncogenic Targets by Tumor-Suppressive <i class="valid" valid="valid" title="valid: True, node: 231, tag: i, level: 13" node_number="231">miR-150-3p</i> in Lung Squamous Cell Carcinoma</a> <div class="valid" valid="valid" title="valid: True, node: 232, tag: div, level: 12" node_number="232"> by <span class="valid" valid="valid" title="valid: True, node: 233, tag: span, level: 13" node_number="233"><div class="valid" valid="valid" title="valid: True, node: 234, tag: div, level: 14" node_number="234">Keiko Mizuno</div>, </span><span class="valid" valid="valid" title="valid: True, node: 235, tag: span, level: 13" node_number="235"><div class="valid" valid="valid" title="valid: True, node: 236, tag: div, level: 14" node_number="236">Kengo Tanigawa</div>, </span><span class="valid" valid="valid" title="valid: True, node: 237, tag: span, level: 13" node_number="237"><div class="valid" valid="valid" title="valid: True, node: 238, tag: div, level: 14" node_number="238">Shunsuke Misono</div>, </span><span class="valid" valid="valid" title="valid: True, node: 239, tag: span, level: 13" node_number="239"><div class="valid" valid="valid" title="valid: True, node: 240, tag: div, level: 14" node_number="240">Takayuki Suetsugu</div>, </span><span class="valid" valid="valid" title="valid: True, node: 241, tag: span, level: 13" node_number="241"><div class="valid" valid="valid" title="valid: True, node: 242, tag: div, level: 14" node_number="242">Hiroki Sanada</div>, </span><span class="valid" valid="valid" title="valid: True, node: 243, tag: span, level: 13" node_number="243"><div class="valid" valid="valid" title="valid: True, node: 244, tag: div, level: 14" node_number="244">Akifumi Uchida</div>, </span><span class="valid" valid="valid" title="valid: True, node: 245, tag: span, level: 13" node_number="245"><div class="valid" valid="valid" title="valid: True, node: 246, tag: div, level: 14" node_number="246">Minami Kawano</div>, </span><span class="valid" valid="valid" title="valid: True, node: 247, tag: span, level: 13" node_number="247"><div class="valid" valid="valid" title="valid: True, node: 248, tag: div, level: 14" node_number="248">Kentaro Machida</div>, </span><span class="valid" valid="valid" title="valid: True, node: 249, tag: span, level: 13" node_number="249"><div class="valid" valid="valid" title="valid: True, node: 250, tag: div, level: 14" node_number="250">Shunichi Asai</div>, </span><span class="valid" valid="valid" title="valid: True, node: 251, tag: span, level: 13" node_number="251"><div class="valid" valid="valid" title="valid: True, node: 252, tag: div, level: 14" node_number="252">Shogo Moriya</div>, </span><span class="valid" valid="valid" title="valid: True, node: 253, tag: span, level: 13" node_number="253"><div class="valid" valid="valid" title="valid: True, node: 254, tag: div, level: 14" node_number="254">Hiromasa Inoue</div> and </span><span class="valid" valid="valid" title="valid: True, node: 255, tag: span, level: 13" node_number="255"><div class="valid" valid="valid" title="valid: True, node: 256, tag: div, level: 14" node_number="256">Naohiko Seki</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 257, tag: div, level: 12" node_number="257"> Biomedicines <b class="valid" valid="valid" title="valid: True, node: 258, tag: b, level: 13" node_number="258">2021</b>, 9(12), 1883; https://doi.org/10.3390/biomedicines9121883 (registering&#160;DOI) - 11 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 259, tag: div, level: 12" node_number="259"> Abstract <div class="valid" valid="valid" title="valid: True, node: 260, tag: div, level: 13" node_number="260"> Several recent studies have shown that both strands of certain miRNAs derived from miRNA duplexes are involved in cancer pathogenesis. Our own recent studies revealed that both strands of the <i class="valid" valid="valid" title="valid: True, node: 261, tag: i, level: 14" node_number="261">miR-150</i> duplex act as tumor-suppressive miRNAs in lung adenocarcinoma (LUAD) through the targeting [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 262, tag: div, level: 13" node_number="262"> Several recent studies have shown that both strands of certain miRNAs derived from miRNA duplexes are involved in cancer pathogenesis. Our own recent studies revealed that both strands of the <i class="valid" valid="valid" title="valid: True, node: 263, tag: i, level: 14" node_number="263">miR-150</i> duplex act as tumor-suppressive miRNAs in lung adenocarcinoma (LUAD) through the targeting of several oncogenes. The aim of the study here was to further investigate the tumor-suppressive roles of <i class="valid" valid="valid" title="valid: True, node: 264, tag: i, level: 14" node_number="264">miR-150-3p</i> (the passenger strand) in lung squamous cell carcinoma (LUSQ) and its control of cancer-promoting genes in LUSQ cells. The downregulation of <i class="valid" valid="valid" title="valid: True, node: 265, tag: i, level: 14" node_number="265">miR-150-3p</i> in LUSQ tissues was confirmed by data in The Cancer Genome Atlas (TCGA). The ectopic expression of <i class="valid" valid="valid" title="valid: True, node: 266, tag: i, level: 14" node_number="266">miR-150-3p</i> attenuated cancer cell aggressive features, e.g., cell cycle arrest, migration and invasive abilities. Our target search strategy successfully identified a total of 49 putative targets that were listed as subjects of <i class="valid" valid="valid" title="valid: True, node: 267, tag: i, level: 14" node_number="267">miR-150-3p</i> regulation in LUSQ cells. Interestingly, among these targets, 17 genes were categorized as related to the &#8220;cell cycle&#8221; based on Gene Ontology (GO) classification, namely <i class="valid" valid="valid" title="valid: True, node: 268, tag: i, level: 14" node_number="268">CENPA</i>, <i class="valid" valid="valid" title="valid: True, node: 269, tag: i, level: 14" node_number="269">CIT</i>, <i class="valid" valid="valid" title="valid: True, node: 270, tag: i, level: 14" node_number="270">CCNE1</i>, <i class="valid" valid="valid" title="valid: True, node: 271, tag: i, level: 14" node_number="271">CCNE2</i>, <i class="valid" valid="valid" title="valid: True, node: 272, tag: i, level: 14" node_number="272">TIMELESS</i>, <i class="valid" valid="valid" title="valid: True, node: 273, tag: i, level: 14" node_number="273">BUB1</i>, <i class="valid" valid="valid" title="valid: True, node: 274, tag: i, level: 14" node_number="274">MCM4</i>, <i class="valid" valid="valid" title="valid: True, node: 275, tag: i, level: 14" node_number="275">HELLS</i>, <i class="valid" valid="valid" title="valid: True, node: 276, tag: i, level: 14" node_number="276">SKA3</i>, <i class="valid" valid="valid" title="valid: True, node: 277, tag: i, level: 14" node_number="277">CDCA2</i>, <i class="valid" valid="valid" title="valid: True, node: 278, tag: i, level: 14" node_number="278">FANCD2</i>, <i class="valid" valid="valid" title="valid: True, node: 279, tag: i, level: 14" node_number="279">NUF2</i>, <i class="valid" valid="valid" title="valid: True, node: 280, tag: i, level: 14" node_number="280">E2F2</i>, <i class="valid" valid="valid" title="valid: True, node: 281, tag: i, level: 14" node_number="281">SUV39H2</i>, <i class="valid" valid="valid" title="valid: True, node: 282, tag: i, level: 14" node_number="282">CASC5</i>, <i class="valid" valid="valid" title="valid: True, node: 283, tag: i, level: 14" node_number="283">ZWILCH</i> and <i class="valid" valid="valid" title="valid: True, node: 284, tag: i, level: 14" node_number="284">CKAP2</i>). Moreover, we show that the expression of <i class="valid" valid="valid" title="valid: True, node: 285, tag: i, level: 14" node_number="285">HELLS</i> (helicase, lymphoid specific) is directly controlled by <i class="valid" valid="valid" title="valid: True, node: 286, tag: i, level: 14" node_number="286">miR-150-3p</i>, and its expression promotes the malignant phenotype of LUSQ cells. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 287, tag: div, level: 12" node_number="287"> (This article belongs to the Special Issue MicroRNA in Solid Tumor and Hematological Diseases 2.0) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 288, tag: div, level: 12" node_number="288"><div class="valid" valid="valid" title="valid: True, node: 289, tag: div, level: 13" node_number="289"><div class="valid" valid="valid" title="valid: True, node: 290, tag: div, level: 14" node_number="290"><p title="valid: False, node: 291, tag: p, level: 15" node_number="291">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 292, tag: div, level: 9" node_number="292"> <div class="valid" valid="valid" title="valid: True, node: 293, tag: div, level: 10" node_number="293"> <div class="valid" valid="valid" title="valid: True, node: 294, tag: div, level: 11" node_number="294"> <div class="valid" valid="valid" title="valid: True, node: 295, tag: div, level: 12" node_number="295"> <div class="valid" valid="valid" title="valid: True, node: 296, tag: div, level: 13" node_number="296"> <a class="valid" valid="valid" title="valid: True, node: 297, tag: a, level: 14" node_number="297"> <i title="valid: False, node: 298, tag: i, level: 15" node_number="298">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 299, tag: div, level: 14" node_number="299"> Supplementary material: Supplementary File 1 (ZIP, 178 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 300, tag: div, level: 13" node_number="300"> <a class="valid" valid="valid" title="valid: True, node: 301, tag: a, level: 14" node_number="301"> <i title="valid: False, node: 302, tag: i, level: 15" node_number="302">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 303, tag: div, level: 13" node_number="303"> <a class="valid" valid="valid" title="valid: True, node: 304, tag: a, level: 14" node_number="304"> <i title="valid: False, node: 305, tag: i, level: 15" node_number="305">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 306, tag: div, level: 14" node_number="306"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 307, tag: div, level: 13" node_number="307">Open AccessArticle</div> Functional Characterization of Spinocerebellar Ataxia Associated Dynorphin A Mutant Peptides <div class="valid" valid="valid" title="valid: True, node: 308, tag: div, level: 13" node_number="308"> by <span class="valid" valid="valid" title="valid: True, node: 309, tag: span, level: 14" node_number="309"><div title="valid: False, node: 310, tag: div, level: 15" node_number="310">Andreas Lieb</div>, </span><span class="valid" valid="valid" title="valid: True, node: 311, tag: span, level: 14" node_number="311"><div title="valid: False, node: 312, tag: div, level: 15" node_number="312">Germana Thaler</div>, </span><span class="valid" valid="valid" title="valid: True, node: 313, tag: span, level: 14" node_number="313"><div title="valid: False, node: 314, tag: div, level: 15" node_number="314">Barbara Fogli</div>, </span><span class="valid" valid="valid" title="valid: True, node: 315, tag: span, level: 14" node_number="315"><div title="valid: False, node: 316, tag: div, level: 15" node_number="316">Olga Trovato</div>, </span><span class="valid" valid="valid" title="valid: True, node: 317, tag: span, level: 14" node_number="317"><div title="valid: False, node: 318, tag: div, level: 15" node_number="318">Mitja Amon Posch</div>, </span><span class="valid" valid="valid" title="valid: True, node: 319, tag: span, level: 14" node_number="319"><div title="valid: False, node: 320, tag: div, level: 15" node_number="320">Teresa Kaserer</div> and </span><span class="valid" valid="valid" title="valid: True, node: 321, tag: span, level: 14" node_number="321"><div title="valid: False, node: 322, tag: div, level: 15" node_number="322">Luca Zangrandi</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 323, tag: div, level: 13" node_number="323"> Biomedicines <b class="valid" valid="valid" title="valid: True, node: 324, tag: b, level: 14" node_number="324">2021</b>, 9(12), 1882; https://doi.org/10.3390/biomedicines9121882 (registering&#160;DOI) - 11 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 325, tag: div, level: 13" node_number="325"> Abstract <div class="valid" valid="valid" title="valid: True, node: 326, tag: div, level: 14" node_number="326"> Mutations in the prodynorphin gene (<i title="valid: False, node: 327, tag: i, level: 15" node_number="327">PDYN</i>) are associated with the development of spinocerebellar ataxia type 23 (SCA23). Pathogenic missense mutations are localized predominantly in the <i title="valid: False, node: 328, tag: i, level: 15" node_number="328">PDYN</i> region coding for the dynorphin A (DynA) neuropeptide and lead to persistently elevated mutant peptide [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 329, tag: div, level: 14" node_number="329"> Mutations in the prodynorphin gene (<i title="valid: False, node: 330, tag: i, level: 15" node_number="330">PDYN</i>) are associated with the development of spinocerebellar ataxia type 23 (SCA23). Pathogenic missense mutations are localized predominantly in the <i title="valid: False, node: 331, tag: i, level: 15" node_number="331">PDYN</i> region coding for the dynorphin A (DynA) neuropeptide and lead to persistently elevated mutant peptide levels with neurotoxic properties. The main DynA target in the central nervous system is the kappa opioid receptor (KOR), a member of the G-protein coupled receptor family, which can elicit signaling cascades mediated by G-protein dissociation as well as &#946;-arrestin recruitment. To date, a thorough analysis of the functional profile for the pathogenic SCA23 DynA mutants at KOR is still missing. To elucidate the role of DynA mutants, we used a combination of assays to investigate the differential activation of G-protein subunits and &#946;-arrestin. In addition, we applied molecular modelling techniques to provide a rationale for the underlying mechanism. Our results demonstrate that DynA mutations, associated with a severe ataxic phenotype, decrease potency of KOR activation, both for G-protein dissociation as well as &#946;-arrestin recruitment. Molecular modelling suggests that this loss of function is due to disruption of critical interactions between DynA and the receptor. In conclusion, this study advances our understanding of KOR signal transduction upon DynA wild type or mutant peptide binding. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 332, tag: div, level: 13" node_number="332"> (This article belongs to the Special Issue Neuropeptides in Biomedicines) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 333, tag: div, level: 13" node_number="333"><div class="valid" valid="valid" title="valid: True, node: 334, tag: div, level: 14" node_number="334"><div title="valid: False, node: 335, tag: div, level: 15" node_number="335"><p title="valid: False, node: 336, tag: p, level: 16" node_number="336">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 337, tag: div, level: 10" node_number="337"> <div class="valid" valid="valid" title="valid: True, node: 338, tag: div, level: 11" node_number="338"> <div class="valid" valid="valid" title="valid: True, node: 339, tag: div, level: 12" node_number="339"> <div class="valid" valid="valid" title="valid: True, node: 340, tag: div, level: 13" node_number="340"> <a class="valid" valid="valid" title="valid: True, node: 341, tag: a, level: 14" node_number="341"> <i title="valid: False, node: 342, tag: i, level: 15" node_number="342">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 343, tag: div, level: 13" node_number="343"> <a class="valid" valid="valid" title="valid: True, node: 344, tag: a, level: 14" node_number="344"> <i title="valid: False, node: 345, tag: i, level: 15" node_number="345">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 346, tag: div, level: 14" node_number="346"> View online as: Abstract Page </div> </div> <div class="valid" valid="valid" title="valid: True, node: 347, tag: div, level: 13" node_number="347">Open AccessArticle</div> Low-Dose Niacin Supplementation Improves Motor Function in US Veterans with Parkinson&#8217;s Disease: A Single-Center, Randomized, Placebo-Controlled Trial <div class="valid" valid="valid" title="valid: True, node: 348, tag: div, level: 13" node_number="348"> by <span class="valid" valid="valid" title="valid: True, node: 349, tag: span, level: 14" node_number="349"><div title="valid: False, node: 350, tag: div, level: 15" node_number="350">Chandramohan Wakade</div>, </span><span class="valid" valid="valid" title="valid: True, node: 351, tag: span, level: 14" node_number="351"><div title="valid: False, node: 352, tag: div, level: 15" node_number="352">Raymond Chong</div>, </span><span class="valid" valid="valid" title="valid: True, node: 353, tag: span, level: 14" node_number="353"><div title="valid: False, node: 354, tag: div, level: 15" node_number="354">Marissa Seamon</div>, </span><span class="valid" valid="valid" title="valid: True, node: 355, tag: span, level: 14" node_number="355"><div title="valid: False, node: 356, tag: div, level: 15" node_number="356">Sharad Purohit</div>, </span><span class="valid" valid="valid" title="valid: True, node: 357, tag: span, level: 14" node_number="357"><div title="valid: False, node: 358, tag: div, level: 15" node_number="358">Banabihari Giri</div> and </span><span class="valid" valid="valid" title="valid: True, node: 359, tag: span, level: 14" node_number="359"><div title="valid: False, node: 360, tag: div, level: 15" node_number="360">John C. Morgan</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 361, tag: div, level: 13" node_number="361"> Biomedicines <b class="valid" valid="valid" title="valid: True, node: 362, tag: b, level: 14" node_number="362">2021</b>, 9(12), 1881; https://doi.org/10.3390/biomedicines9121881 (registering&#160;DOI) - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 363, tag: div, level: 13" node_number="363"> Abstract <div class="valid" valid="valid" title="valid: True, node: 364, tag: div, level: 14" node_number="364"> A six-month double-blind, placebo-controlled randomized study was conducted to ascertain whether low-dose daily niacin supplementation would improve motor symptoms in Parkinson&#8217;s disease (PD) patients. A total of 47 PD patients were assigned to receive low-dose niacin or a placebo. At the end of [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 365, tag: div, level: 14" node_number="365"> A six-month double-blind, placebo-controlled randomized study was conducted to ascertain whether low-dose daily niacin supplementation would improve motor symptoms in Parkinson&#8217;s disease (PD) patients. A total of 47 PD patients were assigned to receive low-dose niacin or a placebo. At the end of the double-blind phase, all participants received open-label niacin for the next six months. All patients were evaluated at baseline, after six months, and after one year of treatment. The primary outcome measure was the Unified Parkinson&#8217;s Disease Rating Scale III (UPDRS III) scores. Secondary outcome measures were depression, sleep quality, mental flexibility and cognition, and physical fatigue. Niacin treatment was well-tolerated by forty-five subjects. The mean [95% CI] change in UPDRS III scores at six months of placebo was &#8722;0.05 [95% CI, &#8722;2.4 to 2.32], and niacin was &#8722;1.06 [95% CI, &#8722;3.68 to 1.57]. From six to twelve months when both groups received open-label niacin supplementation, the average UPDRS III scores significantly decreased for the placebo group by 4.58 [95% CI, &#8722;0.85 to 8.30] and the niacin group by 4.63 [95% CI, 1.42 to 7.83] points. Low-dose niacin supplementation is a well-tolerated adjunct therapy and may improve motor function in PD when taken over a longer period. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 366, tag: div, level: 13" node_number="366"> (This article belongs to the Special Issue Biomarkers in Neurodegenerative Diseases 2.0) </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 367, tag: div, level: 10" node_number="367"> <div class="valid" valid="valid" title="valid: True, node: 368, tag: div, level: 11" node_number="368"> <div class="valid" valid="valid" title="valid: True, node: 369, tag: div, level: 12" node_number="369"> <div class="valid" valid="valid" title="valid: True, node: 370, tag: div, level: 13" node_number="370"> <a class="valid" valid="valid" title="valid: True, node: 371, tag: a, level: 14" node_number="371"> <i title="valid: False, node: 372, tag: i, level: 15" node_number="372">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 373, tag: div, level: 13" node_number="373"> <a class="valid" valid="valid" title="valid: True, node: 374, tag: a, level: 14" node_number="374"> <i title="valid: False, node: 375, tag: i, level: 15" node_number="375">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 376, tag: div, level: 14" node_number="376"> View online as: Abstract Page </div> </div> <div class="valid" valid="valid" title="valid: True, node: 377, tag: div, level: 13" node_number="377">Open AccessArticle</div> The Neuropeptide VIP Limits Human Osteoclastogenesis:Clinical Associations with Bone Metabolism Markers in Patients with Early Arthritis <div class="valid" valid="valid" title="valid: True, node: 378, tag: div, level: 13" node_number="378"> by <span class="valid" valid="valid" title="valid: True, node: 379, tag: span, level: 14" node_number="379"><div title="valid: False, node: 380, tag: div, level: 15" node_number="380">David Castro-Vazquez</div>, </span><span class="valid" valid="valid" title="valid: True, node: 381, tag: span, level: 14" node_number="381"><div title="valid: False, node: 382, tag: div, level: 15" node_number="382">Amalia Lamana</div>, </span><span class="valid" valid="valid" title="valid: True, node: 383, tag: span, level: 14" node_number="383"><div title="valid: False, node: 384, tag: div, level: 15" node_number="384">Paula Arribas-Casta&#241;o</div>, </span><span class="valid" valid="valid" title="valid: True, node: 385, tag: span, level: 14" node_number="385"><div title="valid: False, node: 386, tag: div, level: 15" node_number="386">Irene Guti&#233;rrez-Ca&#241;as</div>, </span><span class="valid" valid="valid" title="valid: True, node: 387, tag: span, level: 14" node_number="387"><div title="valid: False, node: 388, tag: div, level: 15" node_number="388">Ra&#250;l Villanueva-Romero</div>, </span><span class="valid" valid="valid" title="valid: True, node: 389, tag: span, level: 14" node_number="389"><div title="valid: False, node: 390, tag: div, level: 15" node_number="390">Selene P&#233;rez-Garc&#237;a</div>, </span><span class="valid" valid="valid" title="valid: True, node: 391, tag: span, level: 14" node_number="391"><div title="valid: False, node: 392, tag: div, level: 15" node_number="392">Carmen Mart&#237;nez</div>, </span><span class="valid" valid="valid" title="valid: True, node: 393, tag: span, level: 14" node_number="393"><div title="valid: False, node: 394, tag: div, level: 15" node_number="394">Yasmina Juarranz</div>, </span><span class="valid" valid="valid" title="valid: True, node: 395, tag: span, level: 14" node_number="395"><div title="valid: False, node: 396, tag: div, level: 15" node_number="396">Sara Fern&#225;ndez de C&#243;rdoba</div>, </span><span class="valid" valid="valid" title="valid: True, node: 397, tag: span, level: 14" node_number="397"><div title="valid: False, node: 398, tag: div, level: 15" node_number="398">Isidoro Gonz&#225;lez-&#193;lvaro</div>, </span><span class="valid" valid="valid" title="valid: True, node: 399, tag: span, level: 14" node_number="399"><div title="valid: False, node: 400, tag: div, level: 15" node_number="400">Rosa P. Gomariz</div> and </span><span class="valid" valid="valid" title="valid: True, node: 401, tag: span, level: 14" node_number="401"><div title="valid: False, node: 402, tag: div, level: 15" node_number="402">Mar Carri&#243;n</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 403, tag: div, level: 13" node_number="403"> Biomedicines <b class="valid" valid="valid" title="valid: True, node: 404, tag: b, level: 14" node_number="404">2021</b>, 9(12), 1880; https://doi.org/10.3390/biomedicines9121880 (registering&#160;DOI) - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 405, tag: div, level: 13" node_number="405"> Abstract <div class="valid" valid="valid" title="valid: True, node: 406, tag: div, level: 14" node_number="406"> We aimed to evaluate the direct action of VIP on crucial molecules involved in human osteoclast differentiation and function. We also investigated the relationship between VIP serum levels and bone remodeling mediators in early arthritis patients. The expression of VIP receptors and osteoclast [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 407, tag: div, level: 14" node_number="407"> We aimed to evaluate the direct action of VIP on crucial molecules involved in human osteoclast differentiation and function. We also investigated the relationship between VIP serum levels and bone remodeling mediators in early arthritis patients. The expression of VIP receptors and osteoclast gene markers in monocytes and in vitro differentiated osteoclasts was studied by real-time PCR. NFATc1 activity was measured using a TransAM<sup title="valid: False, node: 408, tag: sup, level: 15" node_number="408">&#174;</sup> kit. Osteoclastogenesis was confirmed by quantification of tartrate-resistant acid phosphatase positive multinucleated cells. OsteoAssay<sup title="valid: False, node: 409, tag: sup, level: 15" node_number="409">&#174;</sup> Surface Multiple Well Plate was used to evaluate bone-resorbing activity. The ring-shaped actin cytoskeleton and the VPAC1 and VPAC2 expression were analyzed by immunofluorescence. We described the presence of VIP receptors in monocytes and mature osteoclasts. Osteoclasts that formed in the presence of VIP showed a decreased expression of osteoclast differentiation gene markers and proteolytic enzymes involved in bone resorption. VIP reduced the resorption activity and decreased both &#946;3 integrin expression and actin ring formation. Elevated serum VIP levels in early arthritis patients were associated with lower BMD loss and higher serum OPG concentration. These results demonstrate that VIP exerts an anti-osteoclastogenic action impairing both differentiation and resorption activity mainly through the negative regulation of NFATc1, evidencing its bone-protective effects in humans. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 410, tag: div, level: 13" node_number="410"> (This article belongs to the Special Issue Neuropeptides in Biomedicines) </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 411, tag: div, level: 10" node_number="411"> <div class="valid" valid="valid" title="valid: True, node: 412, tag: div, level: 11" node_number="412"> <div class="valid" valid="valid" title="valid: True, node: 413, tag: div, level: 12" node_number="413"> <div class="valid" valid="valid" title="valid: True, node: 414, tag: div, level: 13" node_number="414"> <a class="valid" valid="valid" title="valid: True, node: 415, tag: a, level: 14" node_number="415"> <i title="valid: False, node: 416, tag: i, level: 15" node_number="416">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 417, tag: div, level: 14" node_number="417"> Supplementary material: Supplementary File 1 (ZIP, 104 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 418, tag: div, level: 13" node_number="418"> <a class="valid" valid="valid" title="valid: True, node: 419, tag: a, level: 14" node_number="419"> <i title="valid: False, node: 420, tag: i, level: 15" node_number="420">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 421, tag: div, level: 13" node_number="421"> <a class="valid" valid="valid" title="valid: True, node: 422, tag: a, level: 14" node_number="422"> <i title="valid: False, node: 423, tag: i, level: 15" node_number="423">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 424, tag: div, level: 14" node_number="424"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 425, tag: div, level: 13" node_number="425">Open AccessArticle</div> <a class="valid" valid="valid" title="valid: True, node: 426, tag: a, level: 13" node_number="426"><i class="valid" valid="valid" title="valid: True, node: 427, tag: i, level: 14" node_number="427">ACTB</i> Mutations Analysis and Genotype&#8211;Phenotype Correlation in Becker&#8217;s Nevus</a> <div class="valid" valid="valid" title="valid: True, node: 428, tag: div, level: 13" node_number="428"> by <span class="valid" valid="valid" title="valid: True, node: 429, tag: span, level: 14" node_number="429"><div title="valid: False, node: 430, tag: div, level: 15" node_number="430">Shangzhi Dai</div>, </span><span class="valid" valid="valid" title="valid: True, node: 431, tag: span, level: 14" node_number="431"><div title="valid: False, node: 432, tag: div, level: 15" node_number="432">Huijun Wang</div> and </span><span class="valid" valid="valid" title="valid: True, node: 433, tag: span, level: 14" node_number="433"><div title="valid: False, node: 434, tag: div, level: 15" node_number="434">Zhimiao Lin</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 435, tag: div, level: 13" node_number="435"> Biomedicines <b class="valid" valid="valid" title="valid: True, node: 436, tag: b, level: 14" node_number="436">2021</b>, 9(12), 1879; https://doi.org/10.3390/biomedicines9121879 (registering&#160;DOI) - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 437, tag: div, level: 13" node_number="437"> Abstract <div class="valid" valid="valid" title="valid: True, node: 438, tag: div, level: 14" node_number="438"> Becker&#8217;s nevus (BN) is a cutaneous hamartoma which is characterized by circumscribed hyperpigmentation with hypertrichosis. Recent studies have revealed that BN patients harbored postzygotic <i title="valid: False, node: 439, tag: i, level: 15" node_number="439">ACTB</i> mutations, which were restricted to arrector pili muscle lineage. We screened for <i title="valid: False, node: 440, tag: i, level: 15" node_number="440">ACTB</i> mutations in 20 Chinese patients [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 441, tag: div, level: 14" node_number="441"> Becker&#8217;s nevus (BN) is a cutaneous hamartoma which is characterized by circumscribed hyperpigmentation with hypertrichosis. Recent studies have revealed that BN patients harbored postzygotic <i title="valid: False, node: 442, tag: i, level: 15" node_number="442">ACTB</i> mutations, which were restricted to arrector pili muscle lineage. We screened for <i title="valid: False, node: 443, tag: i, level: 15" node_number="443">ACTB</i> mutations in 20 Chinese patients with BN and found that recurrent mutations (c.C439A or c.C439T) in <i title="valid: False, node: 444, tag: i, level: 15" node_number="444">ACTB</i> were detected in the majority of BN patients. However, more than 20% of the patients were negative for <i title="valid: False, node: 445, tag: i, level: 15" node_number="445">ACTB</i> mutations, suggesting a possible genetic heterogeneity in Becker&#8217;s nevus. Interestingly, these mutations were also detected in dermal tissues outside the arrector pili muscle. We further performed genotype&#8211;phenotype correlation analysis, which revealed that lesions above the waistline, including the trunk above the anterior superior spine level, upper limbs and face, or covering more than 1% BSA were more likely to be positive for <i title="valid: False, node: 446, tag: i, level: 15" node_number="446">ACTB</i> mutations. Altogether, our results provide further evidence of postzygotic <i title="valid: False, node: 447, tag: i, level: 15" node_number="447">ACTB</i> mutations in BN patients and suggest a possible genotype&#8211;phenotype correlation of BN. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 448, tag: div, level: 13" node_number="448"> (This article belongs to the Special Issue Somatic Mosaicism in Skin Disorders) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 449, tag: div, level: 13" node_number="449"><div class="valid" valid="valid" title="valid: True, node: 450, tag: div, level: 14" node_number="450"><div title="valid: False, node: 451, tag: div, level: 15" node_number="451"><p title="valid: False, node: 452, tag: p, level: 16" node_number="452">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 453, tag: div, level: 10" node_number="453"> <div class="valid" valid="valid" title="valid: True, node: 454, tag: div, level: 11" node_number="454"> <div class="valid" valid="valid" title="valid: True, node: 455, tag: div, level: 12" node_number="455"> <div class="valid" valid="valid" title="valid: True, node: 456, tag: div, level: 13" node_number="456"> <a class="valid" valid="valid" title="valid: True, node: 457, tag: a, level: 14" node_number="457"> <i title="valid: False, node: 458, tag: i, level: 15" node_number="458">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 459, tag: div, level: 13" node_number="459"> <a class="valid" valid="valid" title="valid: True, node: 460, tag: a, level: 14" node_number="460"> <i title="valid: False, node: 461, tag: i, level: 15" node_number="461">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 462, tag: div, level: 14" node_number="462"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 463, tag: div, level: 13" node_number="463">Open AccessArticle</div> BET Proteins Regulate Expression of Osr1 in Early Kidney Development <div class="valid" valid="valid" title="valid: True, node: 464, tag: div, level: 13" node_number="464"> by <span class="valid" valid="valid" title="valid: True, node: 465, tag: span, level: 14" node_number="465"><div title="valid: False, node: 466, tag: div, level: 15" node_number="466">Janina Schreiber</div>, </span><span class="valid" valid="valid" title="valid: True, node: 467, tag: span, level: 14" node_number="467"><div title="valid: False, node: 468, tag: div, level: 15" node_number="468">Nastassia Liaukouskaya</div>, </span><span class="valid" valid="valid" title="valid: True, node: 469, tag: span, level: 14" node_number="469"><div title="valid: False, node: 470, tag: div, level: 15" node_number="470">Lars Fuhrmann</div>, </span><span class="valid" valid="valid" title="valid: True, node: 471, tag: span, level: 14" node_number="471"><div title="valid: False, node: 472, tag: div, level: 15" node_number="472">Alexander-Thomas Hauser</div>, </span><span class="valid" valid="valid" title="valid: True, node: 473, tag: span, level: 14" node_number="473"><div title="valid: False, node: 474, tag: div, level: 15" node_number="474">Manfred Jung</div>, </span><span class="valid" valid="valid" title="valid: True, node: 475, tag: span, level: 14" node_number="475"><div title="valid: False, node: 476, tag: div, level: 15" node_number="476">Tobias B. Huber</div> and </span><span class="valid" valid="valid" title="valid: True, node: 477, tag: span, level: 14" node_number="477"><div title="valid: False, node: 478, tag: div, level: 15" node_number="478">Nicola Wanner</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 479, tag: div, level: 13" node_number="479"> Biomedicines <b class="valid" valid="valid" title="valid: True, node: 480, tag: b, level: 14" node_number="480">2021</b>, 9(12), 1878; https://doi.org/10.3390/biomedicines9121878 (registering&#160;DOI) - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 481, tag: div, level: 13" node_number="481"> Abstract <div class="valid" valid="valid" title="valid: True, node: 482, tag: div, level: 14" node_number="482"> In utero renal development is subject to maternal metabolic and environmental influences affecting long-term renal function and the risk of developing chronic kidney failure and cardiovascular disease. Epigenetic processes have been implicated in the orchestration of renal development and prenatal programming of nephron [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 483, tag: div, level: 14" node_number="483"> In utero renal development is subject to maternal metabolic and environmental influences affecting long-term renal function and the risk of developing chronic kidney failure and cardiovascular disease. Epigenetic processes have been implicated in the orchestration of renal development and prenatal programming of nephron number. However, the role of many epigenetic modifiers for kidney development is still unclear. Bromodomain and extra-terminal domain (BET) proteins act as histone acetylation reader molecules and promote gene transcription. BET family members Brd2, Brd3 and Brd4 are expressed in the nephrogenic zone during kidney development. Here, the effect of the BET inhibitor JQ1 on renal development is evaluated. Inhibition of BET proteins via JQ1 leads to reduced growth of metanephric kidney cultures, loss of the nephron progenitor cell population, and premature and disturbed nephron differentiation. Gene expression of key nephron progenitor transcription factor Osr1 is downregulated after 24 h BET inhibition, while Lhx1 and Pax8 expression is increased. Mining of BRD4 ChIP-seq and gene expression data identify Osr1 as a key factor regulated by BRD4-controlled gene activation. Inhibition of BRD4 by BET inhibitor JQ1 leads to downregulation of Osr1, thereby causing a disturbance in the balance of nephron progenitor cell self-renewal and premature differentiation of the nephron, which ultimately leads to kidney hypoplasia and disturbed nephron development. This raises questions about the potential teratogenic effects of BET inhibitors for embryonic development. In summary, our work highlights the role of BET proteins for prenatal programming of nephrogenesis and identifies Osr1 as a potential target of BET proteins. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 484, tag: div, level: 13" node_number="484"> (This article belongs to the Special Issue Glomerular Microenvironment: Cellular Stress in Chronic Kidney Disease) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 485, tag: div, level: 13" node_number="485"><div class="valid" valid="valid" title="valid: True, node: 486, tag: div, level: 14" node_number="486"><div title="valid: False, node: 487, tag: div, level: 15" node_number="487"><p title="valid: False, node: 488, tag: p, level: 16" node_number="488">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 489, tag: div, level: 10" node_number="489"> <div class="valid" valid="valid" title="valid: True, node: 490, tag: div, level: 11" node_number="490"> <div class="valid" valid="valid" title="valid: True, node: 491, tag: div, level: 12" node_number="491"> <div class="valid" valid="valid" title="valid: True, node: 492, tag: div, level: 13" node_number="492"> <a class="valid" valid="valid" title="valid: True, node: 493, tag: a, level: 14" node_number="493"> <i title="valid: False, node: 494, tag: i, level: 15" node_number="494">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 495, tag: div, level: 14" node_number="495"> Supplementary material: Supplementary File 1 (ZIP, 5893 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 496, tag: div, level: 13" node_number="496"> <a class="valid" valid="valid" title="valid: True, node: 497, tag: a, level: 14" node_number="497"> <i title="valid: False, node: 498, tag: i, level: 15" node_number="498">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 499, tag: div, level: 13" node_number="499"> <a class="valid" valid="valid" title="valid: True, node: 500, tag: a, level: 14" node_number="500"> <i title="valid: False, node: 501, tag: i, level: 15" node_number="501">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 502, tag: div, level: 14" node_number="502"> View online as: Abstract Page </div> </div> <div class="valid" valid="valid" title="valid: True, node: 503, tag: div, level: 13" node_number="503">Open AccessArticle</div> Rapid Androgen-Responsive Proteome Is Involved in Prostate Cancer Progression <div class="valid" valid="valid" title="valid: True, node: 504, tag: div, level: 13" node_number="504"> by <span class="valid" valid="valid" title="valid: True, node: 505, tag: span, level: 14" node_number="505"><div title="valid: False, node: 506, tag: div, level: 15" node_number="506">Jong-Kwang Kim</div>, </span><span class="valid" valid="valid" title="valid: True, node: 507, tag: span, level: 14" node_number="507"><div title="valid: False, node: 508, tag: div, level: 15" node_number="508">Jaehun Jung</div>, </span><span class="valid" valid="valid" title="valid: True, node: 509, tag: span, level: 14" node_number="509"><div title="valid: False, node: 510, tag: div, level: 15" node_number="510">Dong-Hoon Shin</div>, </span><span class="valid" valid="valid" title="valid: True, node: 511, tag: span, level: 14" node_number="511"><div title="valid: False, node: 512, tag: div, level: 15" node_number="512">Hye-Jin You</div>, </span><span class="valid" valid="valid" title="valid: True, node: 513, tag: span, level: 14" node_number="513"><div title="valid: False, node: 514, tag: div, level: 15" node_number="514">Seho Cha</div>, </span><span class="valid" valid="valid" title="valid: True, node: 515, tag: span, level: 14" node_number="515"><div title="valid: False, node: 516, tag: div, level: 15" node_number="516">Bo-Seul Song</div>, </span><span class="valid" valid="valid" title="valid: True, node: 517, tag: span, level: 14" node_number="517"><div title="valid: False, node: 518, tag: div, level: 15" node_number="518">Jae-Young Joung</div>, </span><span class="valid" valid="valid" title="valid: True, node: 519, tag: span, level: 14" node_number="519"><div title="valid: False, node: 520, tag: div, level: 15" node_number="520">Weon-Seo Park</div>, </span><span class="valid" valid="valid" title="valid: True, node: 521, tag: span, level: 14" node_number="521"><div title="valid: False, node: 522, tag: div, level: 15" node_number="522">Kwang-Pyo Kim</div> and </span><span class="valid" valid="valid" title="valid: True, node: 523, tag: span, level: 14" node_number="523"><div title="valid: False, node: 524, tag: div, level: 15" node_number="524">Jae-Kyung Myung</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 525, tag: div, level: 13" node_number="525"> Biomedicines <b class="valid" valid="valid" title="valid: True, node: 526, tag: b, level: 14" node_number="526">2021</b>, 9(12), 1877; https://doi.org/10.3390/biomedicines9121877 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 527, tag: div, level: 13" node_number="527"> Abstract <div class="valid" valid="valid" title="valid: True, node: 528, tag: div, level: 14" node_number="528"> Androgen exerts its functions by binding with an androgen receptor (AR). It can activate many signaling pathways that are important to the progression of castration-resistant prostate cancer (CRPC). Here, we characterized the rapid proteomic changes seen at 5, 15, 30, and 60 min [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 529, tag: div, level: 14" node_number="529"> Androgen exerts its functions by binding with an androgen receptor (AR). It can activate many signaling pathways that are important to the progression of castration-resistant prostate cancer (CRPC). Here, we characterized the rapid proteomic changes seen at 5, 15, 30, and 60 min after the androgen treatment of VCaP cells via the tandem mass tag (TMT) labeling strategy. A total of 5529 proteins were successfully identified and quantified. Dynamic time profiling of protein expression patterns allowed us to identify five protein clusters involved in various stages of androgen-initiated signal transmission and processing. More details of protein functions and localization patterns, and our elucidation of an AR-interacting protein network, were obtained. Finally, we validated the expression level of AR-regulated proteins known to be significantly regulated in CRPC patients using the mouse xenograft model and patient samples. Our work offers a systematic analysis of the rapid proteomic changes induced by androgen and provides a global view of the molecular mechanisms underlying CRPC progression. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 530, tag: div, level: 13" node_number="530"> (This article belongs to the Special Issue Novel Strategy for Treating Castration-Resistant Prostate Cancer) </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 531, tag: div, level: 10" node_number="531"> <div class="valid" valid="valid" title="valid: True, node: 532, tag: div, level: 11" node_number="532"> <div class="valid" valid="valid" title="valid: True, node: 533, tag: div, level: 12" node_number="533"> <div class="valid" valid="valid" title="valid: True, node: 534, tag: div, level: 13" node_number="534"> <a class="valid" valid="valid" title="valid: True, node: 535, tag: a, level: 14" node_number="535"> <i title="valid: False, node: 536, tag: i, level: 15" node_number="536">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 537, tag: div, level: 14" node_number="537"> Supplementary material: Supplementary File 1 (ZIP, 216 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 538, tag: div, level: 13" node_number="538"> <a class="valid" valid="valid" title="valid: True, node: 539, tag: a, level: 14" node_number="539"> <i title="valid: False, node: 540, tag: i, level: 15" node_number="540">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 541, tag: div, level: 13" node_number="541"> <a class="valid" valid="valid" title="valid: True, node: 542, tag: a, level: 14" node_number="542"> <i title="valid: False, node: 543, tag: i, level: 15" node_number="543">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 544, tag: div, level: 14" node_number="544"> View online as: Abstract Page </div> </div> <div class="valid" valid="valid" title="valid: True, node: 545, tag: div, level: 13" node_number="545">Open AccessArticle</div> &#945;-Synuclein Overexpression Increases Dopamine D2/3 Receptor Binding and Immune Activation in a Model of Early Parkinson&#8217;s Disease <div class="valid" valid="valid" title="valid: True, node: 546, tag: div, level: 13" node_number="546"> by <span class="valid" valid="valid" title="valid: True, node: 547, tag: span, level: 14" node_number="547"><div title="valid: False, node: 548, tag: div, level: 15" node_number="548">Kathrine Stokholm</div>, </span><span class="valid" valid="valid" title="valid: True, node: 549, tag: span, level: 14" node_number="549"><div title="valid: False, node: 550, tag: div, level: 15" node_number="550">Majken Borup Thomsen</div>, </span><span class="valid" valid="valid" title="valid: True, node: 551, tag: span, level: 14" node_number="551"><div title="valid: False, node: 552, tag: div, level: 15" node_number="552">Jenny-Ann Phan</div>, </span><span class="valid" valid="valid" title="valid: True, node: 553, tag: span, level: 14" node_number="553"><div title="valid: False, node: 554, tag: div, level: 15" node_number="554">Line K. M&#248;ller</div>, </span><span class="valid" valid="valid" title="valid: True, node: 555, tag: span, level: 14" node_number="555"><div title="valid: False, node: 556, tag: div, level: 15" node_number="556">Cecilie Bay-Richter</div>, </span><span class="valid" valid="valid" title="valid: True, node: 557, tag: span, level: 14" node_number="557"><div title="valid: False, node: 558, tag: div, level: 15" node_number="558">S&#248;ren H. Christiansen</div>, </span><span class="valid" valid="valid" title="valid: True, node: 559, tag: span, level: 14" node_number="559"><div title="valid: False, node: 560, tag: div, level: 15" node_number="560">David P. D. Woldbye</div>, </span><span class="valid" valid="valid" title="valid: True, node: 561, tag: span, level: 14" node_number="561"><div title="valid: False, node: 562, tag: div, level: 15" node_number="562">Marina Romero-Ramos</div> and </span><span class="valid" valid="valid" title="valid: True, node: 563, tag: span, level: 14" node_number="563"><div title="valid: False, node: 564, tag: div, level: 15" node_number="564">Anne M. Landau</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 565, tag: div, level: 13" node_number="565"> Biomedicines <b class="valid" valid="valid" title="valid: True, node: 566, tag: b, level: 14" node_number="566">2021</b>, 9(12), 1876; https://doi.org/10.3390/biomedicines9121876 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 567, tag: div, level: 13" node_number="567"> Abstract <div class="valid" valid="valid" title="valid: True, node: 568, tag: div, level: 14" node_number="568"> Progressive degeneration of dopaminergic neurons, immune activation, and &#945;-synuclein pathology characterize Parkinson&#8217;s disease (PD). We previously reported that unilateral intranigral injection of recombinant adeno-associated viral (rAAV) vectors encoding wild-type human &#945;-synuclein produced a rat model of early PD with dopamine terminal dysfunction. Here [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 569, tag: div, level: 14" node_number="569"> Progressive degeneration of dopaminergic neurons, immune activation, and &#945;-synuclein pathology characterize Parkinson&#8217;s disease (PD). We previously reported that unilateral intranigral injection of recombinant adeno-associated viral (rAAV) vectors encoding wild-type human &#945;-synuclein produced a rat model of early PD with dopamine terminal dysfunction. Here we tested the hypothesis that decreases in dopamine result in increased postsynaptic dopamine D2/D3 receptor expression, neuroinflammation, and reduced synaptic vesicle glycoprotein 2A (SV2A) density. Rats were injected with rAAV encoding &#945;-synuclein or green fluorescent protein and subjected to non-pharmacological motor tests, before euthanization at 12 weeks post-injection. We performed: 1) in situ hybridization of nigral tyrosine hydroxylase mRNA, 2) HPLC of striatal dopamine content, and 3) autoradiography with [<sup title="valid: False, node: 570, tag: sup, level: 15" node_number="570">3</sup>H]raclopride, [<sup title="valid: False, node: 571, tag: sup, level: 15" node_number="571">3</sup>H]DTBZ, [<sup title="valid: False, node: 572, tag: sup, level: 15" node_number="572">3</sup>H]GBR12935, [<sup title="valid: False, node: 573, tag: sup, level: 15" node_number="573">3</sup>H]PK11195, and [<sup title="valid: False, node: 574, tag: sup, level: 15" node_number="574">3</sup>H]UCB-J to measure binding at D2/3 receptors, vesicular monoamine transporter 2, dopamine transporters, mitochondrial translocator protein, and SV2A, respectively. rAAV-&#945;-synuclein induced motor asymmetry and reduced tyrosine hydroxylase mRNA and dopamine content in ipsilateral brain regions. This was paralleled by elevated ipsilateral postsynaptic dopamine D2/3 receptor expression and immune activation, with no changes to synaptic SV2A density. In conclusion, &#945;-synuclein overexpression results in dopaminergic degeneration that induced compensatory increases in D2/3 binding and immune activation, recapitulating many of the pathological characteristics of PD. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 575, tag: div, level: 13" node_number="575"> (This article belongs to the Special Issue Animal Models of Parkinson's Disease) </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 576, tag: div, level: 10" node_number="576"> <div class="valid" valid="valid" title="valid: True, node: 577, tag: div, level: 11" node_number="577"> <div class="valid" valid="valid" title="valid: True, node: 578, tag: div, level: 12" node_number="578"> <div class="valid" valid="valid" title="valid: True, node: 579, tag: div, level: 13" node_number="579"> <a class="valid" valid="valid" title="valid: True, node: 580, tag: a, level: 14" node_number="580"> <i title="valid: False, node: 581, tag: i, level: 15" node_number="581">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 582, tag: div, level: 14" node_number="582"> Supplementary material: Supplementary File 1 (ZIP, 7125 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 583, tag: div, level: 13" node_number="583"> <a class="valid" valid="valid" title="valid: True, node: 584, tag: a, level: 14" node_number="584"> <i title="valid: False, node: 585, tag: i, level: 15" node_number="585">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 586, tag: div, level: 13" node_number="586"> <a class="valid" valid="valid" title="valid: True, node: 587, tag: a, level: 14" node_number="587"> <i title="valid: False, node: 588, tag: i, level: 15" node_number="588">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 589, tag: div, level: 14" node_number="589"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 590, tag: div, level: 13" node_number="590">Open AccessArticle</div> A Novel Peptide-MHC Targeted Chimeric Antigen Receptor T Cell Forms a T Cell-like Immune Synapse <div class="valid" valid="valid" title="valid: True, node: 591, tag: div, level: 13" node_number="591"> by <span class="valid" valid="valid" title="valid: True, node: 592, tag: span, level: 14" node_number="592"><div title="valid: False, node: 593, tag: div, level: 15" node_number="593">Stacie Shiqi Wang</div>, </span><span class="valid" valid="valid" title="valid: True, node: 594, tag: span, level: 14" node_number="594"><div title="valid: False, node: 595, tag: div, level: 15" node_number="595">Kylie Luong</div>, </span><span class="valid" valid="valid" title="valid: True, node: 596, tag: span, level: 14" node_number="596"><div title="valid: False, node: 597, tag: div, level: 15" node_number="597">Fiona Margaret Gracey</div>, </span><span class="valid" valid="valid" title="valid: True, node: 598, tag: span, level: 14" node_number="598"><div title="valid: False, node: 599, tag: div, level: 15" node_number="599">Shareen Jabar</div>, </span><span class="valid" valid="valid" title="valid: True, node: 600, tag: span, level: 14" node_number="600"><div title="valid: False, node: 601, tag: div, level: 15" node_number="601">Brad McColl</div>, </span><span class="valid" valid="valid" title="valid: True, node: 602, tag: span, level: 14" node_number="602"><div title="valid: False, node: 603, tag: div, level: 15" node_number="603">Ryan Stanley Cross</div> and </span><span class="valid" valid="valid" title="valid: True, node: 604, tag: span, level: 14" node_number="604"><div title="valid: False, node: 605, tag: div, level: 15" node_number="605">Misty Rayna Jenkins</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 606, tag: div, level: 13" node_number="606"> Biomedicines <b class="valid" valid="valid" title="valid: True, node: 607, tag: b, level: 14" node_number="607">2021</b>, 9(12), 1875; https://doi.org/10.3390/biomedicines9121875 (registering&#160;DOI) - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 608, tag: div, level: 13" node_number="608"> Abstract <div class="valid" valid="valid" title="valid: True, node: 609, tag: div, level: 14" node_number="609"> Chimeric Antigen Receptor (CAR) T cell therapy is a promising form of adoptive cell therapy that re-engineers patient-derived T cells to express a hybrid receptor specific to a tumour-specific antigen of choice. Many well-characterised tumour antigens are intracellular and therefore not accessible to [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 610, tag: div, level: 14" node_number="610"> Chimeric Antigen Receptor (CAR) T cell therapy is a promising form of adoptive cell therapy that re-engineers patient-derived T cells to express a hybrid receptor specific to a tumour-specific antigen of choice. Many well-characterised tumour antigens are intracellular and therefore not accessible to antibodies at the cell surface. Therefore, the ability to target peptide-MHC tumour targets with antibodies is key for wider applicability of CAR T cell therapy in cancer. One way to evaluate the effectiveness and efficiency of ligating tumour target cells is studying the immune synapse. Here we generated a second-generation CAR to targeting the HLA-A*02:01 restricted H3.3K27M epitope, identified as a possible therapeutic target in ~75% of diffuse midline gliomas, used as a model antigen to study the immune synapse. The pMHCI-specific CAR demonstrated specificity, potent activation, cytokine secretion and cytotoxic function. Furthermore, we characterised killing kinetics using live cell imaging as well as CAR synapse confocal imaging. Here we provide evidence of robust CAR targeting of a model peptide-MHC antigen and that, in contrast to protein-specific CARs, these CARs form a TCR-like immune synapse which facilitates TCR-like killing kinetics. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 611, tag: div, level: 13" node_number="611"> (This article belongs to the Special Issue Novel Small-Molecule and Immune-Modulating Agents for Cancer Therapy) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 612, tag: div, level: 13" node_number="612"><div class="valid" valid="valid" title="valid: True, node: 613, tag: div, level: 14" node_number="613"><div title="valid: False, node: 614, tag: div, level: 15" node_number="614"><p title="valid: False, node: 615, tag: p, level: 16" node_number="615">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 616, tag: div, level: 10" node_number="616"> <div class="valid" valid="valid" title="valid: True, node: 617, tag: div, level: 11" node_number="617"> <div class="valid" valid="valid" title="valid: True, node: 618, tag: div, level: 12" node_number="618"> <div class="valid" valid="valid" title="valid: True, node: 619, tag: div, level: 13" node_number="619"> <a class="valid" valid="valid" title="valid: True, node: 620, tag: a, level: 14" node_number="620"> <i title="valid: False, node: 621, tag: i, level: 15" node_number="621">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 622, tag: div, level: 13" node_number="622"> <a class="valid" valid="valid" title="valid: True, node: 623, tag: a, level: 14" node_number="623"> <i title="valid: False, node: 624, tag: i, level: 15" node_number="624">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 625, tag: div, level: 14" node_number="625"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 626, tag: div, level: 13" node_number="626">Open AccessArticle</div> Vitamin D Prevents High Glucose-Induced Lipid Droplets Accumulation in Cultured Endothelial Cells: The Role of Thioredoxin Interacting Protein <div class="valid" valid="valid" title="valid: True, node: 627, tag: div, level: 13" node_number="627"> by <span class="valid" valid="valid" title="valid: True, node: 628, tag: span, level: 14" node_number="628"><div title="valid: False, node: 629, tag: div, level: 15" node_number="629">Roberta Scrimieri</div>, </span><span class="valid" valid="valid" title="valid: True, node: 630, tag: span, level: 14" node_number="630"><div title="valid: False, node: 631, tag: div, level: 15" node_number="631">Alessandra Cazzaniga</div>, </span><span class="valid" valid="valid" title="valid: True, node: 632, tag: span, level: 14" node_number="632"><div title="valid: False, node: 633, tag: div, level: 15" node_number="633">Sara Castiglioni</div> and </span><span class="valid" valid="valid" title="valid: True, node: 634, tag: span, level: 14" node_number="634"><div title="valid: False, node: 635, tag: div, level: 15" node_number="635">Jeanette A. M. Maier</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 636, tag: div, level: 13" node_number="636"> Biomedicines <b class="valid" valid="valid" title="valid: True, node: 637, tag: b, level: 14" node_number="637">2021</b>, 9(12), 1874; https://doi.org/10.3390/biomedicines9121874 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 638, tag: div, level: 13" node_number="638"> Abstract <div class="valid" valid="valid" title="valid: True, node: 639, tag: div, level: 14" node_number="639"> Vitamin D (VitD) exerts protective effects on the endothelium, which is fundamental for vascular integrity, partly by inhibiting free radical formation. We found that VitD prevents high glucose-induced Thioredoxin Interacting Protein (TXNIP) upregulation. Increased amounts of TXNIP are responsible for the accumulation of [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 640, tag: div, level: 14" node_number="640"> Vitamin D (VitD) exerts protective effects on the endothelium, which is fundamental for vascular integrity, partly by inhibiting free radical formation. We found that VitD prevents high glucose-induced Thioredoxin Interacting Protein (TXNIP) upregulation. Increased amounts of TXNIP are responsible for the accumulation of reactive oxygen species and, as a consequence, of lipid droplets. This is associated with increased amounts of triglycerides as the result of increased lipogenesis and reduced fatty acid oxidation. Remarkably, VitD rebalances the redox equilibrium, restores normal lipid content, and prevents the accumulation of lipid droplets. Our results highlight TXNIP as one of the targets of VitD in high glucose-cultured endothelial cells and shed some light on the protective effect of VitD on the endothelium. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 641, tag: div, level: 13" node_number="641"> (This article belongs to the Special Issue Vitamin D in Health and Disease) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 642, tag: div, level: 13" node_number="642"><div class="valid" valid="valid" title="valid: True, node: 643, tag: div, level: 14" node_number="643"><div title="valid: False, node: 644, tag: div, level: 15" node_number="644"><p title="valid: False, node: 645, tag: p, level: 16" node_number="645">Graphical abstract</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 646, tag: div, level: 10" node_number="646"> <div class="valid" valid="valid" title="valid: True, node: 647, tag: div, level: 11" node_number="647"> <div class="valid" valid="valid" title="valid: True, node: 648, tag: div, level: 12" node_number="648"> <div class="valid" valid="valid" title="valid: True, node: 649, tag: div, level: 13" node_number="649"> <a class="valid" valid="valid" title="valid: True, node: 650, tag: a, level: 14" node_number="650"> <i title="valid: False, node: 651, tag: i, level: 15" node_number="651">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 652, tag: div, level: 14" node_number="652"> Supplementary material: Supplementary File 1 (ZIP, 815 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 653, tag: div, level: 13" node_number="653"> <a class="valid" valid="valid" title="valid: True, node: 654, tag: a, level: 14" node_number="654"> <i title="valid: False, node: 655, tag: i, level: 15" node_number="655">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 656, tag: div, level: 13" node_number="656"> <a class="valid" valid="valid" title="valid: True, node: 657, tag: a, level: 14" node_number="657"> <i title="valid: False, node: 658, tag: i, level: 15" node_number="658">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 659, tag: div, level: 14" node_number="659"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 660, tag: div, level: 13" node_number="660">Open AccessArticle</div> An Orthotopic Model of Uveal Melanoma in Zebrafish Embryo: A Novel Platform for Drug Evaluation <div class="valid" valid="valid" title="valid: True, node: 661, tag: div, level: 13" node_number="661"> by <span class="valid" valid="valid" title="valid: True, node: 662, tag: span, level: 14" node_number="662"><div title="valid: False, node: 663, tag: div, level: 15" node_number="663">Chiara Tobia</div>, </span><span class="valid" valid="valid" title="valid: True, node: 664, tag: span, level: 14" node_number="664"><div title="valid: False, node: 665, tag: div, level: 15" node_number="665">Daniela Coltrini</div>, </span><span class="valid" valid="valid" title="valid: True, node: 666, tag: span, level: 14" node_number="666"><div title="valid: False, node: 667, tag: div, level: 15" node_number="667">Roberto Ronca</div>, </span><span class="valid" valid="valid" title="valid: True, node: 668, tag: span, level: 14" node_number="668"><div title="valid: False, node: 669, tag: div, level: 15" node_number="669">Alessandra Loda</div>, </span><span class="valid" valid="valid" title="valid: True, node: 670, tag: span, level: 14" node_number="670"><div title="valid: False, node: 671, tag: div, level: 15" node_number="671">Jessica Guerra</div>, </span><span class="valid" valid="valid" title="valid: True, node: 672, tag: span, level: 14" node_number="672"><div title="valid: False, node: 673, tag: div, level: 15" node_number="673">Elisa Scalvini</div>, </span><span class="valid" valid="valid" title="valid: True, node: 674, tag: span, level: 14" node_number="674"><div title="valid: False, node: 675, tag: div, level: 15" node_number="675">Francesco Semeraro</div> and </span><span class="valid" valid="valid" title="valid: True, node: 676, tag: span, level: 14" node_number="676"><div title="valid: False, node: 677, tag: div, level: 15" node_number="677">Sara Rezzola</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 678, tag: div, level: 13" node_number="678"> Biomedicines <b class="valid" valid="valid" title="valid: True, node: 679, tag: b, level: 14" node_number="679">2021</b>, 9(12), 1873; https://doi.org/10.3390/biomedicines9121873 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 680, tag: div, level: 13" node_number="680"> Abstract <div class="valid" valid="valid" title="valid: True, node: 681, tag: div, level: 14" node_number="681"> Uveal melanoma is a highly metastatic tumor, representing the most common primary intraocular malignancy in adults. Tumor cell xenografts in zebrafish embryos may provide the opportunity to study in vivo different aspects of the neoplastic disease and its response to therapy. Here, we [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 682, tag: div, level: 14" node_number="682"> Uveal melanoma is a highly metastatic tumor, representing the most common primary intraocular malignancy in adults. Tumor cell xenografts in zebrafish embryos may provide the opportunity to study in vivo different aspects of the neoplastic disease and its response to therapy. Here, we established an orthotopic model of uveal melanoma in zebrafish by injecting highly metastatic murine B16-BL6 and B16-LS9 melanoma cells, human A375M melanoma cells, and human 92.1 uveal melanoma cells into the eye of zebrafish embryos in the proximity of the developing choroidal vasculature. Immunohistochemical and immunofluorescence analyses showed that melanoma cells proliferate during the first four days after injection and move towards the eye surface. Moreover, bioluminescence analysis of luciferase-expressing human 92.1 uveal melanoma cells allowed the quantitative assessment of the antitumor activity exerted by the canonical chemotherapeutic drugs paclitaxel, panobinostat, and everolimus after their injection into the grafted eye. Altogether, our data demonstrate that the zebrafish embryo eye is a permissive environment for the growth of invasive cutaneous and uveal melanoma cells. In addition, we have established a new luciferase-based in vivo orthotopic model that allows the quantification of human uveal melanoma cells engrafted in the zebrafish embryo eye, and which may represent a suitable tool for the screening of novel drug candidates for uveal melanoma therapy. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 683, tag: div, level: 13" node_number="683"> (This article belongs to the Special Issue Zebrafish Models for Development and Disease 3.0) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 684, tag: div, level: 13" node_number="684"><div class="valid" valid="valid" title="valid: True, node: 685, tag: div, level: 14" node_number="685"><div title="valid: False, node: 686, tag: div, level: 15" node_number="686"><p title="valid: False, node: 687, tag: p, level: 16" node_number="687">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 688, tag: div, level: 10" node_number="688"> <div class="valid" valid="valid" title="valid: True, node: 689, tag: div, level: 11" node_number="689"> <div class="valid" valid="valid" title="valid: True, node: 690, tag: div, level: 12" node_number="690"> <div class="valid" valid="valid" title="valid: True, node: 691, tag: div, level: 13" node_number="691"> <a class="valid" valid="valid" title="valid: True, node: 692, tag: a, level: 14" node_number="692"> <i title="valid: False, node: 693, tag: i, level: 15" node_number="693">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 694, tag: div, level: 14" node_number="694"> Supplementary material: Supplementary File 1 (ZIP, 13497 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 695, tag: div, level: 13" node_number="695"> <a class="valid" valid="valid" title="valid: True, node: 696, tag: a, level: 14" node_number="696"> <i title="valid: False, node: 697, tag: i, level: 15" node_number="697">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 698, tag: div, level: 13" node_number="698"> <a class="valid" valid="valid" title="valid: True, node: 699, tag: a, level: 14" node_number="699"> <i title="valid: False, node: 700, tag: i, level: 15" node_number="700">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 701, tag: div, level: 14" node_number="701"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 702, tag: div, level: 13" node_number="702">Open AccessArticle</div> Displacement of Gray Matter and Incidence of Seizures in Patients with Cerebral Cavernous Malformations <div class="valid" valid="valid" title="valid: True, node: 703, tag: div, level: 13" node_number="703"> by <span class="valid" valid="valid" title="valid: True, node: 704, tag: span, level: 14" node_number="704"><div title="valid: False, node: 705, tag: div, level: 15" node_number="705">Chi-Jen Chou</div>, </span><span class="valid" valid="valid" title="valid: True, node: 706, tag: span, level: 14" node_number="706"><div title="valid: False, node: 707, tag: div, level: 15" node_number="707">Cheng-Chia Lee</div>, </span><span class="valid" valid="valid" title="valid: True, node: 708, tag: span, level: 14" node_number="708"><div title="valid: False, node: 709, tag: div, level: 15" node_number="709">Ching-Jen Chen</div>, </span><span class="valid" valid="valid" title="valid: True, node: 710, tag: span, level: 14" node_number="710"><div title="valid: False, node: 711, tag: div, level: 15" node_number="711">Huai-Che Yang</div> and </span><span class="valid" valid="valid" title="valid: True, node: 712, tag: span, level: 14" node_number="712"><div title="valid: False, node: 713, tag: div, level: 15" node_number="713">Syu-Jyun Peng</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 714, tag: div, level: 13" node_number="714"> Biomedicines <b class="valid" valid="valid" title="valid: True, node: 715, tag: b, level: 14" node_number="715">2021</b>, 9(12), 1872; https://doi.org/10.3390/biomedicines9121872 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 716, tag: div, level: 13" node_number="716"> Abstract <div class="valid" valid="valid" title="valid: True, node: 717, tag: div, level: 14" node_number="717"> Seizures are the most common presentation in patients with cerebral cavernous malformations (CCMs). Based on the hypothesis that the volume or proportion of gray matter (GM) displaced by CCMs is associated with the risk of seizure, we developed an algorithm by which to [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 718, tag: div, level: 14" node_number="718"> Seizures are the most common presentation in patients with cerebral cavernous malformations (CCMs). Based on the hypothesis that the volume or proportion of gray matter (GM) displaced by CCMs is associated with the risk of seizure, we developed an algorithm by which to quantify the volume and proportion of displaced GM and the risk of seizure. Image analysis was conducted on 111 patients with solitary CCMs (divided into seizure and nonseizure groups) from our gamma knife radiosurgery (GKRS) database from February 2005 and March 2020. The CCM algorithm proved effective in quantifying the GM and CCM using T1WI MRI images. In the seizure group, 11 of the 12 patients exhibited seizures at the initial presentation, and all CCMs in the seizure group were supratentorial. The location of the limbic lobe within the CCM was significantly associated with the risk of seizure (OR = 19.6, <i title="valid: False, node: 719, tag: i, level: 15" node_number="719">p</i> = 0.02). The risk of seizure increased when the proportion of GM displaced by the CCM exceeded 31%. It was also strongly correlated with the volume of displaced GM. The volume and proportion of displaced GM were both positively correlated with the risk of seizure presentation/development and thus could be used to guide seizure prophylaxis in CCM patients. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 720, tag: div, level: 13" node_number="720"> (This article belongs to the Special Issue Artificial Intelligence in Biological and Biomedical Imaging) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 721, tag: div, level: 13" node_number="721"><div class="valid" valid="valid" title="valid: True, node: 722, tag: div, level: 14" node_number="722"><div title="valid: False, node: 723, tag: div, level: 15" node_number="723"><p title="valid: False, node: 724, tag: p, level: 16" node_number="724">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 725, tag: div, level: 10" node_number="725"> <div class="valid" valid="valid" title="valid: True, node: 726, tag: div, level: 11" node_number="726"> <div class="valid" valid="valid" title="valid: True, node: 727, tag: div, level: 12" node_number="727"> <div class="valid" valid="valid" title="valid: True, node: 728, tag: div, level: 13" node_number="728"> <a class="valid" valid="valid" title="valid: True, node: 729, tag: a, level: 14" node_number="729"> <i title="valid: False, node: 730, tag: i, level: 15" node_number="730">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 731, tag: div, level: 13" node_number="731"> <a class="valid" valid="valid" title="valid: True, node: 732, tag: a, level: 14" node_number="732"> <i title="valid: False, node: 733, tag: i, level: 15" node_number="733">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 734, tag: div, level: 14" node_number="734"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 735, tag: div, level: 13" node_number="735">Open AccessReview</div> The Role of Oxidative Stress and Therapeutic Potential of Antioxidants in Graves&#8217; Ophthalmopathy <div class="valid" valid="valid" title="valid: True, node: 736, tag: div, level: 13" node_number="736"> by <span class="valid" valid="valid" title="valid: True, node: 737, tag: span, level: 14" node_number="737"><div title="valid: False, node: 738, tag: div, level: 15" node_number="738">Tzu-Yu Hou</div>, </span><span class="valid" valid="valid" title="valid: True, node: 739, tag: span, level: 14" node_number="739"><div title="valid: False, node: 740, tag: div, level: 15" node_number="740">Shi-Bei Wu</div>, </span><span class="valid" valid="valid" title="valid: True, node: 741, tag: span, level: 14" node_number="741"><div title="valid: False, node: 742, tag: div, level: 15" node_number="742">Hui-Chuan Kau</div> and </span><span class="valid" valid="valid" title="valid: True, node: 743, tag: span, level: 14" node_number="743"><div title="valid: False, node: 744, tag: div, level: 15" node_number="744">Chieh-Chih Tsai</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 745, tag: div, level: 13" node_number="745"> Biomedicines <b class="valid" valid="valid" title="valid: True, node: 746, tag: b, level: 14" node_number="746">2021</b>, 9(12), 1871; https://doi.org/10.3390/biomedicines9121871 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 747, tag: div, level: 13" node_number="747"> Abstract <div class="valid" valid="valid" title="valid: True, node: 748, tag: div, level: 14" node_number="748"> Graves&#8217; ophthalmopathy (GO) is the most common extrathyroidal manifestation of Graves&#8217; disease. It is characterized initially by an inflammatory process, followed by tissue remodeling and fibrosis, leading to proptosis, exposure keratopathy, ocular motility limitation, and compressive optic neuropathy. The pathogenic mechanism is complex [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 749, tag: div, level: 14" node_number="749"> Graves&#8217; ophthalmopathy (GO) is the most common extrathyroidal manifestation of Graves&#8217; disease. It is characterized initially by an inflammatory process, followed by tissue remodeling and fibrosis, leading to proptosis, exposure keratopathy, ocular motility limitation, and compressive optic neuropathy. The pathogenic mechanism is complex and multifactorial. Accumulating evidence suggests the involvement of oxidative stress in the pathogenesis of GO. Cigarette smoking, a major risk factor for GO, has been shown to induce reactive oxygen species (ROS) generation and oxidative damage in GO orbital fibroblasts. In addition, an elevation in ROS and antioxidant enzymes is observed in tears, blood, and urine, as well as orbital fibroadipose tissues and fibroblasts from GO patients. In vitro and in vivo studies have examined the efficacy of various antioxidant supplements for GO. These findings suggest a therapeutic role of antioxidants in GO patients. This review summarizes the current understanding of oxidative stress in the pathogenesis and potential antioxidants for the treatment of GO. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 750, tag: div, level: 13" node_number="750"> (This article belongs to the Special Issue Oxidative Stress and Inflammation: From Mechanisms to Therapeutic Approaches 3.0) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 751, tag: div, level: 13" node_number="751"><div class="valid" valid="valid" title="valid: True, node: 752, tag: div, level: 14" node_number="752"><div title="valid: False, node: 753, tag: div, level: 15" node_number="753"><p title="valid: False, node: 754, tag: p, level: 16" node_number="754">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 755, tag: div, level: 10" node_number="755"> <div class="valid" valid="valid" title="valid: True, node: 756, tag: div, level: 11" node_number="756"> <div class="valid" valid="valid" title="valid: True, node: 757, tag: div, level: 12" node_number="757"> <div class="valid" valid="valid" title="valid: True, node: 758, tag: div, level: 13" node_number="758"> <a class="valid" valid="valid" title="valid: True, node: 759, tag: a, level: 14" node_number="759"> <i title="valid: False, node: 760, tag: i, level: 15" node_number="760">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 761, tag: div, level: 13" node_number="761"> <a class="valid" valid="valid" title="valid: True, node: 762, tag: a, level: 14" node_number="762"> <i title="valid: False, node: 763, tag: i, level: 15" node_number="763">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 764, tag: div, level: 14" node_number="764"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 765, tag: div, level: 13" node_number="765">Open AccessReview</div> Validity of Anti-PSMA ScFvD2B as a Theranostic Tool: A Narrative-Focused Review <div class="valid" valid="valid" title="valid: True, node: 766, tag: div, level: 13" node_number="766"> by <span class="valid" valid="valid" title="valid: True, node: 767, tag: span, level: 14" node_number="767"><div title="valid: False, node: 768, tag: div, level: 15" node_number="768">Barbara Frigerio</div>, </span><span class="valid" valid="valid" title="valid: True, node: 769, tag: span, level: 14" node_number="769"><div title="valid: False, node: 770, tag: div, level: 15" node_number="770">Elena Luison</div>, </span><span class="valid" valid="valid" title="valid: True, node: 771, tag: span, level: 14" node_number="771"><div title="valid: False, node: 772, tag: div, level: 15" node_number="772">Alessandro Desideri</div>, </span><span class="valid" valid="valid" title="valid: True, node: 773, tag: span, level: 14" node_number="773"><div title="valid: False, node: 774, tag: div, level: 15" node_number="774">Federico Iacovelli</div>, </span><span class="valid" valid="valid" title="valid: True, node: 775, tag: span, level: 14" node_number="775"><div title="valid: False, node: 776, tag: div, level: 15" node_number="776">Chiara Camisaschi</div>, </span><span class="valid" valid="valid" title="valid: True, node: 777, tag: span, level: 14" node_number="777"><div title="valid: False, node: 778, tag: div, level: 15" node_number="778">Ettore C. Seregni</div>, </span><span class="valid" valid="valid" title="valid: True, node: 779, tag: span, level: 14" node_number="779"><div title="valid: False, node: 780, tag: div, level: 15" node_number="780">Silvana Canevari</div> and </span><span class="valid" valid="valid" title="valid: True, node: 781, tag: span, level: 14" node_number="781"><div title="valid: False, node: 782, tag: div, level: 15" node_number="782">Mariangela Figini</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 783, tag: div, level: 13" node_number="783"> Biomedicines <b class="valid" valid="valid" title="valid: True, node: 784, tag: b, level: 14" node_number="784">2021</b>, 9(12), 1870; https://doi.org/10.3390/biomedicines9121870 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 785, tag: div, level: 13" node_number="785"> Abstract <div class="valid" valid="valid" title="valid: True, node: 786, tag: div, level: 14" node_number="786"> Prostate cancer (PCa) is the second leading cause of cancer among men, and its diagnosis and adequate staging are fundamental. Among the biomarkers identified in recent years for PCa management, prostate-specific-membrane-antigen (PSMA), physiologically expressed at a low level on healthy prostate and in [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 787, tag: div, level: 14" node_number="787"> Prostate cancer (PCa) is the second leading cause of cancer among men, and its diagnosis and adequate staging are fundamental. Among the biomarkers identified in recent years for PCa management, prostate-specific-membrane-antigen (PSMA), physiologically expressed at a low level on healthy prostate and in other normal tissues and highly overexpressed in PCa, represents a reliable marker ideal for imaging and therapy. The development of anti-PSMA antibodies, such as D2B, demonstrated slow clearance of intact antibodies compared with fragments resulting in low tumor-to-blood ratios; however, the modular structural and functional nature of antibodies allowed the generation of smaller fragments, such as scFvs. In this review of the anti-PSMA antibody fragment scFvD2B, we combined further characterization of its biomolecular and tissue cross-reactivity characteristics with a comprehensive summary of what has already been performed in preclinical models to evaluate imaging and therapeutic activities. A molecular dynamics study was performed, and ScFvD2B occupied a limited conformational space, characterized by low-energy conformational basins, confirming the high stability of the protein structure. In the cross-reactivity study, the weak/absent immunoreactivity in non-tumor tissues was comparable to the PSMA expression reported in the literature. Biodistribution studies and therapeutic treatments were conducted in different animal models obtained by subcutaneous or locoregional injection of PSMA-positive-versus-negative xenografts. The maximum tumor uptake was observed for <sup title="valid: False, node: 788, tag: sup, level: 15" node_number="788">123</sup>I(SPECT), <sup title="valid: False, node: 789, tag: sup, level: 15" node_number="789">124</sup>I(PET), and optical imaging, which avoids kidney accumulation (compared with radiometals) and leads to an optimal tumor-to-kidney and tumor-to-background ratios. Regarding its possible use in therapy, experimental data suggested a strong and specific antitumor activity, in vitro and in vivo, obtained using CAR-T or NK-92/CAR cells expressing scFvD2B. Based on presented/reviewed data, we consider that scFvD2B, due to its versatility and robustness, seems to: (i) overcome some problems observed in other studied scFvs, very often relatively unstable and prone to form aggregates; (ii) have sufficient tumor-to-background ratios for targeting and imaging PSMA-expressing cancer; (iii) significantly redirect immune killing cells to PSMA-positive tumors when inserted in second-generation CAR-T or NK-92/CAR cells. These data suggest that our product can be considered the right reagent to fill the gap that still exists in PCa diagnosis and treatment. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 790, tag: div, level: 13" node_number="790"> (This article belongs to the Special Issue Antibody Based Delivery of Toxins and Other Active Molecules for Cancer Therapy) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 791, tag: div, level: 13" node_number="791"><div class="valid" valid="valid" title="valid: True, node: 792, tag: div, level: 14" node_number="792"><div title="valid: False, node: 793, tag: div, level: 15" node_number="793"><p title="valid: False, node: 794, tag: p, level: 16" node_number="794">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 795, tag: div, level: 10" node_number="795"> <div class="valid" valid="valid" title="valid: True, node: 796, tag: div, level: 11" node_number="796"> <div class="valid" valid="valid" title="valid: True, node: 797, tag: div, level: 12" node_number="797"> <div class="valid" valid="valid" title="valid: True, node: 798, tag: div, level: 13" node_number="798"> <a class="valid" valid="valid" title="valid: True, node: 799, tag: a, level: 14" node_number="799"> <i title="valid: False, node: 800, tag: i, level: 15" node_number="800">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 801, tag: div, level: 14" node_number="801"> Supplementary material: Supplementary File 1 (ZIP, 425 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 802, tag: div, level: 13" node_number="802"> <a class="valid" valid="valid" title="valid: True, node: 803, tag: a, level: 14" node_number="803"> <i title="valid: False, node: 804, tag: i, level: 15" node_number="804">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 805, tag: div, level: 13" node_number="805"> <a class="valid" valid="valid" title="valid: True, node: 806, tag: a, level: 14" node_number="806"> <i title="valid: False, node: 807, tag: i, level: 15" node_number="807">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 808, tag: div, level: 14" node_number="808"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 809, tag: div, level: 13" node_number="809">Open AccessArticle</div> Deciphering the Role of Pyrvinium Pamoate in the Generation of Integrated Stress Response and Modulation of Mitochondrial Function in Myeloid Leukemia Cells through Transcriptome Analysis <div class="valid" valid="valid" title="valid: True, node: 810, tag: div, level: 13" node_number="810"> by <span class="valid" valid="valid" title="valid: True, node: 811, tag: span, level: 14" node_number="811"><div title="valid: False, node: 812, tag: div, level: 15" node_number="812">Yu-Hsuan Fu</div>, </span><span class="valid" valid="valid" title="valid: True, node: 813, tag: span, level: 14" node_number="813"><div title="valid: False, node: 814, tag: div, level: 15" node_number="814">Chi-Yang Tseng</div>, </span><span class="valid" valid="valid" title="valid: True, node: 815, tag: span, level: 14" node_number="815"><div title="valid: False, node: 816, tag: div, level: 15" node_number="816">Jeng-Wei Lu</div>, </span><span class="valid" valid="valid" title="valid: True, node: 817, tag: span, level: 14" node_number="817"><div title="valid: False, node: 818, tag: div, level: 15" node_number="818">Wen-Hui Lu</div>, </span><span class="valid" valid="valid" title="valid: True, node: 819, tag: span, level: 14" node_number="819"><div title="valid: False, node: 820, tag: div, level: 15" node_number="820">Pei-Qi Lan</div>, </span><span class="valid" valid="valid" title="valid: True, node: 821, tag: span, level: 14" node_number="821"><div title="valid: False, node: 822, tag: div, level: 15" node_number="822">Chien-Yuan Chen</div>, </span><span class="valid" valid="valid" title="valid: True, node: 823, tag: span, level: 14" node_number="823"><div title="valid: False, node: 824, tag: div, level: 15" node_number="824">Da-Liang Ou</div> and </span><span class="valid" valid="valid" title="valid: True, node: 825, tag: span, level: 14" node_number="825"><div title="valid: False, node: 826, tag: div, level: 15" node_number="826">Liang-In Lin</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 827, tag: div, level: 13" node_number="827"> Biomedicines <b class="valid" valid="valid" title="valid: True, node: 828, tag: b, level: 14" node_number="828">2021</b>, 9(12), 1869; https://doi.org/10.3390/biomedicines9121869 (registering&#160;DOI) - 09 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 829, tag: div, level: 13" node_number="829"> Abstract <div class="valid" valid="valid" title="valid: True, node: 830, tag: div, level: 14" node_number="830"> Pyrvinium pamoate, a widely-used anthelmintic agent, reportedly exhibits significant anti-tumor effects in several cancers. However, the efficacy and mechanisms of pyrvinium against myeloid leukemia remain unclear. The growth inhibitory effects of pyrvinium were tested in human AML cell lines. Transcriptome analysis of Molm13 [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 831, tag: div, level: 14" node_number="831"> Pyrvinium pamoate, a widely-used anthelmintic agent, reportedly exhibits significant anti-tumor effects in several cancers. However, the efficacy and mechanisms of pyrvinium against myeloid leukemia remain unclear. The growth inhibitory effects of pyrvinium were tested in human AML cell lines. Transcriptome analysis of Molm13 myeloid leukemia cells suggested that pyrvinium pamoate could trigger an unfolded protein response (UPR)-like pathway, including responses to extracellular stimulus [<i title="valid: False, node: 832, tag: i, level: 15" node_number="832">p</i>-value = 2.78 &#215; 10<sup title="valid: False, node: 833, tag: sup, level: 15" node_number="833">&#8722;6</sup>] and to endoplasmic reticulum stress [<i title="valid: False, node: 834, tag: i, level: 15" node_number="834">p</i>-value = 8.67 &#215; 10<sup title="valid: False, node: 835, tag: sup, level: 15" node_number="835">&#8722;7</sup>], as well as elicit metabolic reprogramming, including sulfur compound catabolic processes [<i title="valid: False, node: 836, tag: i, level: 15" node_number="836">p</i>-value = 2.58 &#215; 10<sup title="valid: False, node: 837, tag: sup, level: 15" node_number="837">&#8722;8</sup>], and responses to a redox state [<i title="valid: False, node: 838, tag: i, level: 15" node_number="838">p</i>-value = 5.80 &#215; 10<sup title="valid: False, node: 839, tag: sup, level: 15" node_number="839">&#8722;5</sup>]; on the other hand, it could elicit a pyrvinium blunted protein folding function, including protein folding [<i title="valid: False, node: 840, tag: i, level: 15" node_number="840">p</i>-value = 2.10 &#215; 10<sup title="valid: False, node: 841, tag: sup, level: 15" node_number="841">&#8722;8</sup>] and an ATP metabolic process [<i title="valid: False, node: 842, tag: i, level: 15" node_number="842">p</i>-value = 3.95 &#215; 10<sup title="valid: False, node: 843, tag: sup, level: 15" node_number="843">&#8722;4</sup>]. Subsequently, pyrvinium was verified to induce an integrated stress response (ISR), demonstrated by activation of the eIF2&#945;-ATF4 pathway and inhibition of mTORC1 signaling, in a dose- and time-dependent manner. Additionally, pyrvinium could co-localize with mitochondria and then decrease the mitochondrial basal oxidative consumption rate, ultimately dysregulating the mitochondrial function. Similar effects were observed in cabozantinib-resistant Molm13-XR cell lines. Furthermore, pyrvinium treatment retarded Molm13 and Molm13-XR xenograft tumor growth. Thus, we concluded that pyrvinium exerts anti-tumor activity, at least, via the modulation of the mitochondrial function and by triggering ISR. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 844, tag: div, level: 13" node_number="844"> (This article belongs to the Special Issue Acute Myeloid Leukemia: From Pathophysiology to Novel Therapeutic Approaches) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 845, tag: div, level: 13" node_number="845"><div class="valid" valid="valid" title="valid: True, node: 846, tag: div, level: 14" node_number="846"><div title="valid: False, node: 847, tag: div, level: 15" node_number="847"><p title="valid: False, node: 848, tag: p, level: 16" node_number="848">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 849, tag: div, level: 10" node_number="849"> <div class="valid" valid="valid" title="valid: True, node: 850, tag: div, level: 11" node_number="850"> <div class="valid" valid="valid" title="valid: True, node: 851, tag: div, level: 12" node_number="851"> <div class="valid" valid="valid" title="valid: True, node: 852, tag: div, level: 13" node_number="852"> <a class="valid" valid="valid" title="valid: True, node: 853, tag: a, level: 14" node_number="853"> <i title="valid: False, node: 854, tag: i, level: 15" node_number="854">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 855, tag: div, level: 13" node_number="855"> <a class="valid" valid="valid" title="valid: True, node: 856, tag: a, level: 14" node_number="856"> <i title="valid: False, node: 857, tag: i, level: 15" node_number="857">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 858, tag: div, level: 14" node_number="858"> View online as: Abstract Page </div> </div> <div class="valid" valid="valid" title="valid: True, node: 859, tag: div, level: 13" node_number="859">Open AccessArticle</div> Catalase Activity in Keratinocytes, Stratum Corneum, and Defatted Algae Biomass as a Potential Skin Care Ingredient <div class="valid" valid="valid" title="valid: True, node: 860, tag: div, level: 13" node_number="860"> by <span class="valid" valid="valid" title="valid: True, node: 861, tag: span, level: 14" node_number="861"><div title="valid: False, node: 862, tag: div, level: 15" node_number="862">Michal Szczepanczyk</div>, </span><span class="valid" valid="valid" title="valid: True, node: 863, tag: span, level: 14" node_number="863"><div title="valid: False, node: 864, tag: div, level: 15" node_number="864">Tautgirdas Ruzgas</div>, </span><span class="valid" valid="valid" title="valid: True, node: 865, tag: span, level: 14" node_number="865"><div title="valid: False, node: 866, tag: div, level: 15" node_number="866">Fredrika Gullfot</div>, </span><span class="valid" valid="valid" title="valid: True, node: 867, tag: span, level: 14" node_number="867"><div title="valid: False, node: 868, tag: div, level: 15" node_number="868">Anna Gustafsson</div> and </span><span class="valid" valid="valid" title="valid: True, node: 869, tag: span, level: 14" node_number="869"><div title="valid: False, node: 870, tag: div, level: 15" node_number="870">Sebastian Bj&#246;rklund</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 871, tag: div, level: 13" node_number="871"> Biomedicines <b class="valid" valid="valid" title="valid: True, node: 872, tag: b, level: 14" node_number="872">2021</b>, 9(12), 1868; https://doi.org/10.3390/biomedicines9121868 - 09 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 873, tag: div, level: 13" node_number="873"> Abstract <div class="valid" valid="valid" title="valid: True, node: 874, tag: div, level: 14" node_number="874"> The generation of reactive oxygen species presents a destructive challenge for the skin organ and there is a clear need to advance skin care formulations aiming at alleviating oxidative stress. The aim of this work was to characterize the activity of the antioxidative [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 875, tag: div, level: 14" node_number="875"> The generation of reactive oxygen species presents a destructive challenge for the skin organ and there is a clear need to advance skin care formulations aiming at alleviating oxidative stress. The aim of this work was to characterize the activity of the antioxidative enzyme catalase in keratinocytes and in the skin barrier (i.e., the stratum corneum). Further, the goal was to compare the activity levels with the corresponding catalase activity found in defatted algae biomass, which may serve as a source of antioxidative enzymes, as well as other beneficial algae-derived molecules, to be employed in skin care products. For this, an oxygen electrode-based method was employed to determine the catalase activity and the apparent kinetic parameters for purified catalase, as well as catalase naturally present in HaCaT keratinocytes, excised stratum corneum samples collected from pig ears with various amounts of melanin, and defatted algae biomass from the diatom <i title="valid: False, node: 876, tag: i, level: 15" node_number="876">Phaeodactylum tricornutum</i>. Taken together, this work illustrates the versatility of the oxygen electrode-based method for characterizing catalase function in samples with a high degree of complexity and enables the assessment of sample treatment protocols and comparisons between different biological systems related to the skin organ or algae-derived materials as a potential source of skin care ingredients for combating oxidative stress. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 877, tag: div, level: 13" node_number="877"> (This article belongs to the Section Molecular and Translational Medicine) </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 878, tag: div, level: 10" node_number="878"> <div class="valid" valid="valid" title="valid: True, node: 879, tag: div, level: 11" node_number="879"> <div class="valid" valid="valid" title="valid: True, node: 880, tag: div, level: 12" node_number="880"> <div class="valid" valid="valid" title="valid: True, node: 881, tag: div, level: 13" node_number="881"> <a class="valid" valid="valid" title="valid: True, node: 882, tag: a, level: 14" node_number="882"> <i title="valid: False, node: 883, tag: i, level: 15" node_number="883">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 884, tag: div, level: 13" node_number="884"> <a class="valid" valid="valid" title="valid: True, node: 885, tag: a, level: 14" node_number="885"> <i title="valid: False, node: 886, tag: i, level: 15" node_number="886">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 887, tag: div, level: 14" node_number="887"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 888, tag: div, level: 13" node_number="888">Open AccessReview</div> PAD Inhibitors as a Potential Treatment for SARS-CoV-2 Immunothrombosis <div class="valid" valid="valid" title="valid: True, node: 889, tag: div, level: 13" node_number="889"> by <span class="valid" valid="valid" title="valid: True, node: 890, tag: span, level: 14" node_number="890"><div title="valid: False, node: 891, tag: div, level: 15" node_number="891">Willie Elliott, Jr.</div>, </span><span class="valid" valid="valid" title="valid: True, node: 892, tag: span, level: 14" node_number="892"><div title="valid: False, node: 893, tag: div, level: 15" node_number="893">Maheedhara R. Guda</div>, </span><span class="valid" valid="valid" title="valid: True, node: 894, tag: span, level: 14" node_number="894"><div title="valid: False, node: 895, tag: div, level: 15" node_number="895">Swapna Asuthkar</div>, </span><span class="valid" valid="valid" title="valid: True, node: 896, tag: span, level: 14" node_number="896"><div title="valid: False, node: 897, tag: div, level: 15" node_number="897">Narasaraju Teluguakula</div>, </span><span class="valid" valid="valid" title="valid: True, node: 898, tag: span, level: 14" node_number="898"><div title="valid: False, node: 899, tag: div, level: 15" node_number="899">Durbaka V. R. Prasad</div>, </span><span class="valid" valid="valid" title="valid: True, node: 900, tag: span, level: 14" node_number="900"><div title="valid: False, node: 901, tag: div, level: 15" node_number="901">Andrew J. Tsung</div> and </span><span class="valid" valid="valid" title="valid: True, node: 902, tag: span, level: 14" node_number="902"><div title="valid: False, node: 903, tag: div, level: 15" node_number="903">Kiran K. Velpula</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 904, tag: div, level: 13" node_number="904"> Biomedicines <b class="valid" valid="valid" title="valid: True, node: 905, tag: b, level: 14" node_number="905">2021</b>, 9(12), 1867; https://doi.org/10.3390/biomedicines9121867 - 09 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 906, tag: div, level: 13" node_number="906"> Abstract <div class="valid" valid="valid" title="valid: True, node: 907, tag: div, level: 14" node_number="907"> Since the discovery of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019, the virus&#8217;s dynamicity has resulted in the evolution of various variants, including the delta variant and the more novel mu variant. With a multitude of mutant strains posing as [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 908, tag: div, level: 14" node_number="908"> Since the discovery of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019, the virus&#8217;s dynamicity has resulted in the evolution of various variants, including the delta variant and the more novel mu variant. With a multitude of mutant strains posing as challenges to vaccine efficacy, it is critical that researchers embrace the development of pharmacotherapeutics specific to SARS-CoV-2 pathophysiology. Neutrophil extracellular traps and their constituents, including citrullinated histones, display a linear connection with thrombotic manifestations in COVID-19 patients. Peptidylarginine deiminases (PADs) are a group of enzymes involved in the modification of histone arginine residues by citrullination, allowing for the formation of NETs. PAD inhibitors, specifically PAD-4 inhibitors, offer extensive pharmacotherapeutic potential across a broad range of inflammatory diseases such as COVID-19, through mediating NETs formation. Although numerous PAD-4 inhibitors exist, current literature has not explored the depth of utilizing these inhibitors clinically to treat thrombotic complications in COVID-19 patients. This review article offers the clinical significance of PAD-4 inhibitors in reducing thrombotic complications across various inflammatory disorders like COVID-19 and suggests that these inhibitors may be valuable in treating the origin of SARS-CoV-2 immunothrombosis. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 909, tag: div, level: 13" node_number="909"> (This article belongs to the Section Microbiology in Human Health and Disease) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 910, tag: div, level: 13" node_number="910"><div class="valid" valid="valid" title="valid: True, node: 911, tag: div, level: 14" node_number="911"><div title="valid: False, node: 912, tag: div, level: 15" node_number="912"><p title="valid: False, node: 913, tag: p, level: 16" node_number="913">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 914, tag: div, level: 10" node_number="914"> <div class="valid" valid="valid" title="valid: True, node: 915, tag: div, level: 11" node_number="915"> <div class="valid" valid="valid" title="valid: True, node: 916, tag: div, level: 12" node_number="916"> <div class="valid" valid="valid" title="valid: True, node: 917, tag: div, level: 13" node_number="917"> <a class="valid" valid="valid" title="valid: True, node: 918, tag: a, level: 14" node_number="918"> <i title="valid: False, node: 919, tag: i, level: 15" node_number="919">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 920, tag: div, level: 13" node_number="920"> <a class="valid" valid="valid" title="valid: True, node: 921, tag: a, level: 14" node_number="921"> <i title="valid: False, node: 922, tag: i, level: 15" node_number="922">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 923, tag: div, level: 14" node_number="923"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 924, tag: div, level: 13" node_number="924">Open AccessReview</div> Metabolic Associated Fatty Liver Disease in Children&#8212;From Atomistic to Holistic <div class="valid" valid="valid" title="valid: True, node: 925, tag: div, level: 13" node_number="925"> by <span class="valid" valid="valid" title="valid: True, node: 926, tag: span, level: 14" node_number="926"><div title="valid: False, node: 927, tag: div, level: 15" node_number="927">Cristina Oana M&#259;rginean</div>, </span><span class="valid" valid="valid" title="valid: True, node: 928, tag: span, level: 14" node_number="928"><div title="valid: False, node: 929, tag: div, level: 15" node_number="929">Lorena Elena Meli&#539;</div> and </span><span class="valid" valid="valid" title="valid: True, node: 930, tag: span, level: 14" node_number="930"><div title="valid: False, node: 931, tag: div, level: 15" node_number="931">Maria Oana S&#259;s&#259;ran</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 932, tag: div, level: 13" node_number="932"> Biomedicines <b class="valid" valid="valid" title="valid: True, node: 933, tag: b, level: 14" node_number="933">2021</b>, 9(12), 1866; https://doi.org/10.3390/biomedicines9121866 - 09 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 934, tag: div, level: 13" node_number="934"> Abstract <div class="valid" valid="valid" title="valid: True, node: 935, tag: div, level: 14" node_number="935"> Non-alcoholic fatty liver disease has become the most common chronic liver disease in children due to the alarmingly increasing incidence of pediatric obesity. It is well-documented that MAFLD prevalence is directly related to an incremental increase in BMI. The multiple hits theory was [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 936, tag: div, level: 14" node_number="936"> Non-alcoholic fatty liver disease has become the most common chronic liver disease in children due to the alarmingly increasing incidence of pediatric obesity. It is well-documented that MAFLD prevalence is directly related to an incremental increase in BMI. The multiple hits theory was designed for providing insights regarding the pathogenesis of steatohepatitis and fibrosis in MAFLD. Recent evidence suggested that the microbiome is a crucial contributor in the pathogenesis of MAFLD. Aside from obesity, the most common risk factors for pediatric MAFLD include male gender, low-birth weight, family history of obesity, MAFLD, insulin resistance, type 2 diabetes mellitus, obstructive sleep apnea, and polycystic ovarium syndrome. Usually, pediatric patients with MAFLD have nonspecific symptoms consisting of fatigue, malaise, or diffuse abdominal pain. A wide spectrum of biomarkers was proposed for the diagnosis of MAFLD and NASH, as well as for quantifying the degree of fibrosis, but liver biopsy remains the key diagnostic and staging tool. Nevertheless, elastography-based methods present promising results in this age group as potential non-invasive replacers for liver biopsy. Despite the lack of current guidelines regarding MAFLD treatment in children, lifestyle intervention was proven to be crucial in the management of these patients. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 937, tag: div, level: 13" node_number="937"> (This article belongs to the Special Issue NAFLD: From Mechanisms to Therapeutic Approaches) </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 938, tag: div, level: 10" node_number="938"> <div class="valid" valid="valid" title="valid: True, node: 939, tag: div, level: 11" node_number="939"> <div class="valid" valid="valid" title="valid: True, node: 940, tag: div, level: 12" node_number="940"> <div class="valid" valid="valid" title="valid: True, node: 941, tag: div, level: 13" node_number="941"> <a class="valid" valid="valid" title="valid: True, node: 942, tag: a, level: 14" node_number="942"> <i title="valid: False, node: 943, tag: i, level: 15" node_number="943">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 944, tag: div, level: 14" node_number="944"> Supplementary material: Supplementary File 1 (ZIP, 262 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 945, tag: div, level: 13" node_number="945"> <a class="valid" valid="valid" title="valid: True, node: 946, tag: a, level: 14" node_number="946"> <i title="valid: False, node: 947, tag: i, level: 15" node_number="947">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 948, tag: div, level: 13" node_number="948"> <a class="valid" valid="valid" title="valid: True, node: 949, tag: a, level: 14" node_number="949"> <i title="valid: False, node: 950, tag: i, level: 15" node_number="950">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 951, tag: div, level: 14" node_number="951"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 952, tag: div, level: 13" node_number="952">Open AccessArticle</div> Pharmacological Inhibition of NOX4 Improves Mitochondrial Function and Survival in Human Beta-Cells <div class="valid" valid="valid" title="valid: True, node: 953, tag: div, level: 13" node_number="953"> by <span class="valid" valid="valid" title="valid: True, node: 954, tag: span, level: 14" node_number="954"><div title="valid: False, node: 955, tag: div, level: 15" node_number="955">Andris Elksnis</div>, </span><span class="valid" valid="valid" title="valid: True, node: 956, tag: span, level: 14" node_number="956"><div title="valid: False, node: 957, tag: div, level: 15" node_number="957">Jing Cen</div>, </span><span class="valid" valid="valid" title="valid: True, node: 958, tag: span, level: 14" node_number="958"><div title="valid: False, node: 959, tag: div, level: 15" node_number="959">Per Wikstr&#246;m</div>, </span><span class="valid" valid="valid" title="valid: True, node: 960, tag: span, level: 14" node_number="960"><div title="valid: False, node: 961, tag: div, level: 15" node_number="961">Per-Ola Carlsson</div> and </span><span class="valid" valid="valid" title="valid: True, node: 962, tag: span, level: 14" node_number="962"><div title="valid: False, node: 963, tag: div, level: 15" node_number="963">Nils Welsh</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 964, tag: div, level: 13" node_number="964"> Biomedicines <b class="valid" valid="valid" title="valid: True, node: 965, tag: b, level: 14" node_number="965">2021</b>, 9(12), 1865; https://doi.org/10.3390/biomedicines9121865 - 08 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 966, tag: div, level: 13" node_number="966"> Abstract <div class="valid" valid="valid" title="valid: True, node: 967, tag: div, level: 14" node_number="967"> Previous studies have reported beneficial effects of NADPH oxidase 4 (NOX4) inhibition on beta-cell survival in vitro and in vivo. The mechanisms by which NOX4 inhibition protects insulin producing cells are, however, not known. The aim of the present study was to investigate [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 968, tag: div, level: 14" node_number="968"> Previous studies have reported beneficial effects of NADPH oxidase 4 (NOX4) inhibition on beta-cell survival in vitro and in vivo. The mechanisms by which NOX4 inhibition protects insulin producing cells are, however, not known. The aim of the present study was to investigate the effects of a pharmacological NOX4 inhibitor (GLX7013114) on human islet and EndoC-&#946;H1 cell mitochondrial function, and to correlate such effects with survival in islets of different size, activity, and glucose-stimulated insulin release responsiveness. We found that maximal oxygen consumption rates, but not the rates of acidification and proton leak, were increased in islets after acute NOX4 inhibition. In EndoC-&#946;H1 cells, NOX4 inhibition increased the mitochondrial membrane potential, as estimated by JC-1 fluorescence; mitochondrial reactive oxygen species (ROS) production, as estimated by MitoSOX fluorescence; and the ATP/ADP ratio, as assessed by a bioluminescent assay. Moreover, the insulin release from EndoC-&#946;H1 cells at a high glucose concentration increased with NOX4 inhibition. These findings were paralleled by NOX4 inhibition-induced protection against human islet cell death when challenged with high glucose and sodium palmitate. The NOX4 inhibitor protected equally well islets of different size, activity, and glucose responsiveness. We conclude that pharmacological alleviation of NOX4-induced inhibition of beta-cell mitochondria leads to increased, and not decreased, mitochondrial ROS, and this was associated with protection against cell death occurring in different types of heterogeneous islets. Thus, NOX4 inhibition or modulation may be a therapeutic strategy in type 2 diabetes that targets all types of islets. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 969, tag: div, level: 13" node_number="969"> (This article belongs to the Special Issue Targeting Pancreatic Islets from a Therapeutic Perspective) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 970, tag: div, level: 13" node_number="970"><div class="valid" valid="valid" title="valid: True, node: 971, tag: div, level: 14" node_number="971"><div title="valid: False, node: 972, tag: div, level: 15" node_number="972"><p title="valid: False, node: 973, tag: p, level: 16" node_number="973">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 974, tag: div, level: 10" node_number="974"> <div class="valid" valid="valid" title="valid: True, node: 975, tag: div, level: 11" node_number="975"> <div class="valid" valid="valid" title="valid: True, node: 976, tag: div, level: 12" node_number="976"> <div class="valid" valid="valid" title="valid: True, node: 977, tag: div, level: 13" node_number="977"> <a class="valid" valid="valid" title="valid: True, node: 978, tag: a, level: 14" node_number="978"> <i title="valid: False, node: 979, tag: i, level: 15" node_number="979">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 980, tag: div, level: 14" node_number="980"> Supplementary material: Supplementary File 1 (ZIP, 631 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 981, tag: div, level: 13" node_number="981"> <a class="valid" valid="valid" title="valid: True, node: 982, tag: a, level: 14" node_number="982"> <i title="valid: False, node: 983, tag: i, level: 15" node_number="983">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 984, tag: div, level: 13" node_number="984"> <a class="valid" valid="valid" title="valid: True, node: 985, tag: a, level: 14" node_number="985"> <i title="valid: False, node: 986, tag: i, level: 15" node_number="986">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 987, tag: div, level: 14" node_number="987"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 988, tag: div, level: 13" node_number="988">Open AccessArticle</div> Anti-Inflammatory Mesenchymal Stromal Cell-Derived Extracellular Vesicles Improve Pathology in Niemann&#8211;Pick Type C Disease <div class="valid" valid="valid" title="valid: True, node: 989, tag: div, level: 13" node_number="989"> by <span class="valid" valid="valid" title="valid: True, node: 990, tag: span, level: 14" node_number="990"><div title="valid: False, node: 991, tag: div, level: 15" node_number="991">Lien Van Hoecke</div>, </span><span class="valid" valid="valid" title="valid: True, node: 992, tag: span, level: 14" node_number="992"><div title="valid: False, node: 993, tag: div, level: 15" node_number="993">Caroline Van Cauwenberghe</div>, </span><span class="valid" valid="valid" title="valid: True, node: 994, tag: span, level: 14" node_number="994"><div title="valid: False, node: 995, tag: div, level: 15" node_number="995">Verena B&#246;rger</div>, </span><span class="valid" valid="valid" title="valid: True, node: 996, tag: span, level: 14" node_number="996"><div title="valid: False, node: 997, tag: div, level: 15" node_number="997">Arnout Bruggeman</div>, </span><span class="valid" valid="valid" title="valid: True, node: 998, tag: span, level: 14" node_number="998"><div title="valid: False, node: 999, tag: div, level: 15" node_number="999">Jonas Castelein</div>, </span><span class="valid" valid="valid" title="valid: True, node: 1000, tag: span, level: 14" node_number="1000"><div title="valid: False, node: 1001, tag: div, level: 15" node_number="1001">Griet Van Imschoot</div>, </span><span class="valid" valid="valid" title="valid: True, node: 1002, tag: span, level: 14" node_number="1002"><div title="valid: False, node: 1003, tag: div, level: 15" node_number="1003">Elien Van Wonterghem</div>, </span><span class="valid" valid="valid" title="valid: True, node: 1004, tag: span, level: 14" node_number="1004"><div title="valid: False, node: 1005, tag: div, level: 15" node_number="1005">Robin Dittrich</div>, </span><span class="valid" valid="valid" title="valid: True, node: 1006, tag: span, level: 14" node_number="1006"><div title="valid: False, node: 1007, tag: div, level: 15" node_number="1007">Wouter Claeys</div>, </span><span class="valid" valid="valid" title="valid: True, node: 1008, tag: span, level: 14" node_number="1008"><div title="valid: False, node: 1009, tag: div, level: 15" node_number="1009">Junhua Xie</div>, </span><span class="valid" valid="valid" title="valid: True, node: 1010, tag: span, level: 14" node_number="1010"><div title="valid: False, node: 1011, tag: div, level: 15" node_number="1011">Bernd Giebel</div> and </span><span class="valid" valid="valid" title="valid: True, node: 1012, tag: span, level: 14" node_number="1012"><div title="valid: False, node: 1013, tag: div, level: 15" node_number="1013">Roosmarijn E. Vandenbroucke</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 1014, tag: div, level: 13" node_number="1014"> Biomedicines <b class="valid" valid="valid" title="valid: True, node: 1015, tag: b, level: 14" node_number="1015">2021</b>, 9(12), 1864; https://doi.org/10.3390/biomedicines9121864 - 08 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 1016, tag: div, level: 13" node_number="1016"> Abstract <div class="valid" valid="valid" title="valid: True, node: 1017, tag: div, level: 14" node_number="1017"> Niemann&#8211;Pick type C (NPC) disease is a rare neurovisceral lipid storage disease with progressive neurodegeneration, leading to premature death. The disease is caused by loss-of-function mutations either in the <i title="valid: False, node: 1018, tag: i, level: 15" node_number="1018">NPC1</i> or <i title="valid: False, node: 1019, tag: i, level: 15" node_number="1019">NPC2</i> gene which results in lipid accumulation in the late endosomes and [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 1020, tag: div, level: 14" node_number="1020"> Niemann&#8211;Pick type C (NPC) disease is a rare neurovisceral lipid storage disease with progressive neurodegeneration, leading to premature death. The disease is caused by loss-of-function mutations either in the <i title="valid: False, node: 1021, tag: i, level: 15" node_number="1021">NPC1</i> or <i title="valid: False, node: 1022, tag: i, level: 15" node_number="1022">NPC2</i> gene which results in lipid accumulation in the late endosomes and lysosomes. The involved disease mechanisms are still incompletely understood, making the design of a rational treatment very difficult. Since the disease is characterized by peripheral inflammation and neuroinflammation and it is shown that extracellular vesicles (EVs) obtained from mesenchymal stromal cells (MSCs) provide immunomodulatory capacities, we tested the potential of MSC-EV preparations to alter NPC1 disease pathology. Here, we show that the administration of an MSC-EV preparation with in vitro and in vivo confirmed immune modulatory capabilities is able to reduce the inflammatory state of peripheral organs and different brain regions of NPC1-diseased mice almost to normal levels. Moreover, a reduction of foamy cells in different peripheral organs was observed upon MSC-EV treatment of NPC1<sup title="valid: False, node: 1023, tag: sup, level: 15" node_number="1023">&#8722;/&#8722;</sup> mice. Lastly, the treatment was able to decrease microgliosis and astrogliosis, typical features of NPC1 patients that lead to neurodegeneration. Altogether, our results reveal the therapeutic potential of MSC-EVs as treatment for the genetic neurovisceral lipid storage disease NPC, thereby counteracting both central and peripheral features. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1024, tag: div, level: 13" node_number="1024"> (This article belongs to the Special Issue Extracellular Vesicles in Neurological Disorders: Translational Research) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 1025, tag: div, level: 13" node_number="1025"><div class="valid" valid="valid" title="valid: True, node: 1026, tag: div, level: 14" node_number="1026"><div title="valid: False, node: 1027, tag: div, level: 15" node_number="1027"><p title="valid: False, node: 1028, tag: p, level: 16" node_number="1028">Figure 1</p></div></div></div> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1029, tag: div, level: 9" node_number="1029"> More Articles... </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1030, tag: div, level: 6" node_number="1030"> <div class="valid" valid="valid" title="valid: True, node: 1031, tag: div, level: 7" node_number="1031"> <div class="valid" valid="valid" title="valid: True, node: 1032, tag: div, level: 8" node_number="1032"> <div class="valid" valid="valid" title="valid: True, node: 1033, tag: div, level: 9" node_number="1033"> <a class="valid" valid="valid" title="valid: True, node: 1034, tag: a, level: 10" node_number="1034"> Submit to <i class="valid" valid="valid" title="valid: True, node: 1035, tag: i, level: 11" node_number="1035">Biomedicines</i> </a> Review for Biomedicines <div class="valid" valid="valid" title="valid: True, node: 1036, tag: div, level: 10" node_number="1036"> Share </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1037, tag: div, level: 9" node_number="1037"> <h2 class="valid" valid="valid" title="valid: True, node: 1038, tag: h2, level: 10" node_number="1038">Journal Menu</h2> &#9658; &#9660; Journal Menu <ul class="valid" valid="valid" title="valid: True, node: 1039, tag: ul, level: 10" node_number="1039"> <li class="valid" valid="valid" title="valid: True, node: 1040, tag: li, level: 11" node_number="1040"> <ul class="valid" valid="valid" title="valid: True, node: 1041, tag: ul, level: 12" node_number="1041"> <li class="valid" valid="valid" title="valid: True, node: 1042, tag: li, level: 13" node_number="1042"> Biomedicines Home </li> <li class="valid" valid="valid" title="valid: True, node: 1043, tag: li, level: 13" node_number="1043"> Aims Scope </li> <li class="valid" valid="valid" title="valid: True, node: 1044, tag: li, level: 13" node_number="1044"> Editorial Board </li> <li class="valid" valid="valid" title="valid: True, node: 1045, tag: li, level: 13" node_number="1045"> Reviewer Board </li> <li class="valid" valid="valid" title="valid: True, node: 1046, tag: li, level: 13" node_number="1046"> Topical Advisory Panel </li> <li class="valid" valid="valid" title="valid: True, node: 1047, tag: li, level: 13" node_number="1047"> Instructions for Authors </li> <li class="valid" valid="valid" title="valid: True, node: 1048, tag: li, level: 13" node_number="1048"> Special Issues </li> <li class="valid" valid="valid" title="valid: True, node: 1049, tag: li, level: 13" node_number="1049"> Sections Collections </li> <li class="valid" valid="valid" title="valid: True, node: 1050, tag: li, level: 13" node_number="1050"> Article Processing Charge </li> <li class="valid" valid="valid" title="valid: True, node: 1051, tag: li, level: 13" node_number="1051"> Indexing Archiving </li> <li class="valid" valid="valid" title="valid: True, node: 1052, tag: li, level: 13" node_number="1052"> Most Cited Viewed </li> <li class="valid" valid="valid" title="valid: True, node: 1053, tag: li, level: 13" node_number="1053"> Journal Statistics </li> <li class="valid" valid="valid" title="valid: True, node: 1054, tag: li, level: 13" node_number="1054"> Journal History </li> <li class="valid" valid="valid" title="valid: True, node: 1055, tag: li, level: 13" node_number="1055"> Journal Awards </li> <li class="valid" valid="valid" title="valid: True, node: 1056, tag: li, level: 13" node_number="1056"> Society Collaborations </li> <li class="valid" valid="valid" title="valid: True, node: 1057, tag: li, level: 13" node_number="1057"> Conferences </li> <li class="valid" valid="valid" title="valid: True, node: 1058, tag: li, level: 13" node_number="1058"> Editorial Office </li> </ul> </li> </ul> </div> <h2 class="valid" valid="valid" title="valid: True, node: 1059, tag: h2, level: 9" node_number="1059">Journal Browser</h2> &#9658; &#9660; Journal Browser <div class="valid" valid="valid" title="valid: True, node: 1060, tag: div, level: 9" node_number="1060"> <div class="valid" valid="valid" title="valid: True, node: 1061, tag: div, level: 10" node_number="1061"> <ul class="valid" valid="valid" title="valid: True, node: 1062, tag: ul, level: 11" node_number="1062"> <li class="valid" valid="valid" title="valid: True, node: 1063, tag: li, level: 12" node_number="1063"> <a class="valid" valid="valid" title="valid: True, node: 1064, tag: a, level: 13" node_number="1064"> <i class="valid" valid="valid" title="valid: True, node: 1065, tag: i, level: 14" node_number="1065"> arrow_forward_ios </i> Forthcoming issue </a> <a class="valid" valid="valid" title="valid: True, node: 1066, tag: a, level: 13" node_number="1066"> <i class="valid" valid="valid" title="valid: True, node: 1067, tag: i, level: 14" node_number="1067"> arrow_forward_ios </i> Current issue </a> </li> <div class="valid" valid="valid" title="valid: True, node: 1068, tag: div, level: 12" node_number="1068"> <div class="valid" valid="valid" title="valid: True, node: 1069, tag: div, level: 13" node_number="1069"> <div class="valid" valid="valid" title="valid: True, node: 1070, tag: div, level: 14" node_number="1070"> <li title="valid: False, node: 1071, tag: li, level: 15" node_number="1071"> Vol.&#160;9&#160;(2021) </li> <li title="valid: False, node: 1072, tag: li, level: 15" node_number="1072"> Vol.&#160;8&#160;(2020) </li> <li title="valid: False, node: 1073, tag: li, level: 15" node_number="1073"> Vol.&#160;7&#160;(2019) </li> <li title="valid: False, node: 1074, tag: li, level: 15" node_number="1074"> Vol.&#160;6&#160;(2018) </li> <li title="valid: False, node: 1075, tag: li, level: 15" node_number="1075"> Vol.&#160;5&#160;(2017) </li> <li title="valid: False, node: 1076, tag: li, level: 15" node_number="1076"> Vol.&#160;4&#160;(2016) </li> <li title="valid: False, node: 1077, tag: li, level: 15" node_number="1077"> Vol.&#160;3&#160;(2015) </li> <li title="valid: False, node: 1078, tag: li, level: 15" node_number="1078"> Vol.&#160;2&#160;(2014) </li> <li title="valid: False, node: 1079, tag: li, level: 15" node_number="1079"> Vol.&#160;1&#160;(2013) </li> </div> </div> </div> </ul> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1080, tag: div, level: 7" node_number="1080"> <div class="valid" valid="valid" title="valid: True, node: 1081, tag: div, level: 8" node_number="1081"> <h2 class="valid" valid="valid" title="valid: True, node: 1082, tag: h2, level: 9" node_number="1082">Highly Accessed Articles</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1083, tag: div, level: 8" node_number="1083"> <div class="valid" valid="valid" title="valid: True, node: 1084, tag: div, level: 9" node_number="1084"> View More... </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1085, tag: div, level: 7" node_number="1085"> <div class="valid" valid="valid" title="valid: True, node: 1086, tag: div, level: 8" node_number="1086"> <h2 class="valid" valid="valid" title="valid: True, node: 1087, tag: h2, level: 9" node_number="1087">Latest Books</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1088, tag: div, level: 8" node_number="1088"> <div class="valid" valid="valid" title="valid: True, node: 1089, tag: div, level: 9" node_number="1089"> More Open Access Books... </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1090, tag: div, level: 6" node_number="1090"> <div class="valid" valid="valid" title="valid: True, node: 1091, tag: div, level: 7" node_number="1091"> <div class="valid" valid="valid" title="valid: True, node: 1092, tag: div, level: 8" node_number="1092"> <h2 class="valid" valid="valid" title="valid: True, node: 1093, tag: h2, level: 9" node_number="1093">E-Mail Alert</h2> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1094, tag: div, level: 7" node_number="1094"> <div class="valid" valid="valid" title="valid: True, node: 1095, tag: div, level: 8" node_number="1095"> <h2 class="valid" valid="valid" title="valid: True, node: 1096, tag: h2, level: 9" node_number="1096">News</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1097, tag: div, level: 8" node_number="1097"> <div class="valid" valid="valid" title="valid: True, node: 1098, tag: div, level: 9" node_number="1098"> 9 December 2021 Biomedicines | 10th Anniversary </div> <div class="valid" valid="valid" title="valid: True, node: 1099, tag: div, level: 9" node_number="1099"> 22 November 2021 720 MDPI Editorial Board Members Receiving "2021 Highly Cited Researchers" Distinction </div> <div class="valid" valid="valid" title="valid: True, node: 1100, tag: div, level: 9" node_number="1100"> 16 November 2021 Topical Advisory Panel Established to Support Editorial Board </div> <div class="valid" valid="valid" title="valid: True, node: 1101, tag: div, level: 9" node_number="1101"> More News Announcements... </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1102, tag: div, level: 7" node_number="1102"> <div class="valid" valid="valid" title="valid: True, node: 1103, tag: div, level: 8" node_number="1103"> <h2 class="valid" valid="valid" title="valid: True, node: 1104, tag: h2, level: 9" node_number="1104">Topics</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1105, tag: div, level: 8" node_number="1105"> <div class="valid" valid="valid" title="valid: True, node: 1106, tag: div, level: 9" node_number="1106"><div class="valid" valid="valid" title="valid: True, node: 1107, tag: div, level: 10" node_number="1107"> Topic in Life, Biomedicines</div> Microangiopathy in Rheumatic Diseases Editor-in-Chief: Sevdalina LambovaDeadline: 15 December 2021</div> <div class="valid" valid="valid" title="valid: True, node: 1108, tag: div, level: 9" node_number="1108"><div class="valid" valid="valid" title="valid: True, node: 1109, tag: div, level: 10" node_number="1109"> Topic in Biomedicines, BioMed, Reports</div> Photodynamic Therapy Editor-in-Chief: Stefano BacciDeadline: 31 December 2021</div> <div class="valid" valid="valid" title="valid: True, node: 1110, tag: div, level: 9" node_number="1110"><div class="valid" valid="valid" title="valid: True, node: 1111, tag: div, level: 10" node_number="1111"> Topic in IJMS, Biomedicines, Antioxidants, CIMB, JCM</div> Sterile Inflammation in Solid Organ Transplantation Editors-in-Chief: Jerzy W. Kupiec-Weglinski, Joan Rosell&#243;-Catafau, Ren&#233; Adam, Teresa Carbonell Cam&#243;s, Arnau Panisello-Rosell&#243;Deadline: 10 February 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1112, tag: div, level: 9" node_number="1112"><div class="valid" valid="valid" title="valid: True, node: 1113, tag: div, level: 10" node_number="1113"> Topic in IJMS, Biomedicines, Life, BioMed, Reprod. Med.</div> Pathogenesis of Pregnancy-Related Complications Editors-in-Chief: Ilona Hromadnikova, Katerina KotlabovaDeadline: 28 February 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1114, tag: div, level: 9" node_number="1114"> More Topics </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1115, tag: div, level: 7" node_number="1115"> <div class="valid" valid="valid" title="valid: True, node: 1116, tag: div, level: 8" node_number="1116"> <h2 class="valid" valid="valid" title="valid: True, node: 1117, tag: h2, level: 9" node_number="1117">Conferences</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1118, tag: div, level: 8" node_number="1118"> <div class="valid" valid="valid" title="valid: True, node: 1119, tag: div, level: 9" node_number="1119"> Announce Your Conference </div> <div class="valid" valid="valid" title="valid: True, node: 1120, tag: div, level: 9" node_number="1120"> 5&#8211;8 April 2022 Viruses 2022 - At the Leading Edge of Virology Research</div> <div class="valid" valid="valid" title="valid: True, node: 1121, tag: div, level: 9" node_number="1121"> More Conferences... </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1122, tag: div, level: 7" node_number="1122"> <div class="valid" valid="valid" title="valid: True, node: 1123, tag: div, level: 8" node_number="1123"> <h2 class="valid" valid="valid" title="valid: True, node: 1124, tag: h2, level: 9" node_number="1124">Special Issues</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1125, tag: div, level: 8" node_number="1125"> <div class="valid" valid="valid" title="valid: True, node: 1126, tag: div, level: 9" node_number="1126"> Edit a Special Issue </div> <div class="valid" valid="valid" title="valid: True, node: 1127, tag: div, level: 9" node_number="1127"><div class="valid" valid="valid" title="valid: True, node: 1128, tag: div, level: 10" node_number="1128"> Special Issue in Biomedicines</div> Hydrogels for Biomedical Application Guest Editors: Elvira De Giglio, Maria A. BonifacioDeadline: 15 December 2021</div> <div class="valid" valid="valid" title="valid: True, node: 1129, tag: div, level: 9" node_number="1129"><div class="valid" valid="valid" title="valid: True, node: 1130, tag: div, level: 10" node_number="1130"> Special Issue in Biomedicines</div> Peptide-Based Drug Development Guest Editors: William Lubell, Jackie Wilce, Johan RosengrenDeadline: 31 December 2021</div> <div class="valid" valid="valid" title="valid: True, node: 1131, tag: div, level: 9" node_number="1131"><div class="valid" valid="valid" title="valid: True, node: 1132, tag: div, level: 10" node_number="1132"> Special Issue in Biomedicines</div> Endothelial Dysfunction: From a Pathophysiological Mechanism to a Potential Therapeutic Target Guest Editor: Pasquale AmbrosinoDeadline: 15 January 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1133, tag: div, level: 9" node_number="1133"><div class="valid" valid="valid" title="valid: True, node: 1134, tag: div, level: 10" node_number="1134"> Special Issue in Biomedicines</div> New Insights in Radiotherapy Guest Editor: Carlos Martinez-CampaDeadline: 25 January 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1135, tag: div, level: 9" node_number="1135"> More Special Issues </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1136, tag: div, level: 7" node_number="1136"> <div class="valid" valid="valid" title="valid: True, node: 1137, tag: div, level: 8" node_number="1137"> <h2 class="valid" valid="valid" title="valid: True, node: 1138, tag: h2, level: 9" node_number="1138">Topical Collections</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1139, tag: div, level: 8" node_number="1139"> <div class="valid" valid="valid" title="valid: True, node: 1140, tag: div, level: 9" node_number="1140"><div class="valid" valid="valid" title="valid: True, node: 1141, tag: div, level: 10" node_number="1141"> Topical Collection in Biomedicines</div> Stem Cells and Cancer Therapeutics Collection Editors: Lluis Espinosa, Teresa Lobo-Jarne</div> <div class="valid" valid="valid" title="valid: True, node: 1142, tag: div, level: 9" node_number="1142"><div class="valid" valid="valid" title="valid: True, node: 1143, tag: div, level: 10" node_number="1143"> Topical Collection in Biomedicines</div> Targeting Cell Metabolism as Cancer Therapy Collection Editor: Veronique Baud</div> <div class="valid" valid="valid" title="valid: True, node: 1144, tag: div, level: 9" node_number="1144"><div class="valid" valid="valid" title="valid: True, node: 1145, tag: div, level: 10" node_number="1145"> Topical Collection in Biomedicines</div> Neurotoxicity: Mechanisms and Potential Therapeutic Strategies Collection Editor: David R. Wallace</div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1146, tag: div, level: 7" node_number="1146"> <div class="valid" valid="valid" title="valid: True, node: 1147, tag: div, level: 8" node_number="1147"> <h2 class="valid" valid="valid" title="valid: True, node: 1148, tag: h2, level: 9" node_number="1148">Jobs in Research</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1149, tag: div, level: 8" node_number="1149"> <div class="valid" valid="valid" title="valid: True, node: 1150, tag: div, level: 9" node_number="1150"> Post New Job Opening </div> </div> </div> </div> </div> </div> </section> <div class="valid" valid="valid" title="valid: True, node: 1151, tag: div, level: 3" node_number="1151"> <div class="valid" valid="valid" title="valid: True, node: 1152, tag: div, level: 4" node_number="1152"> Biomedicines, EISSN 2227-9059, Published by MDPI <span class="valid" valid="valid" title="valid: True, node: 1153, tag: span, level: 5" node_number="1153"> Disclaimer <div class="valid" valid="valid" title="valid: True, node: 1154, tag: div, level: 6" node_number="1154"> The statements, opinions and data contained in the journal Biomedicines are solely those of the individual authors and contributors and not of the publisher and the editor(s). MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. </div> </span> <div class="valid" valid="valid" title="valid: True, node: 1155, tag: div, level: 5" node_number="1155"> RSS Content Alert </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1156, tag: div, level: 4" node_number="1156"> <div class="valid" valid="valid" title="valid: True, node: 1157, tag: div, level: 5" node_number="1157"> <h3 class="valid" valid="valid" title="valid: True, node: 1158, tag: h3, level: 6" node_number="1158"> Further Information </h3> Article Processing Charges Pay an Invoice <a class="valid" valid="valid" title="valid: True, node: 1159, tag: a, level: 6" node_number="1159"> Open Access Policy </a> <a class="valid" valid="valid" title="valid: True, node: 1160, tag: a, level: 6" node_number="1160"> Contact MDPI </a> <a class="valid" valid="valid" title="valid: True, node: 1161, tag: a, level: 6" node_number="1161"> Jobs at MDPI </a> </div> <div class="valid" valid="valid" title="valid: True, node: 1162, tag: div, level: 5" node_number="1162"> <h3 class="valid" valid="valid" title="valid: True, node: 1163, tag: h3, level: 6" node_number="1163"> Guidelines </h3> <a class="valid" valid="valid" title="valid: True, node: 1164, tag: a, level: 6" node_number="1164"> For Authors </a> <a class="valid" valid="valid" title="valid: True, node: 1165, tag: a, level: 6" node_number="1165"> For Reviewers </a> <a class="valid" valid="valid" title="valid: True, node: 1166, tag: a, level: 6" node_number="1166"> For Editors </a> <a class="valid" valid="valid" title="valid: True, node: 1167, tag: a, level: 6" node_number="1167"> For Librarians </a> <a class="valid" valid="valid" title="valid: True, node: 1168, tag: a, level: 6" node_number="1168"> For Publishers </a> <a class="valid" valid="valid" title="valid: True, node: 1169, tag: a, level: 6" node_number="1169"> For Societies </a> </div> <div class="valid" valid="valid" title="valid: True, node: 1170, tag: div, level: 5" node_number="1170"> <h3 class="valid" valid="valid" title="valid: True, node: 1171, tag: h3, level: 6" node_number="1171"> MDPI Initiatives </h3> <a class="valid" valid="valid" title="valid: True, node: 1172, tag: a, level: 6" node_number="1172"> Sciforum </a> <a class="valid" valid="valid" title="valid: True, node: 1173, tag: a, level: 6" node_number="1173"> MDPI Books </a> <a class="valid" valid="valid" title="valid: True, node: 1174, tag: a, level: 6" node_number="1174"> Preprints </a> <a class="valid" valid="valid" title="valid: True, node: 1175, tag: a, level: 6" node_number="1175"> Scilit </a> <a class="valid" valid="valid" title="valid: True, node: 1176, tag: a, level: 6" node_number="1176"> SciProfiles </a> <a class="valid" valid="valid" title="valid: True, node: 1177, tag: a, level: 6" node_number="1177"> Encyclopedia </a> <a class="valid" valid="valid" title="valid: True, node: 1178, tag: a, level: 6" node_number="1178"> JAMS </a> <a class="valid" valid="valid" title="valid: True, node: 1179, tag: a, level: 6" node_number="1179"> Proceedings Series </a> </div> <div class="valid" valid="valid" title="valid: True, node: 1180, tag: div, level: 5" node_number="1180"> <h3 class="valid" valid="valid" title="valid: True, node: 1181, tag: h3, level: 6" node_number="1181"> Follow MDPI </h3> <a class="valid" valid="valid" title="valid: True, node: 1182, tag: a, level: 6" node_number="1182"> LinkedIn </a> <a class="valid" valid="valid" title="valid: True, node: 1183, tag: a, level: 6" node_number="1183"> Facebook </a> <a class="valid" valid="valid" title="valid: True, node: 1184, tag: a, level: 6" node_number="1184"> Twitter </a> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1185, tag: div, level: 4" node_number="1185"> <div class="valid" valid="valid" title="valid: True, node: 1186, tag: div, level: 5" node_number="1186"> <div class="valid" valid="valid" title="valid: True, node: 1187, tag: div, level: 6" node_number="1187"> &#169; 1996-2021 MDPI (Basel, Switzerland) unless otherwise stated </div> <div class="valid" valid="valid" title="valid: True, node: 1188, tag: div, level: 6" node_number="1188"> <a class="valid" valid="valid" title="valid: True, node: 1189, tag: a, level: 7" node_number="1189"> Disclaimer </a> <div class="valid" valid="valid" title="valid: True, node: 1190, tag: div, level: 7" node_number="1190"> The statements, opinions and data contained in the journals are solely those of the individual authors and contributors and not of the publisher and the editor(s). MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. </div> <a class="valid" valid="valid" title="valid: True, node: 1191, tag: a, level: 7" node_number="1191"> Terms and Conditions </a> <a class="valid" valid="valid" title="valid: True, node: 1192, tag: a, level: 7" node_number="1192"> Privacy Policy </a> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1193, tag: div, level: 3" node_number="1193"> <div class="valid" valid="valid" title="valid: True, node: 1194, tag: div, level: 4" node_number="1194"> We use cookies on our website to ensure you get the best experience. Read more about our cookies <a class="valid" valid="valid" title="valid: True, node: 1195, tag: a, level: 5" node_number="1195">here</a>. </div> <div class="valid" valid="valid" title="valid: True, node: 1196, tag: div, level: 4" node_number="1196"> <a class="valid" valid="valid" title="valid: True, node: 1197, tag: a, level: 5" node_number="1197">Accept</a> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1198, tag: div, level: 3" node_number="1198"> <div class="valid" valid="valid" title="valid: True, node: 1199, tag: div, level: 4" node_number="1199"> We have just recently launched a new version of our website. Help us to further improve by taking part in this short 5 minute survey here. here. </div> <div class="valid" valid="valid" title="valid: True, node: 1200, tag: div, level: 4" node_number="1200"> <a class="valid" valid="valid" title="valid: True, node: 1201, tag: a, level: 5" node_number="1201">Never show this again</a> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1202, tag: div, level: 2" node_number="1202"> <div class="valid" valid="valid" title="valid: True, node: 1203, tag: div, level: 3" node_number="1203"> <div class="valid" valid="valid" title="valid: True, node: 1204, tag: div, level: 4" node_number="1204"> <h2 class="valid" valid="valid" title="valid: True, node: 1205, tag: h2, level: 5" node_number="1205">Share Link</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1206, tag: div, level: 4" node_number="1206"> <a class="valid" valid="valid" title="valid: True, node: 1207, tag: a, level: 5" node_number="1207">Copy</a> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 1208, tag: a, level: 3" node_number="1208"> <i class="valid" valid="valid" title="valid: True, node: 1209, tag: i, level: 4" node_number="1209">clear</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 1210, tag: div, level: 2" node_number="1210"> <div class="valid" valid="valid" title="valid: True, node: 1211, tag: div, level: 3" node_number="1211"> <div class="valid" valid="valid" title="valid: True, node: 1212, tag: div, level: 4" node_number="1212"> <h2 class="valid" valid="valid" title="valid: True, node: 1213, tag: h2, level: 5" node_number="1213">Share</h2> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 1214, tag: a, level: 3" node_number="1214"> <i class="valid" valid="valid" title="valid: True, node: 1215, tag: i, level: 4" node_number="1215">clear</i> </a> </div> <a class="valid" valid="valid" title="valid: True, node: 1216, tag: a, level: 2" node_number="1216">Back to TopTop</a> </body>
        <style tyle='text/css'>
body{
    position: relative;
    padding-left: 30px;
    top: 60px;
}
* {
    border: 1px solid #eee;
    padding: 5px 12px;
    margin: 3px 0;
    box-sizing: content-box;
    background-color: #fff;
    cursor: no-drop;
}
main:hover > *, section:hover > *, header:hover > *, nav:hover > *, a:hover > *, div:hover > *, p:hover > *, ul:hover > *, h1:hover > *, h2:hover > *, h3:hover > *, li:hover > *, span:hover > *{
    border: 2px solid green;
    background-color: #fffeee;
    padding: 5px 23px !important;
    margin: 1px 0;
    color: green;
}
main:hover, section:hover, header:hover, nav:hover, a:hover, div:hover, p:hover, ul:hover, h1:hover, h2:hover, h3:hover, li:hover, span:hover{
    border: 1px solid #fff;
    background-color: #eee;
}
a, span {
    display: block;
}
.selected {
    border: 2px solid orchid !important;
    opacity: 0.8;
    color: orchid !important;
}
.selected * {
    padding: 2px !important;
    color: orchid !important;
}
.valid {
  cursor: pointer;
}
.btn{
  cursor: pointer;
  font-weight: bolder;
  padding: 8px;
}
</style> 
        <script>function OpenOriginalLink($event){
    $event.stopPropagation();
    console.log(url);
}

function removeItem($event){
    $event.stopPropagation();
    console.log('Remove item: ', url)
    localStorage.removeItem(url)
}

function exportData($event){
    $event.stopPropagation();

    result = []
    for(let i=0; i<localStorage.length; i++) {
        let key = localStorage.key(i);
        result.push(localStorage.getItem(key))
    }
    const _url = URL.createObjectURL(new Blob([result.join("\n")], {type: 'text/plain'}))
    $event.target.href = _url;
    localStorage.clear()
}

var removeItemBtn = document.createElement("BUTTON");   // Create a <button> element
removeItemBtn.innerHTML = "Remove Item";
removeItemBtn.classList.add('btn');
removeItemBtn.style.position = "fixed";
removeItemBtn.style.left = '5px';
removeItemBtn.style.top = 0;
removeItemBtn.style.border = "1px solid";
removeItemBtn.style.boxShadow = "3px 3px #888";
removeItemBtn.onclick = removeItem;
document.body.appendChild(removeItemBtn);

var goToOriginLink = document.createElement("A");   // Create a <button> element
goToOriginLink.innerHTML = "GoToOrigin";
goToOriginLink.classList.add('btn');
goToOriginLink.style.position = "fixed"
goToOriginLink.style.left = '115px'
goToOriginLink.style.top = 0;
goToOriginLink.onclick = OpenOriginalLink;
goToOriginLink.setAttribute('href', decodeURIComponent(url));
goToOriginLink.target = '_blank';
document.body.appendChild(goToOriginLink);

var current = new Date
var exportDataLink = document.createElement("A");   // Create a <button> element
exportDataLink.innerHTML = "Export data";
exportDataLink.classList.add('btn');
exportDataLink.download = current.toISOString() + '.exported.txt';
exportDataLink.style.position = "fixed";
exportDataLink.style.right = '5px';
exportDataLink.style.top = 0;
exportDataLink.style.border = "1px solid #888";
exportDataLink.style.boxShadow = "3px 3px #888";
exportDataLink.onclick = exportData;
document.body.appendChild(exportDataLink);

data = {
    'title': null ,
    'article': null
}

var body = document.getElementsByTagName("body")[0];

body.onclick = function($e){
    var num = $e.target.getAttribute('node_number')
    var valid = $e.target.getAttribute('valid')

    if(!valid){
        console.log("Element is invalid")
        return
    }

    if(data.length > 2){
        data = data.splice(0, 2)
    }

    console.log("node:", $e.target)

    if(!data.title && !data.article){
        data.title = num;
        console.log("data:", data)
        $e.target.classList.add('selected')
    }else if (data.title && !data.article){
        data.article = num;
        console.log("data:", data)
        $e.target.classList.add('selected')
    }else{
        selected = Array.from(document.getElementsByClassName("selected"))
        selected.forEach(function(el){
            el.classList.remove('selected')
        })

        data.title = num;
        data.article = null;
        $e.target.classList.add('selected')

    }

    if(data.title && data.article){
        var obj = {
            url: url,
            text: body_html,
            title: data.title,
            article: data.article,
        }

        var datasetItem = JSON.stringify(obj)
        localStorage.setItem(url, datasetItem)
    }
}
</script> 
      </html>